Archives

Exploring Implicit Bias and Its Impact in Pharmacy

Learning Objectives

 

After completing this application-based continuing education activity, pharmacists will be able to

·       DEFINE different types of bias and how they are formed
·       RECOGNIZE what bias may look like in the pharmacy setting
·       IDENTIFY how bias can impact patient care
·       APPLY methods to address and mitigate bias in the workplace

 

After completing this application-based continuing education activity, pharmacy technicians will be able to:

·       DEFINE different types of bias and how they are formed
·       RECOGNIZE what bias may look like in the pharmacy setting
·       IDENTIFY how bias can impact patient care
·       ILLUSTRATE methods to address and mitigate bias in the workplace

 

 

     

    Release Date: March 20, 2024

    Expiration Date: March 20, 2027

    Course Fee

    FREE

    There is no funding for this CE.

    ACPE UANs

    Pharmacist: 0009-0000-24-017-H04-P

    Pharmacy Technician:  0009-0000-24-015-H04-T

    Session Codes

    Pharmacist:  24YC17-TKF38

    Pharmacy Technician:  24YC17-FTK43

    Accreditation Hours

    2.0 hours of CE

    Accreditation Statements

    The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-24-017-H04-P/T will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

     

    Disclosure of Discussions of Off-label and Investigational Drug Use

    The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

    Faculty

    Jessica Bylyku
    PharmD Candidate 2024
    UConn School of Pharmacy
    Storrs, CT

     

    Jeannette Y. Wick RPh, MBA, FCCP
    Director Office Pharmacy Professional Development
    UConn School of Pharmacy
    Storrs, CT

    Faculty Disclosure

    In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

    Neither Ms. Wick nor Ms. Bylyku have any relationships with ineligible companies.

     

    ABSTRACT

    Implicit bias is an important buzzword in healthcare. It has received much attention in the past few years because many researchers have documented its pervasive existence among healthcare providers. Implicit bias involves consciously or unconsciously thinking of some patient groups (or some coworkers) as less important than others, less deserving of care, or simply “less than.” Related concepts include second victim phenomena and imposter syndrome. Good research documents that many people from disenfranchised groups experience implicit or explicit bias when they visit pharmacies. Educational institutions have started to develop programs to educate pharmacists about potential implicit bias before they graduate. Yet most pharmacy personnel who work in clinical contexts have not had such education and need to understand the basic concepts of implicit bias. Pharmacy staff who take time to examine their own attitudes can improve care in influential ways and become significantly more enlightened. This continuing education activity provides basic education on implicit bias and refers readers to evaluation tools.

    CONTENT

    Content

    INTRODUCTION

    Can you solve this riddle?

    A father and son are involved in a car crash. The son is rushed to the hospital. As the son is about to enter surgery the surgeon says, “I can’t operate—that boy is my son!”

    People answer this question in a variety of ways, revealing different implicit biases. Some answers include 1) the boy has two fathers or 2) the father was actually a priest or 3) the whole thing was a dream. Researchers asked this question to two focus groups, one consisting of 197 college students from Boston University and the other, 103 children from Brookline Summer camps.1 Only 14% of college students and 15% of children answered correctly with the “mom’s the surgeon."1 A majority of people didn’t guess that the surgeon was the boy’s mother until a few tries, revealing the implicit bias that females are not meant to be doctors or surgeons. 

    TYPES OF BIAS 

    Implicit biases are unconscious mental processes that create unintentional automatic associations and reactions.2 Implicit bias is more than a stereotype, which is a fixed set of characteristics associated with a particular social group. Implicit bias occurs when people harbor biases unconsciously. A person can develop negative feelings or attitudes towards another person by failing to connect to another person’s identities. The other person may then become part of an “out-group.”2 This is not to say that those with shared identities hold no bias towards each other; some women think that women cannot be surgeons, for example. It’s important to look at other factors that cause implicit bias. Besides obvious differences in identities, social norms can influence biases and media outlets, public policy, and even education may magnify bias.2 People may not often express implicit biases out loud because of their hidden, unconscious nature. Implicit biases contribute to a person’s explicit biases.

    Explicit biases include peoples’ conscious preferences, beliefs, and attitudes, and people may communicate them outright.2 For example, people may express explicit biases verbally and expose their prejudicial opinions. Prejudice—a biased response towards a social group and its members based on preconceptions3—may lead to irrational hostility directed towards an individual or group.  

    In-Group vs Out-Group

    Social psychologists have long known that people define themselves in terms of social groups and often malign or disparage others who don't fit into their social groups. People who are part of the “in-group” feel they belong to that group because of social perceptions. People part of the in-group generally have positive views of each other and perceive that the group is composed of individual people.4 In direct comparison, in-group members view people in the “out-group” negatively because they do not belong to the in-group. People in the in-group characterize the out-group as a homogeneous collective rather than individuals. Thus, it becomes easy for members of the in-group to label the out-group as “all the same” rather than treat them like individuals.4

    Simply put, in-vs-out group labeling becomes a case of “us-vs-them" with those in the in-group being “us” and those in the out-group being “them.”4 This tendency explains why hostility can exist between certain groups based on factors like political parties, race, or sexual orientation. This concept of “othering” people is fundamental to understanding how bias can influence personal opinions. Healthcare workers must be mindful of their opinions to ensure biases do not interfere with patient care.

     

    Differentiating Stereotypes, Microaggressions, and Discrimination

    Stereotypes are a fixed set of attributes associated with a particular group.2 Stereotypes are often untrue or unfair generalizations about people who may appear or identify a certain way. Stereotypical beliefs can lead to displays of microaggression, discrimination, and harmful judgment. Some common examples of stereotypes include

    • People who wear glasses are smart
    • Boys are stronger than girls
    • People with tattoos are dangerous
    • Men are better drivers than women

    Microaggressions are physical or verbal acts that subtly express stereotypical thoughts. A 2010 study tracked high school students (N = 342) over their four-year progression and found that students had experienced 21 different types of microaggressions at least once.5 Some examples of reported microaggressions included5

    • Teachers assuming a Black student was poor or illiterate
    • Hispanic and Asian students were asked to teach “native words” even if they only spoke English
    • Students of color being called on to speak on behalf of their race

    Discrimination is the result of implicit or explicit biases. It causes unfair treatment of individuals and communities based on general policies, practices, or norms.2

    PAUSE AND PONDER: What kinds of implicit bias have you observed in your workplace?

    Consider this example: Kate was shopping at the rear of a beauty store when suddenly, someone robbed the cashier located at the front of the store. She rushed home and immediately called her friends Mark and Sylvia to share what she had experienced. Mark asked what the robber looked like. Sylvia says, “I didn’t see him. He was probably Black. They usually are.” This demonstrates a stereotype about Black people. Her comments are the microaggressions in this case. Sylvia’s racial bias is what contributed to this reaction.

     BIAS SUBGROUPS

    Bias comes in many forms and is not limited to particular set of individuals. It can affect any group. Common biases are based on6

    • Beauty
    • Educational background
    • Gender
    • Race/Ethnicity
    • Religion
    • Sexual orientation
    • Socioeconomic background

     

    Unconscious biases are more difficult to identify given that people rarely verbalize them, but they still play crucial roles in affecting behavior and judgment. Bias is a large umbrella term that can further be broken down into subgroups and sub-definitions. Table 1 lists some common categories of unconscious or implicit bias. The SIDEBAR discusses recency bias, a type of bias that can have significant influence on providers’ and patients’ healthcare decisions.

    Table 1. Major Biases Present in Everyday Life6

    Affinity bias Unconscious preference for people with whom you share qualities or interests
    Ageism Negative feelings towards others based on their age
    Attribution bias Related to how you infer the reasons that others act as they do and misunderstand motivations; individuals may attribute their own accomplishments to skill, but assign no fault to their failures; they may be less generous in their thinking when examining others’ behaviors
    Beauty bias Belief that attractive people are more successful, competent, and qualified than unattractive people; physical appearance is used to judge competency
    Confirmation bias Searching for information that backs the opinion an individual holds and rejecting information that contradicts that opinion
    Conformity bias Others’ views influence an individual’s views; this concept is related to peer pressure and acceptance seeking

     

    SIDEBAR: RECENCY BIAS7,8

    Recency bias affects cognitive decision-making by favoring recent events over historic events to estimate future events. Recency bias is also defined as the tendency to base thinking on what comes easily to mind based on recent events.

    For example, an employer is conducting employee evaluations and greets an employee who consistently meets performance goals and expectations. However, the employer chooses to deny the employee a promotion based on a recent mistake. Despite consistent success, a recent error influenced the employer’s decision.

    In healthcare settings, some examples of recency bias include

    • Rejecting older evidence that disproves new (mis)information
    • Emphasizing recent information and failing to consider the entire evidence set
    • Seeking new information rather than older, more voluminous, and more consistent facts

     

    ETIOLOGY OF BIAS

    Science offers some explanation as to how and why biases form in the human mind. The amygdala and the prefrontal cortex (PFC) are most involved in forming bias.9 The amygdala, a small structure located in the temporal lobe of the brain, is responsible for receiving direct information from all the body’s sensory organs.3 It is the part of the brain that generates responses to stimuli, whether that be arousal, attention, or fear.3 The amygdala controls the body’s fight-or-flight response, which is activated in situations that are frightening like walking down a dark alleyway, hearing unfamiliar sounds, or seeing unfamiliar people.3,10

    Several neuroimaging studies have shown that activity in the amygdala heightens when people view pictures that trigger biases. For instance, when people see facial images of those from a different ethnic background than that of their own, the amygdala is activated more so than seeing people who look similar to them.3,10

    The PFC processes cues and is involved with contingency-based learning, decision-making, and evaluation.3 Essentially, the PFC communicates with the amygdala to signal that visual or auditory cues may not be a danger at all; it effectively regulates or “calms” immediate amygdala activation based on situational surroundings.9,10 The PFC functions to help the brain adjust to fit the environment’s social norms.

     

    Influences of Bias

    Social attitudes and expectations that reinforce stereotypes and microaggressions change the way the brain processes behavior. That said, implicit bias is not intrinsic (or hard-wired), meaning although it may exist in the unconscious parts of the brain, it can be “un-wired.”10 Experiments involving children who had diverse friend groups show less reactive amygdala activation, meaning their brains did not automatically associate negative reactions based on skin color.9

    What does this have to do with bias? It suggests that bias is not inherently present in children from birth and develops in adolescence.9 The social, physical, and economic environment in which people are raised affects brain development and ultimately alters individual implicit biases.

     

    Identity, Individuality, and Intersectionality

    People use their social identity to compartmentalize themselves into specific groups or categories. In 1974, sociologist Henri Tajfel first proposed the social identity theory that suggested social identity derives from the “knowledge of membership” in a group (or groups), and that membership in those groups creates individual significance and value.11 Social identity defines how individuals characterize their own traits. Common identities include things like12

    • Disability
    • Ethnicity
    • Gender or sex
    • Nationality
    • Political party
    • Race
    • Religion
    • Economic status

    Personal identities are adjectives used to describe oneself, like smart, tall, or funny.12

    Social identity is dynamic in that it can develop in various ways.10 For example, society classifies people born in the early 1980s to mid-1990s as being part of the millennial generation. Although membership requires nothing other than birth at a specific time, others group millennials into a category (their generation) that has over time acquired certain characteristics typical of group members. Individuals can also develop identity through conscious choices, like choosing to go into a healthcare profession or going to school to be a writer.10 People are not usually limited to one identity, but rather possess multiple social identities that work to influence a person’s experiences in life.12 For example, a White man fits into categorical groups of (1) White person and (2) male sex, yet his life experience may differ depending on if he is born into higher socioeconomic class, identifies as heterosexual, or has a disability.

     

    Society’s cultural norms shape identities.13 As attitudes towards cultures (or groups) change over time, societal standards change as well. Certain identities may have more value and importance than others because society emphasizes those differences. Identities may also shift importance based on the context in which a person lives. A White American living in North America might think about national identity only infrequently. However, if that person takes a job in China, national identity might suddenly feel like a significant part of individual identity, because it will likely impact how others see the person and how the person interprets experiences.12

     

    Social identity overlaps strongly with intersectionality, or the multifaceted interplay of social identities, systems of power, and oppression of certain groups.13 As mentioned above, social identities exist in various combinations that make individuals unique. Intersectionality allows us to see how different identities may affect one another, and how that in turn relates back to concepts of bias, discrimination, and stereotypes.13

     

    Bias within groups can affect intersectionality. For example, studies show that people of color who also identify as part of a sexuality minority experience internalized stigma related to gender and/or sexual orientation within their racial groups; these people experience what is called intersectional minority stress.14 Individuals experiencing discrimination in both racial and gender or sexuality identities are more vulnerable to poor health outcomes given the increased bias and discrimination they face.14

     

    A public health researcher from the University of Michigan introduced the “weathering” hypothesis, which suggests that Blacks experience health deterioration as a result of chronic social and economic stressors or political marginalization.15 Some studies have explored and validated this hypothesis. A recent study found that the COVID-19 mortality rate was 2.1 times higher for Black Americans than that of White Americans.16 The researchers indicate that weathering from chronic and toxic stress magnified COVID-19’s effects in people of color. People of color are more likely to suffer job loss as a result of the COVID-19 outbreak, which in turn affects health insurance coverage and thus contributes to poorer health outcomes. Regardless, even those who possess employment and health insurance are more likely to receive inferior care due to the implicit biases present in healthcare. This study emphasizes the concept of “weathering” in a way that is relevant in our world today.16

    PAUSE AND PONDER: How might implicit biases in your workplace affect patient care and outcomes?

    Bias and social identity are entwined. Social identities stem from a person belonging to a group, whether that be an “in-group” or “out-group.” Figure 1 provides examples of the groups, such as middle class or documented citizens. A person can belong to more than one group. Society tends to label certain groups as more valuable than others, which leads to re-enforcement of certain biases. People tend to conform to societal standards, and placing oneself into these groups creates the foundation for bias, stereotypes, and prejudice to occur. It is still important to recognize that while our personal and social identities place us into groups with shared attributes, we are still unique individuals.

     

    Image showing how different aspects of personalities impact levels of power 

    SOURCE: Adapted from James R Vanderwoerd ("Web of Oppression"), and Sylvia Duckworth ("Wheel of Power/Privilege")

     

    Institutional Bias

    “Power tends to corrupt, and absolute power corrupts absolutely.”

    – Lord Acton, British Historian

     

    All people have unconscious or conscious biases. Ultimately, biases result from social identities’ influence on the brain and our environment. But what happens when a collection of individuals with a shared bias comes together? Biases can become discrimination. While prejudice is the pre-conceived notion about someone based on bias, discrimination is conscious, intentionally disparate treatment.17

     

    Institutional bias, known also as structural bias, ties many issues that arise from discrimination together. Institutional bias—the established laws, customs and practices that methodically reflect and produce group-based inequities in any society—involves policies and practices that are discriminatory beyond that of the individual level.18 Even in an ideal situation wherein individuals do not possess a certain bias or prejudice towards a group of people, discrimination may still occur because the institutions in which they are involved may have biased practices in place.18

     

    Nearly every type of social institution exhibits some form of bias against groups of people. Examples of institutions include18

    • Education
    • Environmental management
    • Healthcare
    • Law/Criminal justice
    • Military
    • Politics
    • Politics
    • Retail and housing market
    • Workforce

    Some people allege that individual and institutional bias may not co-exist, but that belief is a bit contradictory. Since the civil rights movement, individual expression of stereotypes and prejudice against Black people in the United States has declined. However, racial discrimination is still widespread and may be as prevalent as it was before the civil right movement in some areas. In 2007, the legal system incarcerated Black people at a rate four times higher than White people in the U.S.18 Although other factors may contribute to this disparity, institutional racism is still prevalent regardless of individuals’ attitudes or bias towards Black people.18

     

    Power and legitimacy also influence institutional biases.18 Groups in power are more likely to control institutional bias since they are most likely to control the institutions and create policy.18 Legitimacy is a word used to describe the perception that a policy that is detrimental to the oppressed group is fair or somehow justified.18

     

    For example, the housing market enables implicit associations between minorities and the risk they present to the value of the neighborhood in which they live or seek to live. As a result, the perception influences certain housing and lending practices for minority applicants.19 Another example is more nuanced. Adults younger than 21 cannot purchase or drink alcohol in the United States; one may argue that this is a form of bias against this age group. However, given the shared societal attitude that teens and young adults should not drink alcohol due to its potential to cause impairment, few people fight against this bias.18

     

    While some biases are widely accepted, others are clearly not. For example, some immigrants don’t qualify for high level positions within companies. Members of immigrant groups are more likely to take low-level, undesirable positions. As a result, they tend not to stay at that company for long, increasing turnover and decreasing ambition within their fields.18 A similar predicament is the standardized college admission tests; depending on their exam score, students may not qualify for admission to certain schools, perpetuating the idea that they are not smart enough to be admitted.18 Standardized tests fail to take into account students’ different backgrounds; some students benefit from simply being in a higher socioeconomic status with resources available to ensure success.

     

    IMPLICATIONS OF BIAS

    Negative attitudes have the potential to affect decision making and health outcomes across various healthcare settings. In 2021, the three largest motivations for hate crimes in the U.S. were race, sexual orientation, and religion.20 Maternal mortality rates in the U.S. by race are disproportionate. Black women die during childbirth nearly three times more often than White or Hispanic women.21 These discrepancies are due to institutional biases and existing racism toward Black women in healthcare. The Centers for Disease Prevention and Control adds that implicit bias prevents people of color from having fair opportunities for economic, physical, and emotional health.22 As part of the healthcare workforce, pharmacists and pharmacy technicians should be able to identify how implicit biases can adversely impact relationships with patients and customers.

    PAUSE AND PONDER: Which interventions described in this CE might help you and your coworkers
    have frank discussion about bias and discrimination?

    Recent research shows people have self-reported experiences of discrimination in healthcare. These instances frequently occur in the following groups of people23:

    • LGBTQ (lesbian, gay, bisexual, transgender, queer)
    • Low socioeconomic status
    • Older adults
    • Overweight or obese
    • Poor health
    • Racial/ethnic minorities
    • Uninsured
    • Women

     

    Patterns of bias and discrimination towards marginalized groups becomes evident. As a result, these individuals can feel perceived discrimination, which is anticipation of unfair treatment they may receive due to their characteristics.23 These groups are more likely to have high stress and mental health disorders such as anxiety, depression, and substance abuse.23 Table 2 lists examples of studies that highlight implicit biases related to healthcare.

    Table 2. Studies that Highlight Implicit Biases Related to Healthcare24-28

    A study (N = 142) of emergency response situations showed that White bystanders were slower to provide help to Black victims than the speed at which White bystanders helped White victims. White participants helped 88% of White victims compared to 58% of Black victims. “Help Time” was ~120 sec for Black victims compared to ~40 sec for White victims.
    A review (N = 7070) found Black and Latino patients are less likely to receive medication, especially opioids, to alleviate acute pain in the emergency department than White patients (OR 0.60 [95%-CI], 0.43-0.83).
    Asian Americans (N = 521) reported feeling like their doctors do not involve them in shared decision making, do not listen to their concerns, and spend less time with them. They were also less likely to receive counseling on mental health or lifestyle issues compared to White patients (N = 3205) in the survey.
    An analysis found doctors perceived Black patients (N = 618) to be less educated, less likable, less intelligent, and nonadherent to medical advice and medication therapy. Physicians were less likely to agree that Black patients vs. White patients are `the kind of person they could be friends with’ (34% of White vs. 27% of Black patients).
    A survey (N = 316) showed transgender or gender nonconforming people worry about discrimination when they use pharmacy services; 41.6% reported discrimination associated with such services, and 52.5% reported pharmacists as having very little or no competency in providing gender-affirming care.

     

    Gender-Diverse Care and Ageism

    An emerging topic is gender-diverse care. The Human Rights Campaign Foundation and the American Pharmacist Association (APhA) released a joint pharmacy resource guide for gender diverse care. The guide includes key terms, inclusive communication, staff training and other essential points of patient centered care for gender diverse patients.29 It is accessible for free at https://www.thehrcfoundation.org/professional-resources/transgender-pharmacy-guide

    Nicole Avant, PharmD, BCACP, founder, owner, and consultant at Avant Consulting Group, presented key studies on implicit bias during a session at the 2022 National Community Pharmacy Association Annual Convention. They include30

    • Black women are more likely to die after being diagnosed with breast cancer.
    • Patients of color (POC) receive fewer cardiovascular interventions and fewer renal transplants than White patients.
    • POC who have diabetes are more likely to undergo leg amputation.

     

    Poor provider-based interactions negatively impact the quality of care and the desire to seek medical help. This fosters mistrust of healthcare and healthcare workers, like pharmacists and pharmacy technicians. Poor interactions can significantly delay treatment-seeking, which worsens health complications by creating avoidable increases in emergency healthcare use and increasing health disparities. The SIDEBAR provides an example of poor care.

     

    SIDEBAR: A Health Professional’s Observation31

    Joanne Whitney is a retired pharmacy professor who has shared her experiences when interacting with healthcare providers.

    • She went to the emergency room for a urinary tract infection (UTI) and severe pain. She asked for hydromorphone (Dilaudid) since it had helped her before, but a young physician told her that they don’t prescribe opioids to “those who seek them.”
    • Her pain continued for eight hours. She states, “When older people come in like that, they don’t get the same level of commitment to do something to rectify the situation. It’s like ‘Oh, here’s an old person with pain. Well, that happens a lot to older people.’”
    • She also told the physician the prescribed antibiotic was incorrect for her UTI, but the provider disregarded her concern despite her pharmacy background.

     

    The prejudice in this case is the notion that older people are unpleasant and difficult to treat. Discrimination occurs when healthcare providers do not manage older adults’ needs appropriately or treat them less favorably than younger patients.

    Her experience emphasizes ageism in healthcare settings. More than half a million Americans aged 65 and up encountered ageism during the COVID-19 pandemic.

    Ageism can be explicit in some healthcare settings. In 2021, an advocacy group for older adults filed a lawsuit in Idaho over the state’s crisis guidelines for hospitals that were overwhelmed with COVID-19 patients. The protocol stated staff should triage and treat younger patients before older adults because “they have more years left” to live.32

    Other examples of ageism prevalent in healthcare today include

    • Assuming older patients who talk slowly are cognitively compromised
    • Rushing patients, not listening to their concerns
    • Only speaking to the patient’s family member
    • Ignoring or minimizing pain complaints

     

    Racism in Pharmacies

    A 2021 U.S. Qualtrics Survey found that nearly 20% of people perceived racial discrimination in community pharmacy settings.23 Of those people, one-third of them felt they had to be particularly careful about their appearance to receive “good service” and avoid harassment.23 On average, people visit doctors and specialists a handful of times but can visit their community pharmacies up to 35 times a year. The study showed that perceived discrimination significantly affects healthcare. One third of respondents stated they tried to avoid certain pharmacies, and 17% reported switching pharmacies.  Switching pharmacies may seem like an adequate temporary solution, but in actuality fragments medical records, increases the likelihood that pharmacists will miss potential drug interactions, and compounds adherence issues.23

     

    Thus, healthcare providers must be cognizant of their biases and avoid acting on them when interacting with patients in pharmacy settings. Pharmacy workers should strive to be fair and aware of their personal implicit biases. They should also be conscientious and deliberate when interacting with patients. Management must ensure adequate training is in place for pharmacists and technicians to create a welcoming, inclusive atmosphere. If it is not, pharmacy employees should suggest it is needed.

     

    Becoming conscious about implicit biases should begin during the education of future pharmacists. Six PharmD programs surveyed students (N = 357) using the Harvard Race Implication Test.33 The test determines implicit associations by measuring the time it takes a person to connect two concepts, i.e. (Black/White to good/bad). The survey found that pharmacy students exhibited preference for White patients and moderately negative implicit and explicit bias towards Black patients.33 Although many pharmacy schools have already incorporated the concepts of cultural competence, increasing awareness of how implicit biases negatively affect patient interactions should be a focus area.

     

    Bias Affecting Decision-Making Processes 

    Implicit bias has been associated with several downstream effects. Consider “second victim” effect. The term “second victim” describes healthcare professionals and the unanticipated emotional impact they feel after making a medical or clinical error.34 Medical errors are one of the top leading causes of death in the U.S.35 The first victim is the patient who experiences the medical error. The second victim—the person who made the errors—feels distress and personal responsibility after an unexpected adverse patient outcome or error. This directly impacts the healthcare professional’s career and life.34 In many cases, implicit bias is not a factor in second victim effect, but sometimes it is. For example, consider a provider who has an implicit bias towards Black women. The provider fails to intervene aggressively when a patient, a Black woman, is experiencing pain and hemorrhaging due to complications during childbirth. The patient soon becomes unconscious from blood loss. The patient unfortunately dies. The patient’s family files a complaint with the hospital regarding the provider’s lack of standard care during her birthing process. The provider is then afflicted by second-victim effect.

     

    Many second victims suffer from job-related emotional and physical stress, and their additional feelings of powerlessness and insecurity can prompt them to leave the profession.34 Lack of support for coworkers and management contributes to the second victim phenomenon, and coworkers and managers may be less likely to support the second victim if they have biases against that person for some reason.34 The second victim’s self-blaming negative feelings could influence future decision making.

     

    Nearly half of healthcare professionals experience second victim effect at least once in their careers.34 This effect may lead to changes in clinical judgment and inadvertently affect patient care. It is important to recognize when it occurs. To combat second victim phenomenon’s negative effects, mindfulness-based interventions have shown efficacy in reducing stress and burnout.34 Also, psychological first aid fosters resilience in healthcare professionals by establishing formal support teams within health institutions.36 This includes education about normal responses to traumatic events, active listening skills, understanding the importance of nutrition and rest, and clarifying when to seek help.36

     

    Interprofessional Bias

    Interprofessional collaboration is an important part of managing and delivering quality patient care. Biases about other professions can create conflict within the team, which has negative consequences for communication, decision-making, and trust.37 Implicit biases influence a person’s actions unconsciously and can intrude in various cultural and structural settings. For example, individuals may have preferences for certain specialties or simply certain people over others. Their implicit biases can influence decisions, like who rounds on an inpatient hospital team. The traditional hierarchy of physicians as team “leaders” can create tension within a group that must work with (as equals), but not for (as subordinates), that physician.37

     

    Research shows that biases adversely affect the quality of healthcare delivered to patients. A systematic review on implicit biases in interprofessional collaboration found that biases between professions were predominately negative.37 The review mentioned the concept of internalization, which describes how people internalize biases towards their profession towards their own self and behaviors.37 For example, physicians mostly saw themselves as leaders while nurses consistently perceived themselves as powerless and lacking authority. As such, physicians exhibit behaviors such as authoritatively shutting down communication in case conferences, whereas non-physician professionals tended to be silent, less engaged, or chose to skip team meetings. Bias internalization influenced which professions voiced their opinions and inhibited the team’s overall growth.37 Consequently, these healthcare teams developed feelings of disrespect and mistrust, which impedes patient care. Another study found that when team members perceived they were not consulted about a decision, they exhibited defensive posturing and frustration in meetings.38

     

    Imposter Syndrome

    Imposter syndrome is defined as self-doubt about intellect, skills or accomplishments among high achieving individuals.39 Imposter syndrome and disorders such as depression and anxiety are often comorbid.39 Many healthcare professionals strive for perfection, but those with imposter syndrome tend to associate their success with random chance as opposed to their own intelligence.39 Imposter syndrome tends to be more common in marginalized groups (e.g., minority races) in high pressure settings due to underrepresentation in the field; poor representation and pressure exacerbate imposter syndrome.39 It may also be a result of lifelong bias and discrimination, which can affect professionals in their clinical roles as well.

     

    Interestingly, a study of pharmacy residents (N = 720) found higher Clance Imposter Scale scores correlated with the number of hours worked per week and prior mental health treatment, factors associated with high stakes learning environments.40 This study validates other studies done with various medical professionals and demonstrates the connection between highly focused academic and healthcare areas and the increased likelihood of imposter syndrome.40

    Imposter syndrome, like the second victim effect, can affect clinical judgement in healthcare professions. It may promote certain biases when they normally would not be due to those feelings of inadequacy, and thus mistakes occur.

     

    Bias in the Pharmacy

    Pharmacists hold crucial positions in healthcare, especially since they engage with diverse groups of patients regardless of the setting in which they work. Pharmacists can stimulate broader efforts to address health disparities, especially as their scope of practice widens.41 Social determinants of health (SDOH) are the social and structural conditions in which people are born, live, and work.42 Figure 2 shows the key SDOH.

    Image showing the 5 social determinants of health: education access and quality, healthcare access and quality, neighborhood and built environment, social and community context, and economic stability

    Source: Healthy People 2030, U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Retrieved July 28, 2023, from https://health.gov/healthypeople/objectives-and-data/social-determinants-health

     

    A 2016 review of pharmacy literature highlighted issues stemming from SDOH affecting pharmacies. These factors are known to influence health outcomes, and pharmacy workers need to be aware when SDH may affect the population they serve. The study showed the following knowledge gaps among pharmacists41:

    • Mental illness
    • Substance/drug abuse with prescription and illicit drugs
    • Those at risk for HIV/AIDS or hepatitis C infection

     

    Although pharmacists provide care to groups that suffer from effects of SDH, they may not understand entirely or have access to information that could expose SDH. More education on cultural competency is needed within pharmacy.41

     

    Bias can influence the pharmacy workforce. Perhaps one of the most relevant examples of bias in pharmacy workers concerns opioid use disorder (OUD). The U.S. has battled the opioid crisis for more than two decades.43 Those who suffer with OUD are often stigmatized. Pharmacists and pharmacy technicians frequently interact with patients who are diagnosed with such disorders. The lack of knowledge and understanding surrounding OUD underscores biases that exist towards people with OUD.

     

    A small study that examined pharmacy technicians’ attitudes (N = 46) using focus groups found that participants had negative perceptions of patients using opioids. Pharmacy technicians reported “ever-present” negative feelings (meaning they persisted over time) toward patients with OUD, even if they did not know opioid’s indication for a particular person.43 The researchers asked pharmacy technicians to recount their experiences with patients who recieved opioids. Figure 3 highlights their perceptions.43

    Figure 3. Comments from Pharmacy Staff about Patients with OUD43

    Image showing quotes from pharmacy technicians regarding patients with OUD

     

    A multitude of reasons may explain why participants felt this way. Their experiences may be tied to aggressive encounters between healthcare professionals and patients who use opioids and negative media portrayals of opioid use.43 The study went into further detail on early refills, a situation where patients want to fill a prescription when their fill histories indicate it’s too early. Most technicians stated they tried to be compassionate and non-judgmental in these situations to overcome the stigmas associated with opioid prescriptions.43

     

    The discussion further explained that the negative perception of patients who take opioids compromises quality of care because it is difficult to reverse formed opinions. The National Institute on Drug Abuse stresses the importance of accurate, complete medication histories and reporting to prescription drug monitoring programs to create healthier patient-provider relationships in the pharmacy.43

     

    Another study focused on pharmacy personnel responses to expedited partner therapy (EPT) in the management of sexually transmitted infections. EPT effectively prevents chlamydia and gonorrhea infections for partners of patients already infected.44 Providers can give patients diagnosed with chlamydia or gonorrhea prescriptions for the partner without having to name the partner. EPT is protected by law in 41 states and supported by numerous organizations including44

    • American Academy of Pediatrics
    • American Academy of Family Physicians
    • American Congress of Obstetricians and Gynecologists
    • Society of Adolescent Health and Medicine

     

    The study (N = 50) found pharmacists refused to fill 58% of EPT prescriptions, and suburban pharmacists were more likely to refuse than city pharmacists.44 Refusal was more likely if the pharmacists were older than the patient and if patients were White. Pharmacists most commonly cited lack of name on the prescription as the reason for refusal, even if the law does not require a partner name. This indicates a general lack of knowledge about EPT among study participants, which may have contributed to their decisions.44

     

    A literature review on weight management programs found implicit and explicit weight bias exists within the pharmacy profession. Weight management programs can vary, and pharmacies offer some in conjunction with prescription medications and nonpharmacologic lifestyle interventions.45 The review found stigmatizing language in the screening processes for weight management programs. It is unclear to what extent weight biased communication exists between pharmacists to patients.45 The stigma that surrounds obesity affects other related health problems, like diabetes or cardiovascular concerns, and can weaken the pharmacist-patient relationship.45

     

    ADDRESSING BIAS

    Implicit biases are present in all people, but the importance lies not in the existence of bias, but how to overcome it. Several strategies address biases, the most important being education in pharmacy school curriculums. Many studies use the IAT to measure implicit bias. The test is free to the public and can be found here: https://implicit.harvard.edu/implicit/

    Learners should note that this is not just one test, but a series of different tests.

     

    The IAT measures the time it takes for the individual to match concepts in categories to descriptive words, like race, skin tone, and weight to good, bad, or other stereotypical language.46,47 An individual’s underlying beliefs drive responses time, thus measuring the strength of the association between concepts (a person, image, etc.) and evaluations (good, bad). Researchers recommend incorporating the IAT in curriculums prior to before direct patient exposure.46

     

    Other interventions that may be helpful in pharmacy education and other pharmacy settings include44

    • Practicing mindfulness (directing active, open attention to the present to examine one’s thoughts and feelings without judging them). Mindfulness reduces the likelihood of activating implicit biases and enhances the ability to control biases in patient care situations.
    • Self-awareness/self-reflection training: After completing the IAT, individuals can reflect on identified biases.
    • Activating goals: Healthcare workers can identify goals that promote fairness and equality for patients and coworkers.
    • Stereotype replacement: Individuals who collect information that is opposite of cultural stereotypes can replace stereotypical thoughts with non-biased thoughts.
    • Case studies observing implicit bias: Analyzing case studies where implicit bias was involved helps people recognize how to approach situations differently.
    • Individuating: This action challenges people to see others for their individual traits as opposing to grouping them by their stereotypical components.
    • Perspective-taking: This “walk a mile in their shoes” activity asks individuals to assume the perspective of a stigmatized or marginalized member to build empathy.

     

    The University of Utah Pharmacy Residency program implemented an implicit bias awareness and action seminar with four training modules and a pre- and post-test survey. After training, pharmacy residents indicated higher comfort and confidence addressing personal biases and were better able to identify biases of others.47 While not accessible to the public, this shows that implementing training programs makes a difference in future of pharmacy delivered care.

     

    Conclusion

    Implicit biases have overall negative effects on patient care, which is detrimental to patients and those that harbor the implicit biases. Pharmacists and pharmacy technicians who are aware of and take steps to address their implicit biases will improve the way they treat patients and each other as colleagues.

     

    Pharmacist Post Test (for viewing only)

    Exploring Implicit Bias and Its Impact in Pharmacy
    POST-TEST Pharmacists
    Learning Objectives
    After completing the continuing education activity, pharmacists will be able to
    • DEFINE different types of bias and how they are formed
    • RECOGNIZE what bias may look like in the pharmacy setting
    • IDENTIFY how bias can impact patient care
    • APPLY methods to address and mitigate bias in the workplace

    1. You are a 52-year-old clinical pharmacist who works with an interprofessional team. The doctor is a 33-year-old resident who has just started working at the hospital. He does not ask for your input, yet you have caught several prescribing errors he made. He also ignores your questions. He has openly stated that he thinks pharmacists “don’t know what they are talking about.” What potential bias may be occurring?
    a. Age bias
    b. Interprofessional bias
    c. Confirmation bias

    2. Which strategy could potentially help mitigate implicit biases in pharmacy education or clinical settings?
    a. Behavioral therapy
    b. Anonymous reporting
    c. Self-awareness training

    3. Which of the following statements best describes an explicit bias?
    a. “Women who have children are not serious about professional careers.”
    b. “Pharmacists and doctors have more clinical education than nurses do.”
    c. “Patients of color receive fewer primary care interventions than White patients.”

    4. Which of the following statements is CORRECT regarding the etiology of bias?
    a. The amygdala processes cues and “calms” the PFC to adjust to social norms.
    b. Neuroimaging studies do not associate amygdala activity and bias.
    c. Bias triggers amygdala activity and affects decision-making processes.

    5. How does bias negatively impact marginalized pharmacy customers?
    a. Patients struggle to fill medications due to shortages.
    b. Patients feel they have to be careful of their appearance.
    c. There is not really bias towards patients in pharmacy.

    6. A new pharmacy resident was paged to attend a stroke code and unfortunately, the patient died because the resident did not know which medication to give at the moment. This was the fifth unsuccessful stroke code this month, and the resident is troubled. He starts drinking more after his work shift to help cope with the feelings of loss. After several months, he is diagnosed with depression. He is often late to work and his supervisors counsel him several times. What is the resident experiencing?
    a. The resident is experiencing second victim syndrome.
    b. The resident does not like his job or his bosses.
    c. The resident is experiencing imposter syndrome.

    7. Which choice correctly defines social identity and intersectionality?
    a. Social identity is the relationship between intersectionality and systems of power; intersectionality is the process of being placed into a group
    b. Social identity and intersectionality are different terms for the same concept, and researcher tend to use the two interchangeably in studies and review articles
    c. Social identity relates to being placed in an “out-group” or “in-group”; intersectionality is the relationship between social identities and power systems

    8. How does the Implicit Association Test (IAT) work?
    a. It measures how fast White responders help Black victims in emergencies.
    b. It measures the strength of participants’ personal beliefs towards minorities.
    c. It measures how quickly participants associate concepts to categories.

    9. Which of the following statements about bias internalization is TRUE?
    a. Internalized bias has no impact on teamwork, and affects only the individual.
    b. Internalized bias has no impact on individual, and affects only the whole team.
    c. A bias toward a group of people can be internalized and applied to one’s self.

    10. A recently pharmacy graduated has been hired to work on your team. You notice that the new pharmacist tends to hand off minority patients who need a language interpreter to other coworkers. You bring this up to your supervisor, who asks for your suggestions. Which statement is the best intervention?
    a. The supervisor should call a team meeting and directly address the new pharmacist in front of everyone to hold that person accountable.
    b. The team should review case studies similar to the minority patients so the new pharmacist can feel more comfortable working on those cases.
    c. The manager should fire the new pharmacist because recent graduates should know how to manage all cases, even when an interpreter is needed.

    Pharmacy Technician Post Test (for viewing only)

    Pharmacy technician post-test

    After completing the continuing education activity, the pharmacy technician will be able to:
    • define different types of bias and how they are formed
    • recognize what bias may look like in the pharmacy setting
    • identify how bias can impact patient care
    • illustrate understanding of strategies that mitigate bias

    1. A female technician has worked in a retail pharmacy for several years. She notices the pharmacist always asks for the male technicians to help her put away the order, despite her being there much longer than they have. When she asks the pharmacist why she doesn’t ask for her help, the pharmacist says, “Oh, I just thought it was too heavy for you.” Which statement best describes this case?
    a. Male technicians are better and more efficient workers than female technicians.
    b. The pharmacist does not like working with the female technician.
    c. The pharmacist’s thinking that females are not as strong as males is gender bias.

    2. Which statement correctly identifies the differences between explicit and implicit bias?
    a. Implicit biases are unconscious; explicit biases are conscious.
    b. Explicit biases are harsher than implicit biases.
    c. Implicit biases do not have anything to do with explicit biases.

    3. You work in a retail pharmacy and a patient drops off a new prescription for Suboxone. When the patient comes to pick up the medication, you notice he is defensive when you ask to see an ID for verification purposes. What is one possible reason for their reaction?
    a. The patient feels you may be judging him for his prescription.
    b. The patient is offended and thinks you are calling him old.
    c. The patient does not have his ID with him at the moment.

    4. A female inpatient pharmacy technician is working with a male pharmacy resident to perform a medication history review. The tech notices the resident tends to rush through the interactions with older patients and will only speak to the family if they are present in the room. The tech has overheard this resident state he thinks the nurses should take medication histories since residents have “more important jobs than nurses.” With regard to the pharmacy resident, which bias may negatively affect patient care the most?
    a. Affinity bias
    b. Interprofessional bias
    c. Age bias

    5. Which statement is a microaggression?
    a. A doctor says “Black women are at higher risks for maternal mortality.”
    b. A faculty member says, “Most Black students are poor or illiterate”
    c. A patient says, “I want to speak with to the doctor I saw last month.”

    6. An APRN is concerned with a medication dose and asks to speak to the pharmacist. When finished with the call, the pharmacist turns to you and says, “APRNs are so incompetent. They never know how to send things over the right way.” Which statement describes the bias the pharmacist is displaying?
    a. The pharmacist shows interprofessional bias towards the APRN.
    b. The pharmacist in this example is not showing any explicit bias.
    c. The pharmacist shows unprofessional bias towards the APRN.

    7. How can practicing mindfulness help reduce biases in healthcare settings?
    a. It reduces the likelihood of activating implicit biases and enhances the ability to control biases in patient care.
    b. It helps healthcare providers take on the perspective of stigmatized or marginalized group members to build empathy.
    c. It is designed to let healthcare providers develop goals that promote fairness and equality among coworkers.

    8. Over the course of your career in pharmacy, you come to realize that your initial belief that patients who are prescribed multiple refills of opioids are abusing them is wrong. What is this an example of?
    a. Stereotype
    b. Interprofessional Bias
    c. Ageism

    9. Which statement describes how the brain plays a role in forming bias?
    a. The amygdala and PFC both process social cues that turn to bias most of the time.
    b. The PFC is triggered by sensory information while the amygdala processes cues.
    c. The amygdala is triggered by sensory information while the PFC processes cues.

    10. Which is an example of how implicit biases can influence institutional bias?
    a. A Black male is unable to cast his vote at the ballots because he forgot his ID at home
    b. A young Hispanic female is denied pain medication because the doctor thinks she’s exaggerating her pain
    c. A disabled male athlete does not qualify for a sporting event because he places last in the competition

    References

    Full List of References

    References

       

      1. Barlow R. Bu research: A Riddle reveals depth of gender bias: BU Today. Boston University. Published January 16, 2014. Accessed April 10, 2023. https://www.bu.edu/articles/2014/bu-research-riddle-reveals-the-depth-of-gender-bias/
      2. Vela MB, Erondu AI, Smith NA, Peek ME, Woodruff JN, Chin MH. Eliminating Explicit and Implicit Biases in Health Care: Evidence and Research Needs. Annu Rev Public Health. 2022;43:477-501. doi:10.1146/annurev-publhealth-052620-103528
      3. Amodio DM. The neuroscience of prejudice and stereotyping. Nat Rev Neurosci. 2014;15(10):670-682. doi:10.1038/nrn3800
      4. Ashcraft D, Treadwell T. Chapter VII: The Social Psychology of Online Collaborative Learning: The Good, the Bad, and the Awkward. In Orvis K, Lassiter A, eds. Computer-Supported Collaborative Learning: Best Practices and Principles for Instructors. IGI Global; 2008:11-15. doi.org/10.4018/978-1-59904-753-9.ch007
      5. Sparks SD. Fighting Subtle Bias: Classroom Biases Hinder Students’ Learning. Published October 27, 2015; Accessed April 10, 2023. https://www.edweek.org/leadership/classroom-biases-hinder-students-learning/2015/10
      6. Murphy N. Types of Bias. CPD Online College. Published November 10, 2021. Updated May 27, 2022. Accessed April 10, 2023. https://cpdonline.co.uk/knowledge-base/safeguarding/types-of-bias/
      7. Phillips-Wren G, Power DJ, Mora M. Cognitive bias, decision styles, and risk attitudes in decision making and DSS. J Decision Syst. 2019;28(2):63-66. doi: 10.1080/12460125.2019.1646509
      8. Salim A, Johnson WE. How Bias and Perception Impact Complicance.https://assets.hcca-info.org/Portals/0/PDFs/Resources/Conference_Handouts/Compliance_Institute/2019/304_Bias%20and%20Perception.pdf
      9. Weichselbaum C, Banks K. Racism on the Brain. Fron Young Minds. 2021;9:1-8. doi:10.3389/frym.2021.608843
      10. Agarwal P. What Neuroimaging Can Tell Us about Our Unconscious Biases. Published April 12, 2020. Accessed April 12, 2023 https://blogs.scientificamerican.com/observations/what-neuroimaging-can-tell-us-about-our-unconscious-biases/
      11. Everett JAC, Faber NS, Crockett M. Preferences and beliefs in ingroup favoritism. Fron Behav Neurosci. 2015;9:1-21. doi:10.3389/fnbeh.2015.00015
      12. Leading Effectively Staff. Understand Social Identity to Lead in a Changing World. Published February 7, 2023. Accessed April 10, 2023. https://www.ccl.org/articles/leading-effectively-articles/understand-social-identity-to-lead-in-a-changing-world/
      13. Kearney, DB. Universal Design for Learning (UDL) for Inclusion, Diversity, Equity, and Accessibility (IDEA). Module 4.2 Positionality and Intersectionality. eCampus Ontario; 2022. Accessed April 10, 2023. https://ecampusontario.pressbooks.pub/universaldesign/
      14. Sarno EL, Swann G, Newcomb ME, Whitton SW. Intersectional minority stress and identity conflict among sexual and gender minority people of color assigned female at birth. Cultur Divers Ethnic Minor Psychol. 2021;27(3):408-417. doi:10.1037/cdp0000412
      15. Geronimus AT, Hicken M, Keene D, Bound J. "Weathering" and age patterns of allostatic load scores among blacks and whites in the United States. Am J Public Health. 2006;96(5):826-833. doi:10.2105/AJPH.2004.060749
      16. Johnson-Agbakwu, C.E., Ali, N.S., Oxford, C.M. et al. Racism, COVID-19, and Health Inequity in the USA: a Call to Action. J. Racial Ethn Health Disparities. 2022;9: 52–58.
      17. López L, Betancourt JR. Racial and Ethnic Disparities in Health Care. In: Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson J. eds. Harrison's Principles of Internal Medicine, 21e. McGraw Hill; 2022. Accessed April 10, 2023. https://accesspharmacy.mhmedical.com/content.aspx?bookid=3095§ionid=263343935
      18. Henry, P. Institutional Bias. In: Dovidio JF, Hewstone M, Glick P, Esses VM, eds. Handbook of Prejudice, Stereotyping, and Discrimination. Sage; 2010:426-440
      19. Olinger J, Capatosto K, McKay MA, et al. Challenging Race as Risk: How Implicit Bias Undermines Housing Opportunity in America. Ohio State University; 2017:1-85. Accessed July 20, 2023. https://kirwaninstitute.osu.edu/research/challenging-race-risk-implicit-bias-housing
      20. FBI. Number of Victims of Hate Crime in The United States in 2021, by Motivation. Statista. Published March 13, 2023, Accessed April 10, 2023. https://www.statista.com/statistics/737648/number-of-hate-crime-victims-in-the-us-by-motivation/
      21. Hoyert DL. Maternal mortality rates in the United States, 2020. NCHS Health E-Stats. 2022. doi.org/10.15620/cdc:113967
      22. Working Together to Reduce Black Maternal Mortality. CDC. Updated April 3, 2023. Accessed April 10, 2023. https://www.cdc.gov/healthequity/features/maternal-mortality/index.htm
      23. Baffoe JO, Moczygemba LR, Brown CM. Perceived discrimination in the community pharmacy: A cross-sectional, national survey of adults. J Am Pharm Assoc. 2022;63(2):518-528. doi:10.1016/j.japh.2022.10.016
      24. Kunstman JW, Plant EA. Racing to help: Racial bias in high emergency helping situations. J Pers Socl Psych. 2008;95(6)1499-1510. doi.org/10.1037/a0012822
      25. Lee P, Le Saux M, Siegel R, et al. Racial and ethnic disparities in the management of acute pain in US emergency departments: Meta-analysis and systematic review. Am J Emerg Med. 2019;37(9):1770-1777. doi:10.1016/j.ajem.2019.06.014
      26. Ngo-Metzger Q, Legedza AT, Phillips RS. Asian Americans' reports of their health care experiences. Results of a national survey. J Gen Intern Med. 2004;19(2):111-119. doi:10.1111/j.1525-1497.2004.30143.x
      27. van Ryn M, Burke J. The effect of patient race and socio-economic status on physicians' perceptions of patients. Soc Sci Med. 2000;50(6):813-828. doi:10.1016/s0277-9536(99)00338-x
      28. Lewis NJW, Batra P, Misiolek BA, Rockafellow S, Tupper C. Transgender/gender nonconforming adults' worries and coping actions related to discrimination: Relevance to pharmacist care. Am J Health Syst Pharm. 2019;76(8):512-520. doi:10.1093/ajhp/zxz023
      29. Human Rights Campaign Foundation, APhA. Providing Inclusive Care and Services for the Transgender and Gender Diverse Community: A Pharmacy Resource Guide. Published March 2021. Accessed April 10, 2023. https://www.thehrcfoundation.org/professional-resources/transgender-pharmacy-guide#overview
      30. Hippensteele A. Expert: 'we all hold implicit biases' that may contradict explicit beliefs, impact patient health. Pharmacy Times. Published October 2, 2022. Accessed April 10, 2023. https://www.pharmacytimes.com/view/expert-we-all-hold-implicit-biases-that-may-contradict-explicit-beliefs-impact-patient-health
      31. Graham J. 'they treat me like I'm old and stupid': Seniors decry health providers' age bias. KFF Health News. Published October 20, 2021. Accessed April 10, 2023. https://kffhealthnews.org/news/article/ageism-health-care-seniors-decry-bias-inappropriate-treatment/
      32. Boone R. Civil rights complaint targets Idaho Health Care Rationing. AP News. Published September 24, 2021. Accessed April 10, 2023. https://apnews.com/article/coronavirus-pandemic-business-discrimination-race-and-ethnicity-idaho-4a152d4f4f809bfb6588b9025c400d6b
      33. Santee J, Barnes K, Borja-Hart N, et al. Correlation Between Pharmacy Students' Implicit Bias Scores, Explicit Bias Scores, and Responses to Clinical Cases. Am J Pharm Educ. 2022;86(1):8587. doi:10.5688/ajpe858
      34. Miller CS, Scott SD, Beck M. Second victims and mindfulness: A systematic review. J Pat Saf Risk Manag. 2019;24(3):108-117. doi:10.1177/2516043519838176
      35. Coughlan B, Powell D, Higgins MF. The Second Victim: a Review. Eur J Obstet Gynecol Reprod Biol. 2017;213:11-16. doi:10.1016/j.ejogrb.2017.04.002
      36. Everly GS. Psychological first aid to support healthcare professionals. J Pat Saf Risk Manag. 2020;25(4):159-162. doi:10.1177/2516043520944637
      37. Sukhera J, Bertram K, Hendrikx S, et al. Exploring implicit influences on interprofessional collaboration: a scoping review. J Interprof Care. 2022;36(5):716-724. doi:10.1080/13561820.2021.1979946
      38. Simpson A. The impact of team processes on psychiatric case management. J Adv Nurs. 2007;60(4):409-418 doi:10.1111/j.1365-2648.2007.04402.x
      39. Huecker MR, Shreffler J, McKeny PT, Davis D. Imposter Phenomenon. In: StatPearls. Treasure Island (FL): StatPearls Publishing; September 9, 2022.
      40. Sullivan JB, Ryba NL. Prevalence of impostor phenomenon and assessment of well-being in pharmacy residents. Am J Health Syst Pharm. 2020;77(9):690-696. doi:10.1093/ajhp/zxaa041
      41. Wenger LM, Rosenthal M, Sharpe JP, Waite N. Confronting inequities: A scoping review of the literature on pharmacist practice and health-related disparities. Res Social Adm Pharm. 2016;12(2):175-217. doi:10.1016/j.sapharm.2015.05.011
      42. CDC. Social Determinants of Health. Centers for Disease Control and Prevention. Published 2022. https://www.cdc.gov/about/sdoh/index.html
      43. Cernasev A, Desselle S, Hohmeier KC, Canedo J, Tran B, Wheeler J. Pharmacy Technicians, Stigma, and Compassion Fatigue: Front-Line Perspectives of Pharmacy and the US Opioid Epidemic. Int J Envir Res Pub Health. 2021; 18(12):6231. doi:10.3390/ijerph18126231
      44. Borchardt LN, Pickett ML, Tan KT, Visotcky AM, Drendel AL. Expedited Partner Therapy: Pharmacist Refusal of Legal Prescriptions. Sex Transm Dis. 2018;45(5):350-353. doi:10.1097/OLQ.0000000000000751
      45. Murphy AL, Gardner DM. A scoping review of weight bias by community pharmacists towards people with obesity and mental illness. Can Pharm J (Ott). 2016;149(4):226-235. doi:10.1177/1715163516651242
      46. Prasad-Reddy L, Fina P, Kerner D, Daisy-Bell B. The Impact of Implicit Biases in Pharmacy Education. Am J Pharm Educ. 2022;86(1):8518. doi:10.5688/ajpe8518
      47. Terry K, Nickman NA, Mullin S, Ghule P, Tyler LS. Implementation of implicit bias awareness and action training in a pharmacy residency program. Am J Health Syst Pharm. 2022;79(21):1929-1937. doi:10.1093/ajhp/zxac199

      All “Prior Authorizations” are Not Created Equal: A Guide to Medicare Part D Prescription Drug Coverage

      Learning Objectives

       

      After completing this application-based continuing education activity, pharmacists will be able to

      • Describe the different types of prescription drug coverage available to Medicare patients
      • Explain the patient costs associated with Medicare Part D prescription drug coverage
      • Demonstrate use of a patient’s Medicare Part D formulary to determine the appropriate type of coverage determination
      • Identify prescriptions that Medicare Part D does not cover

       

      After completing this application-based continuing education activity, pharmacy technicians will be able to:

      • Describe the different types of prescription drug coverage available to Medicare patients
      • Explain the patient costs associated with Medicare Part D prescription drug coverage
      • Identify the types of coverage determinations available for Medicare Part D prescriptions
      • Outline the timeframes involved in Medicare Part D coverage determination and appeal decisions

       

         

        Release Date: March 15, 2024

        Expiration Date: March 15, 2027

        Course Fee

        Pharmacists:  $7

        Pharmacy Technicians: $4

        There is no funding for this CE.

        ACPE UANs

        Pharmacist: 0009-0000-24-015-H04-P

        Pharmacy Technician:  0009-0000-24-015-H04-T

        Session Codes

        Pharmacist:  24YC15-XTK93

        Pharmacy Technician:  24YC15-KFV48

        Accreditation Hours

        2.0 hours of CE

        Accreditation Statements

        The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-24-015-H04-P/T will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

         

        Disclosure of Discussions of Off-label and Investigational Drug Use

        The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

        Faculty

        Lori R. Donnelly, PharmD
        Consultant
        BluePeak Advisors
        Chardon, OH

        Faculty Disclosure

        In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

        Dr. Donnelly is a consultant with Blue Peak Consultancy that assists those with government healthcare concerns. Any conflict of interest has been mitigated.

         

        ABSTRACT

        Millions of Americans are enrolled in Medicare Part D, with hundreds of specific Part D plans available across the country. The Centers for Medicare & Medicaid Services (CMS) regulates Part D coverage. Part D plans must submit their plan costs and formularies, including formulary restrictions, to CMS for annual approval. Patient costs for Part D coverage vary based on the specific choice of plan and the benefit phase. All Part D plans must provide a process for requesting coverage of prescription medications that are not on the formulary or on the formulary with restrictions. Pharmacists and pharmacy technicians are valuable resources and can advise Part D patients and prescribers about prescription costs and the options available for non-covered medications.

        CONTENT

        Content

        INTRODUCTION

        As of April 2023, more than 51 million Americans were enrolled in prescription drug coverage through Medicare, with the number of enrollees steadily increasing every year.1 Private insurance companies contracted by the Centers for Medicare & Medicaid Services (CMS) provide Medicare prescription drug coverage. Although specific plans’ details differ, CMS requires that all plans offer certain features.

        Pharmacists and pharmacy technicians can assist patients in navigating these features to maximize their prescription benefits. This continuing education activity will review the types of Medicare prescription drug coverage, associated patient costs, formulary structure, and the options available when a patient’s Part D plan does not cover a medication.

        MEDICARE AND PRESCRIPTION DRUG COVERAGE

        CMS provides “Original Medicare” to most Americans aged 65 and older. Original Medicare includes2:

        • Part A: Most Americans are eligible for Medicare Part A at no additional cost, as long as they or their spouses have paid sufficient Medicare taxes. Medicare Part A includes coverage for inpatient hospital stays, hospice, and skilled nursing facility care.
        • Part B: Medicare Part B is optional and usually requires additional fees. Part B coverage includes outpatient and home health care, preventive services, and durable medical equipment.

        CMS contracts with private insurance companies to provide prescription drug coverage. Individuals enrolled in Original Medicare may purchase a standalone Part D Prescription Drug plan (PDP) for outpatient prescription drug coverage.

        Rather than using CMS coverage, individuals may purchase Medicare-approved private insurance called Medicare Advantage (MA), also known as Part C. With this arrangement, the MA Plan supersedes Medicare Part A and Part B for most coverage. MA plans often have lower patient costs and extra benefits compared to Original Medicare but may have fewer covered hospitals and physicians.2 Medicare Advantage Prescription Drug (MAPD) plans are MA plans that include prescription drug coverage and eliminate the need for a separate PDP.

         

        SIDEBAR: Patient Costs Defined

        Monthly Premium: a monthly payment that maintains enrollment in the plan; not impacted by deductible, copay, or coinsurance amounts

        Annual Deductible: a yearly dollar amount the patient pays before insurance starts to contribute

        Copayment (or Copay): a specific, pre-determined dollar amount the patient pays for each prescription, office visit, or other type of care after satisfying the deductible

        Coinsurance: an alternative to a copay, the percentage of the total cost the patient pays for each prescription, office visit, or other type of care after satisfying the deductible

         

        Medicare plans are associated with various costs to the enrollee (see SIDEBAR: Patient Costs Defined). Individuals with income higher than a predefined threshold pay a higher premium for their Part B coverage due to Medicare’s Income Related Monthly Adjustment Amount (IRMAA). IRMAA does not change any of the other costs associated with Medicare coverage. CMS may also issue a late enrollment penalty (LEP) to people who do not sign up for Part D (from either a PDP or MAPD) as soon as they become eligible for Medicare. Once assigned, CMS adds the LEP to the patient’s monthly Part D premium for the remainder of their enrollment in Part D, regardless of which Part D plan they choose. Even people not actively taking prescription medications should consider choosing a Part D plan with a low monthly premium and/or no annual deductible to avoid incurring LEP.2

        Individuals and couples with incomes and assets less than an annual threshold set by CMS may qualify for a Low Income Subsidy (LIS), also known as “extra help.” For people who qualify, the LIS reduces or eliminates the Part D monthly premium, deductible, and copay/coinsurance. CMS automatically enrolls most qualified patients into extra help, but a manual application process is also available. Pharmacy personnel should refer patients to 1-800-MEDICARE or https://www.medicare.gov/basics/costs/help/drug-costs to see if they qualify for LIS.3

        Once a patient decides between Original Medicare or MAPD coverage, the next step is choosing a specific plan. CMS provides a comprehensive platform, called Medicare Plan Finder (MPF) for patients to shop and compare costs for PDP and MAPD plans. Patients can enter their medication list and see detailed cost information for each prescription. MPF also includes information about participating pharmacies and Star Ratings, a system CMS uses to measure each Part D plan’s performance in the areas of customer service, member experience, drug safety, and drug pricing accuracy. CMS rates plans on a scale of one to five stars, with five stars indicating the highest level of performance.4

        The MPF tool is located at www.medicare.gov/plan-compare.

        It is not necessary for pharmacy personnel to distinguish between MAPD and PDP coverage before processing prescription claims. The member’s prescription drug card provides the details needed to submit pharmacy claims to either type of Part D plan. If the member’s prescription drug card is not available, CMS provides a process known as an E1 transaction that returns Part D coverage information using basic demographic information. Pharmacists and technicians should consult their employer’s training materials for specific instructions on submitting an E1 transaction.5

        The Part D Coverage Cycle

        The Part D coverage cycle runs January to December each year. Regardless of when an individual reaches each phase of coverage, summarized in Figure 1, they start over in the deductible phase each year on January 1st. Only “True Out-of-Pocket” (TrOOP) costs as defined by CMS go toward the thresholds to move patients through each of the four coverage phases. Patient costs excluded from TrOOP are6

        • Medications not covered by the Part D plan
        • Prescriptions obtained at non-participating (i.e., out-of-network [OON]) pharmacies, except those specifically allowed under the Part D plan’s rules
        • Costs reimbursed by an organization other than the Part D plan

        Wheel showing Medicare coverage timeline sections

        PAUSE AND PONDER: Some patients with lower prescription costs do not complete their annual deductible until November or December. They are surprised when their out-of-pocket costs increase again in January. How would you explain the increase?

         

        Patients with higher prescription costs may also be subject to the coverage gap, commonly known as the “Donut Hole” (see SIDEBAR: Explaining the Donut Hole). The coverage gap occurs when a patient’s prescription drug costs exceed a defined threshold under Medicare Part D. In the coverage gap, a patient’s out-of-pocket cost for brand name prescriptions may increase. 7 Patients with very high prescription drug costs may reach the end of the coverage gap to enter catastrophic coverage, where they pay nothing out of pocket. The Inflation Reduction Act of 2022 removed patient costs from the catastrophic phase starting in 2024 and eliminated the coverage gap starting in 2025.8

         

        SIDEBAR: Explaining the Donut Hole

        Have you ever wondered why the Medicare Part D coverage gap is called the “Donut Hole?”

        Imagine a giant donut, a circle with a hole in the middle, big enough to drive through. Half of the donut is plain, but the other half has frosting and sprinkles. In January, you start driving in a straight line through the plain half of the donut, toward the frosted half. Your drug costs determine your speed.

        The plain half of the donut represents the annual deductible and initial coverage phases where you are subject to normal coverage amounts.

        If high drug costs cause you to drive faster, you exit the plain half of the donut and enter the donut’s hole before the end of the year. You are now driving where there is no donut, and you must pay more than the normal amount for brand name drugs.

        If your drug costs are high enough that you speed to the other side of the hole before the end of the year, then you enter the frosting and sprinkles half of the donut. Frosting and sprinkles represent the additional Part D contributions in the catastrophic phase and you pay nothing out of pocket.

        Unfortunately, your car has only a 365-day warranty, so when January comes, you must start all over at the plain side of the donut.

         

        An annual bidding process determines the specific costs for each Part D plan. Each year, CMS sets limits and thresholds for certain aspects of Part D coverage but allows flexibility within these parameters for both PDP and MAPD plans. Insurance companies submit bids that demonstrate how their plans comply with CMS’s annual limits and thresholds. The financial information that contributes to each plan’s annual bid is highly complex, and CMS can either accept or reject each bid.

        As part of the annual bidding process, CMS defines standard prescription drug coverage. For a “basic” Part D plan, a bid must either match or be financially equivalent to the CMS definition of standard coverage. Table 1 provides the 2023 and 2024 standard benefit parameters, as defined by CMS.9

         

        Table 1. Limits and Thresholds for 2023 and 2024 Medicare Part D Plans9

        2023 2024
        Annual Deductible Limit $505 $545
        Initial Coverage Limit (starts the coverage gap) $4660 total drug costs $5030 total drug costs
        Out-of-Pocket Limit (ends the coverage gap and starts catastrophic phase) $7400 patient cost $8000 patient cost

         

        Insurance companies may also offer “enhanced” Part D plans with coverage that is more robust than the defined standard. Most plans with enhanced coverage have higher monthly premiums compared to basic plans but offer corresponding advantages such as reduced deductibles, lower copays/coinsurance, and lower costs in the coverage gap.

        Individuals should choose their Part D plans carefully because they can only sign up or change Part D plans during certain periods2:

        • During the 3-month initial enrollment period that starts 1 month before and ends 1 month after an individual’s 65th birthday; coverage starts the month after initial enrollment
        • During the annual open enrollment period that runs from mid-October to early December each year; coverage starts on January 1 of the following year for people who enroll during annual open enrollment
        • During the Medicare Advantage open enrollment period that runs from January through March each year; during this time, CMS only allows certain types of changes
        • During special enrollment periods for qualifying events such as relocation or the loss of employer or Medicaid coverage. Natural disasters that disrupt the initial or annual enrollment period may also create special enrollment periods

        Prescription Coverage Under Medicare Parts A and B

        Original Medicare provides prescription drug coverage under very limited circumstances and CMS prohibits Part D from covering anything covered under Medicare Parts A or B.

        Medicare Part A covers hospice care, including medications related to the hospice diagnosis. Hospice providers receive payment for these medications from CMS and are responsible for paying the pharmacy. Medicare Part D is prohibited from covering medications related to any hospice diagnosis.10

        Medicare Part B provides the only coverage options for some items, such as diabetic testing supplies and certain vaccines. Coverage for other items may fall under Part B or Part D, depending on the specific circumstances. Table 2 compares Part B and Part D coverage for the most common examples.10

        Table 2. Medicare Part B and Part D Coverage of Common Products

        Product(s) Part B Coverage Part D Coveragea
        Nebulizer Solutions (such as albuterol sulfate and ipratropium bromide) For patients residing at home. For patients residing in a long-term care facility.
        Influenza, Hepatitis B, Pneumonia, and Coronavirus (COVID-19) Vaccines Yes No
        Immunosuppressants (such as cyclosporine and mycophenolate mofetil) When used to prevent rejection of a Medicare-covered transplant. When used for a medically accepted indication other than a Medicare-covered transplant.
        Oral Anti-Cancer Drugs (such as cyclophosphamide and methotrexate) When used to treat cancer. When used to treat a medically accepted indication other than cancer.
        Oral Anti-Emetic Drugs (such as ondansetron and promethazine) When used to treat or prevent chemotherapy-related nausea and vomiting. When used to treat or prevent medically accepted indications other than chemotherapy-related nausea and vomiting.
        Insulin When used in an insulin pump. When not used in an insulin pump.
        Diabetic Testing Supplies (such as test strips and lancets) Yes No
        Insulin Injection Supplies (such as needles and alcohol swabs) No Yes
        aCoverage may be subject to formulary restrictions.

         

        Part D plans are responsible for rejecting pharmacy claims for medications that may be covered under Part A or Part B. Pharmacy personnel should refer to claim reject messaging and redirect the claim appropriately.

         

        Other Prescription Drug Coverage

        Most people who qualify for Medicare are covered by some combination of Parts A, B, C, and D as described above. However, other prescription drug coverage options are available under special circumstances:

        • Employer Group Waiver plans (EGWPs): Employers may choose to provide prescription drug coverage for their retirees by contracting with a Part D plan for EGWP coverage. Retirees with EGWP plans that start as soon as they become eligible for Medicare are exempt from LEP. When providing an EGWP plan for their retirees, employers may also add additional benefits paid either through Part D or by the employer themselves.11
        • Medicare Supplemental Insurance (Medigap): Medigap coverage helps with costs not covered by Medicare Parts A and B, such as copays and deductibles. Certain Medigap plans also help with skilled nursing facility or hospice costs and emergency care while traveling outside of the United States. Individuals who enrolled in Medigap prior to 2006 may have prescription drug coverage included, but those who are newer to Medigap should purchase separate Part D coverage to avoid LEP.12
        • Employer Coverage: Individuals who are actively employed (not retired) may have coverage through their employer to replace Medicare or use Medicare as secondary coverage. Covered employees are exempt from the LEP if the employer coverage is equivalent to at least a basic Part D plan.2
        • Consolidated Omnibus Budget Reconciliation Act (COBRA): People who have recently separated from an employer may be eligible for COBRA. Individuals enrolled in COBRA may still be subject to LEP because COBRA is usually not equivalent to Medicare coverage.2
        • Medicaid: People with low incomes who qualify for both Medicaid and Medicare receive the LIS and have Part D coverage with reduced patient costs. In most cases, Medicare pays first and Medicaid helps with remaining costs.2
        • Manufacturer Discount Programs: Many drug manufacturers provide coupons, discount cards, and patient assistance programs to help cover their products’ cost. Federal law prohibits using these manufacturer payments in combination with Medicare prescription drug coverage.13 Medicare patients may choose manufacturer coupons or patient assistance programs for certain prescriptions only when they do not use their Part D coverage.
        • Prescription Discount Cards: Unlike manufacturer discounts, which are limited to products produced by that manufacturer, prescription discount cards offer discounts on a wide range of medications. Also known as “cash cards”, prescription discount cards reduce the cash price of prescriptions, but are not used in combination with insurance, including Medicare.14 Patients who choose a prescription discount card cannot use it in combination with their Part D coverage for the same medication.

        MEDICARE PART D FORMULARIES

        CMS requires Part D plans to maintain a list of covered drugs, called a formulary. CMS reviews each Part D formulary to ensure sufficient coverage under each drug class. The copay or coinsurance for each medication on the formulary is determined by its “tier.” Medications on lower tiers generally cost less than drugs on higher tiers.15 CMS allows some flexibility on how Part D plans define their formulary tiers, so tier structure differs between plans. Figure 2 provides an example of a formulary tier arrangement.

        Image showing Tier 1-5 of covered medications, where tier 1 has the lowest copay and tier 5 has the highest copay

         

        Drug Placement and Formulary Restrictions

        Specialty medications are high-cost prescription products used to treat complicated medical conditions. CMS limits the patient cost portion for these medications and Part D plans typically place all specialty mediations into designated formulary tiers.10

        CMS requires that Part D plans cover adult vaccines (excluding those covered under Part B) recommended by The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices at no cost to the patient, regardless of formulary tier or benefit phase.16

        In 2023, CMS began setting a maximum copay for insulin products covered under Part D. Currently, the maximum copay is $35 for a one-month supply and is subject to change on an annual basis. Insulin copays may be lower if a Part D plan includes specific insulin products on a formulary tier where the monthly copay is lower than the CMS maximum. A similar program exists for insulin used in an insulin pump and covered under Part B.16

        Part D plans may put restrictions on formulary medications to ensure appropriate coverage and to control costs. CMS reviews the restrictions and will not allow overly restrictive formularies. Plans may place four types of restrictions on formulary medications10:

        • Quantity Limit: Quantity limit restrictions define the maximum number of dosage units allowed for a specific time period.
        • Step Therapy: Step therapy restrictions require patients to first try a different medication, usually a lower cost alternative, before the prescribed medication.
        • Prior Authorization: Prior authorizations require patients to meet specific criteria, which may be as simple as providing the diagnosis or more complicated (e.g., specific lab tests, involvement of a specialist physician).
        • Drug Utilization Review (DUR): May be “hard edits” that require a coverage determination or “soft edits” that require the dispensing pharmacist to obtain clinical information and enter a set of codes into the prescription claim.

        CMS defines six drug classes—those used to treat disorders where changes or interruptions in therapy involve higher risk—as “protected class.” CMS requires that Part D formularies include most medications within these classes with at least one medication on a preferred tier and no restrictions. Plans are not, however, required to include all variations of each medication (i.e., brand name and generic or immediate and extended-release versions). The six protected classes are10

        • immunosuppressants (used to prevent organ transplant rejection)
        • antidepressants (used to treat depression)
        • antipsychotics (used to treat mental health disorders)
        • anticonvulsants (used to treat seizure disorders)
        • antiretrovirals (used to treat human immunodeficiency virus)
        • antineoplastics (used to treat cancer)

        CMS allows plans to add medications and make other positive changes to their formulary throughout the year but restricts medication removal and other negative changes until the following January. This restriction protects patients from losing coverage for their prescriptions during the time when they cannot switch to a different Part D plan. Marketplace removal, safety concerns, and the availability of a new generic are examples of situations when CMS would allow removal of a medication from a Part D formulary during the year.

        Part D plans must provide patients with ongoing access to their formulary information. Most Part D plans post formularies online and only provide paper copies upon request. Patients can also see the formulary status for their specific medications when comparing Part D plans using the MPF website.

         

        COVERAGE DETERMINATIONS AND APPEALS

        Patients and pharmacy personnel commonly generalize the term “prior authorization” to describe any situation that requires insurance approval before insurance covers a prescription. Under Medicare Part D, this is known as the coverage determination process. Part D patients may use the coverage determination process to request approval for a non-formulary medication or a formulary medication with restrictions.

        Who hasn’t been frustrated after contacting a prescriber to change a non-formulary prescription to a formulary medication, only to have the formulary medication require prior authorization? Part D plans usually include messaging within rejected claims to help determine which type of coverage determination is needed. When faced with a prescription rejection, pharmacists and pharmacy technicians who understand the nuances of the coverage determination process are equipped to advise their Part D patients on the best course of action.

        Several specific types of coverage determinations are available and each type of coverage determination has specific criteria for approval.16,17 Table 3 provides a summary of coverage determination types, their uses, and the information required for approval.

        Table 3. Types of Coverage Determinations and Their Uses16,17

        Medication Status Coverage Determination Requirements for Approval
        On the formulary, but dosing regimen requires more than the formulary allowance or requires tablet splitting Quantity Limit Exception The quantity allowed by the plan’s formulary is not effective in treating the patient’s condition or requires tablet-splitting to achieve the prescribed dosing regimen.
        On the formulary with step therapy restrictions Step Therapy Exception

         

        The patient tried the step medication and either did not achieve therapeutic effect or experienced an adverse outcome.
        Step Therapy The patient is likely to experience an adverse outcome if they must first try the step medication.
        On the formulary with prior authorization or “hard” DUR restrictions Prior Authorization

         

        The patient meets the Part D plan’s specific criteria for the prescribed medication.
        On the formulary with a “soft” DUR restriction None DUR “soft edits” may require dispensing pharmacists to contact prescribers and obtain clinical information, but do not require a coverage determination.
        Sometimes by Medicare Part B Prior Authorization Why the patient’s situation warrants coverage under Part D for the prescribed medication.
        On the formulary, but the patient cannot afford the copay/coinsurance Tier Exception The required number of lower tier drugs for the same condition are less effective or likely to result in an adverse outcome.

         

        Not available for specialty or non-formulary medications and cannot provide a brand name medication at the generic cost.

        Not on the formulary Non-formulary Exception

         

        The required number of formulary alternative medication(s) were ineffective or likely to result in an adverse outcome.

        Patients should consult their specific plan information to find out how many alternatives are required for tier or non-formulary exceptions.

        Part D plans will only approve a coverage determination request if the product is medically necessary and if the information submitted by the prescriber meets the plan’s criteria. Prescribers may submit information over the phone, by fax, or by mail. Most Part D plans also have an electronic portal to accept information from prescribers. Dispensing pharmacists are only permitted to supply information in place of the prescriber under limited circumstances, such as prior authorizations to determine Part B versus Part D coverage.

        Approval and Denial Parameters

        For exception requests that meet approval criteria, CMS requires Part D plans to maintain the approval at least through the end of the year. Part D plans may approve prior authorizations for a shorter time only if clinically appropriate and approved by CMS as part of the annual formulary approval process.

        Part D plans will deny requests with incomplete information and requests that do not meet approval criteria. Part D plans will also deny any type of coverage determination if the medication is being used for a non-medically accepted indication. Medically accepted indications are uses approved by the United States Food and Drug Administration or listed in one of the references that CMS defines as approved compendia10:

        • American Hospital Formulary Service Drug Information
        • DRUGDEX Information System
        • Peer-reviewed medical literature (only allowed for biologics and anti-cancer chemotherapy medications)

        Common examples of medications prescribed for non-medically accepted indications include the use of fentanyl lollipops/lozenges for non-cancer pain and hydroxychloroquine for coronavirus disease 2019 (COVID-19). Federal and state laws may allow prescriptions for non-medically accepted indications, but patients cannot use their Part D coverage to pay for them. Part D plans must block medication coverage if the determination process reveals a non-medically accepted indication, even for previously covered medications, quantities less than the predetermined limit, and any tier cost after a tier exception request.10 Pharmacists are not required to confirm medically accepted indications before dispensing prescriptions because CMS considers this a plan responsibility. As a result, Part D plans will often reject claims and require a prior authorization for medications commonly prescribed for non-medically accepted indications. Pharmacists and pharmacy technicians can assist patients and prescribers by communicating rejected claim information and explaining the CMS requirement for medically accepted indications. 10

        In addition to medications covered under Part A or B, CMS specifically excludes certain types of medications from Part D coverage10:

        • Products used for weight loss or weight gain
        • Fertility medications
        • Cosmetic and hair growth products
        • Treatments for the symptomatic relief of cough and colds
        • Non-prescription medications
        • Prescription vitamins, except prenatal and fluoride products
        • Erectile dysfunction treatments

        Bulk powders and inert excipients used for compounded prescriptions are also excluded from Part D coverage. Compounds may contain other ingredients that are covered with or without restrictions under Part D. When pharmacies bill some of a compound’s ingredients to Part D, CMS prohibits them from charging patients for the non-Part D portion.10

        Patients cannot obtain Part D coverage for excluded medications using the coverage determination process. Employers may cover some of these medications and manufacturer coupons or prescription discount cards may help make these products more affordable for individuals without employer coverage.

        PAUSE AND PONDER: Generic sildenafil is prescribed for both erectile dysfunction (excluded from Part D coverage) and pulmonary hypertension (eligible for Part D coverage). Can a dispensing pharmacist distinguish between the two to bill Part D for the appropriate product?

        Part D plans may dismiss requests that are inappropriate, unnecessary, or filed incorrectly. CMS requires Part D plans to provide written notification and a reason for the dismissal to the patient and prescriber. 17

        If the patient or prescriber decides that a request is unnecessary, they can withdraw the request before a decision is issued. Withdrawing a request does not prevent the patient or prescriber from submitting a later request for the same medication.17

        When a Part D plan denies a coverage determination, CMS requires them to send the specific reason(s) for the denial to the patient and the prescriber. Part D plans may choose to also send a copy of this information to the dispensing pharmacy.17 Depending on the reason for the denial, the patient or prescriber may choose to appeal the Part D plan’s decision.

        Appeal requests must be within 60 days of the denial, unless good cause is established for missing the 60-day deadline. If the Part D plan denies the appeal, beneficiaries have up to four additional opportunities to appeal through entities outside of their Part D plan. After the second level, higher levels of appeal are only available if the drug cost meets a specific threshold set by CMS.18 Figure 3 outlines the five levels of appeal available to Part D patients.

        Image showing timeline of insurance coverage denials and appeals

        A patient or prescriber can request a re-opening instead of the next level appeal if they feel that a coverage determination or appeal decision is in error. Part D plans may also initiate a re-opening if they identify a decision error.

        Direct Member Reimbursements

        Patients who pay for a covered Part D prescription without using their Part D Insurance may be eligible for reimbursement from their Part D plan through a process called Direct Member Reimbursement (DMR). To qualify for DMR, the prescription must meet the Part D plan’s coverage requirements and not be covered by any other type of insurance or discount card. Prescriptions obtained at an OON pharmacy must meet the Part D plan’s OON rules to qualify for reimbursement.19

        Pharmacies should submit Part D prescriptions to the patient’s Part D plan whenever possible because a DMR reimbursement may not result in a full refund of the cash price.

         

        Timeframes

        Part D plans must offer both standard and expedited timeframes for coverage determination and appeal requests (listed in Table 4). Expedited requests are available when the standard timeframe could result in a significant adverse outcome. DMR requests do not qualify for expedited timeframes because the patient has already received the medication.17

        Table 4. Plan Timeframes for Medicare Part D Requests16

        Request Level Request Urgency Request Type Required Timeframe
        Initial Coverage Determination Standard Quantity Limit Exception

        Step Therapy Exception

        Tier Exception

        Non-Formulary Exception

        72 hours from supporting statement but no longer than 14 days from request received

         

        Initial Coverage Determination Expedited Quantity Limit Exception

        Step Therapy Exception

        Tier Exception

        Non-Formulary Exception

        24 hours from supporting statement but no longer than 14 days from request received

         

        Initial Coverage Determination Standard Prior Authorization

        Step Therapy (non-exception)

        72 hours from request received
        Initial Coverage Determination Expedited Prior Authorization

        Step Therapy (non-exception)

        24 hours from request received
        Initial Coverage Determination N/A Direct Member Reimbursement 14 days from request received
        First Level Appeal Standard Quantity Limit Exception

        Step Therapy Exception

        Tier Exception

        Non-Formulary Exception

        Prior Authorization

        7 days from request received
        First Level Appeal Expedited Quantity Limit Exception

        Step Therapy Exception

        Tier Exception

        Non-Formulary Exception

        Prior Authorization

        72 hours from request received
        First Level Appeal N/A Direct Member Reimbursement Notification of Decision: 14 days from request received

        Payment (if approved): 30 days from request received

         

        Part D plans may automatically apply the expedited timeframe if the clinical information submitted for the coverage determination indicates that waiting may harm the patient’s health. Alternatively, Part D plans may downgrade an expedited request if they determine that the patient’s health will not be harmed by using the standard timeframe. CMS requires Part D plans to notify the patient if a request is downgraded from expedited to standard.17

        All Part D timeframes are based on calendar hours/days and include weekends and holidays. Timeframes start as soon as the Part D plan receives a non-exception coverage determination or any type of valid appeal request, regardless of how much clinical information is included with the request. For exception requests, the timeframe starts as soon as the Part D plan receives clinical information from the prescriber to support the request (known as the prescriber’s supporting statement). When a supporting statement is missing from an exception request, CMS allows up to 14 days for plans to obtain it.17 The following examples demonstrate Part D timeframes over weekends and holidays:

        • A patient requests a standard prior authorization on Friday afternoon, December 23. The prescriber’s office is closed for the three-day holiday weekend. The plan must deny the request in 72 hours (on Monday afternoon), even though the prescriber’s office was not available to provide information during that timeframe.
        • A different patient requests a standard non-formulary exception the same day. Their prescriber’s office is also closed for the three-day holiday weekend but contacts the plan with the supporting information on Tuesday morning. Since this is an exception request, 72 hour timeframe starts on Tuesday morning and the plan has until Friday morning to complete the request.

        When clinical information is incomplete, CMS requires that Part D plans make reasonable efforts to contact the prescriber and obtain the missing information. Once the timeframe has started, making outreach attempts and waiting for additional information does not extend the request timeframe. The Part D plan will deny the request if they do not receive sufficient clinical information by the end of the allotted timeframe.17

        PAUSE AND PONDER: It’s late Friday afternoon and your patient is anxious to request a prior authorization for her medication. The physician’s office is closed for the weekend. Could requesting an expedited coverage determination at this point cause more of a delay?

        When a Part D plan does not process a request within the required timeframe, they must send the request to the IRE as an “auto-forward.” This is the same IRE that processes Part D second-level appeals. Part D plans must notify patients in the event of an auto-forward. CMS monitors Part D plans’ timeliness and issues penalties for excessive numbers of auto-forwards.

        How to Submit Requests

        CMS requires that Part D plans accept coverage determination requests via phone, fax, or mail. For appeals, plans must accept both standard and expedited requests via fax or mail. Verbal requests by phone are required for expedited appeals but optional for standard appeals.17 Many plans also choose to accept electronic requests via an online portal.

        Patients should follow the instructions from their specific Part D plan for requesting a DMR. Part D plans usually require hard copies of payment receipts, so most patients file DMR requests by mail.

        CMS does not permit Part D plans to require a specific form to submit a coverage determination, appeal, or DMR request.17 Although optional, using a form provided by the plan usually streamlines the process and reduces the risk of submitting incomplete information.

        CMS does not allow dispensing pharmacists or pharmacy technicians to request a Part D coverage determination or appeal on behalf of the patient. Only the patient, the patient’s appointed representative, the prescriber, or the prescriber’s staff can request a coverage determination or appeal. Only patients or their appointed representative can request a DMR.17

        The handout entitled “Medicare Prescription Drug Coverage and Your Rights” that dispensing pharmacies supply to patients when prescriptions cannot be filled under their Part D plan provides additional instructions for submitting requests.17,20

        CONCLUSION

        Medicare patients have many choices available for their prescription drug coverage. CMS requires that all Part D plans conform to a set of common standards while allowing specific plans to offer a wide range of benefit options.

        Pharmacists and pharmacy technicians with a basic understanding of Part D coverage options, patient costs, formulary structure, and the coverage determination and appeals process can help patients maximize the benefit from their Part D plan. Although CMS does not allow them to initiate coverage determinations and appeals, pharmacy personnel can advise Part D patients and their physicians on the most effective next steps when faced with a non-covered prescription.

        Pharmacist Post Test (for viewing only)

        All “Prior Authorizations” are Not Created Equal: A Guide to Medicare Part D Prescription Drug Coverage

        Pharmacists Post-test

        After completing this continuing education activity, pharmacists will be able to
        1. Describe the different types of prescription drug coverage available to Medicare patients.
        2. Explain the patient costs associated with Medicare Part D prescription drug coverage.
        3. Demonstrate use of a patient’s Medicare Part D formulary to determine the appropriate type of coverage determination.
        4. Identify prescriptions that Medicare Part D does not cover.

        1. Which of the following is the correct description for the type of Medicare coverage?
        A. Medicare Part A: Covers outpatient and home health care, preventative services, and durable medical equipment.
        B. Medicare Part B: Offered by private insurance companies for prescription drug coverage.
        C. Medicare Part C: Offered by private insurance companies to provide Part A and Part B coverage.

        2. What is an appropriate combination of coverage?
        A. Medicare Part A + Medicare Part B + Medicare Part D
        B. Medicare Part A + Medicare Part B + MAPD
        C. Employer Coverage + Medigap + MAPD

        3. A patient who is turning 65 next month asks you about delaying Part D coverage because she only takes two prescriptions that are very low cost using a prescription discount card. What is the possible risk of this approach when she eventually signs up for Part D coverage at a later date?
        A. She may pay higher monthly premiums due to the coverage gap.
        B. She may pay higher annual deductibles due to the late enrollment penalty.
        C. She may pay higher monthly premiums due to the late enrollment penalty.

        4. It’s January and a patient who paid a $10 copay for his prescription last month now has to pay 100% of the cost. What is the most likely explanation?
        A. He is paying the annual deductible
        B. He is in the coverage gap
        C. His Part D plan doesn’t cover his medication

        5. A patient who takes several expensive medications experiences a sharp increase in her out-of-pocket costs around midyear. What is the most likely explanation?
        A. She has entered the deductible phase
        B. She has entered the coverage gap phase
        C. She has entered the catastrophic coverage phase

        6. A patient’s Part D Plan is rejecting a prescription for apixaban. You locate its formulary online and find that dabigatran is listed, but not apixaban. What type of coverage determination does this patient need from this Part D Plan?
        A. Step Therapy
        B. Non-formulary
        C. Prior Authorization

        7. A patient’s Part D Plans is rejecting a prescription for alirocumab. You locate the formulary online and find that alirocumab is on the formulary but is not covered unless simvastatin has been tried first. What type of coverage determination does this patient need from this Part D Plan?
        A. Step Therapy
        B. Prior Authorization
        C. Tier Exception

        8. A Part D patient is struggling to afford his medication, even after the Part D Plan approved a non-formulary exception. What is their best option for lowering costs?
        A. Talk to the prescriber about switching to an alternative on a lower formulary tier.
        B. Ask their Part D Plan for a tier exception.
        C. Find a manufacturer discount coupon to cover their Part D copay.

        9. A Part D patient presents a prescription for a highly advertised diabetic medication and confides in you that she is not diabetic but hoping the medication will help with weight loss. Her Part D Plan requires prior authorization to establish medically accepted indication. What coverage option is available to them?
        A. Part D after prior authorization approval
        B. Manufacturer discount program
        C. Medicare Advantage

        10. A Medicare Part D Plan is rejecting claims for your patient’s diabetic test strips and lancets. What do you recommend as the next course of action?
        A. Call the Part D Plan and request a coverage determination.
        B. Pay out of pocket and ask the Part D Plan for direct member reimbursement.
        C. Compile the documentation required to submit the claims to Part B.

        Pharmacy Technician Post Test (for viewing only)

        All “Prior Authorizations” are Not Created Equal: A Guide to Medicare Part D Prescription Drug Coverage

        Pharmacy Technician Post-test

        After completing this continuing education activity, pharmacy technicians will be able to
        1. Describe the different types of prescription drug coverage available to Medicare patients.
        2. Explain the patient costs associated with Medicare Part D prescription drug coverage.
        3. Identify the types of coverage determinations available for Medicare Part D prescriptions.
        4. Outline the timeframes involved in Medicare Part D coverage determination and appeal decisions.

        1. Which of the following is the correct description for the type of Medicare coverage?
        A. Medicare Part A: Covers outpatient and home health care, preventative services, and durable medical equipment.
        B. Medicare Part B: Offered by private insurance companies for prescription drug coverage.
        C. Medicare Part C: Offered by private insurance companies to replace Part A and Part B coverage.

        2. What is an appropriate combination of coverage?
        A. Medicare Part A + Medicare Part B + Medicare Part D
        B. Medicare Part A + Medicare Part B + MAPD
        C. Employer Coverage + MAPD

        3. A patient who is turning 65 next month asks you about delaying Part D coverage because she only takes two prescriptions that are very low cost using a prescription discount card. What is the possible risk of this approach when she eventually signs up for Part D coverage at a later date?
        A. She may pay higher monthly premiums due to the coverage gap.
        B. She may pay higher annual deductibles due to the late enrollment penalty.
        C. She may pay higher monthly premiums due to the late enrollment penalty.

        4. It’s January and a patient who paid a $10 copay for his prescription last month now has to pay 100% of the cost. What is the most likely explanation?
        A. He is paying the annual deductible
        B. He is in the coverage gap
        C. His Part D plan doesn’t cover his medication

        5. A patient who takes several expensive medications experiences a sharp increase in her out-of-pocket costs around midyear. What is the most likely explanation?
        A. She has entered the deductible phase.
        B. She has entered the coverage gap phase.
        C. She has entered the catastrophic coverage phase.

        6. Which of the following combinations of coverage determinations may be required for a single prescription?
        A. Non-formulary + Quantity Limit
        B. Quantity Limit + Prior Authorization
        C. Tier Exception + Non-formulary

        7. Which type of reject requires a Part D coverage determination?
        A. Non-formulary
        B. Refill too soon
        C. DUR soft edit

        8. Which of the following is the correct description for a type of coverage determination under Medicare Part D?
        A. Non-formulary exceptions: Used to request larger quantities of a medication
        B. Tier Exceptions: Used to request a lower copay for a medication
        C. Prior Authorization: Used to request a non-formulary medication

        9. A patient called her Part D plan yesterday morning to request an urgent appeal for their medication. This afternoon, she has not received a response and the claim is still rejecting. How much longer might she have to wait for a response?
        A. The appeal is already out of timeframe because it has been longer than 24 hours
        B. 6 more days, for a total of 7 days
        C. 2 more days, for a total of 3 days

        10. You are working on a prescription that the Part D Plan is rejecting due to a quantity limit. The patient is not out of medication, so you advise him to call and ask for a standard quantity limit exception. How long should the patient expect to wait for the Part D Plan to make a decision?
        A. 24 hours after the patient calls their Part D Plan to request the coverage determination
        B. 24 hours after their prescriber provides clinical information to the Part D Plan
        C. 72 hours after their prescriber provides clinical information to the Part D Plan

        References

        Full List of References

        References

           

          1. Centers for Medicare & Medicaid Services. Medicare Enrollment Dashboard. Accessed August 28, 2023. https://data.cms.gov/tools/medicare-enrollment-dashboard
          2. Centers for Medicare & Medicaid Services. Medicare & You Handbook. Accessed September 5, 2023. https://www.medicare.gov/medicare-and-you
          3. Centers for Medicare & Medicaid Services. Help with Drug Costs. Accessed September 6, 2023. https://www.medicare.gov/basics/costs/help/drug-costs
          4. Centers for Medicare & Medicaid Services. Explore Your Medicare Coverage Options. Accessed September 13, 2023. www.medicare.gov/plan-compare
          5. RelayHealth. Medicare Eligibility Verification Transaction. Accessed December 28, 2023. https://medifacd.mckesson.com/e1/
          6. Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual Chapter 5: Benefits and Beneficiary Protections. September 20, 2011. Accessed September 5, 2023. https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovcontra/downloads/memopdbmanualchapter5_093011.pdf
          7. Centers for Medicare & Medicaid Services. Costs in the Coverage Gap. Accessed September 6, 2023. https://www.medicare.gov/drug-coverage-part-d/costs-for-medicare-drug-coverage/costs-in-the-coverage-gap
          8. Kaiser Family Foundation. Changes to Medicare Part D in 2024 and 2025 Under the Inflation Reduction Act and How Enrollees Will Benefit. Accessed December 27, 2023. https://www.kff.org/medicare/issue-brief/changes-to-medicare-part-d-in-2024-and-2025-under-the-inflation-reduction-act-and-how-enrollees-will-benefit
          9. Centers for Medicare & Medicaid Services. Announcement of Calendar Year (CY) 2024 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies. March 31, 2023. Accessed September 6, 2023. https://www.cms.gov/files/document/2024-announcement-pdf.pdf
          10. Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual Chapter 6 – Part D Drugs and Formulary Requirements. January 15, 2026. Accessed August 23, 2023. https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovcontra/downloads/part-d-benefits-manual-chapter-6.pdf
          11. Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual Chapter 12 – Employer/Union Sponsored Group Health plans. November 7, 2008. Accessed September 5, 2023. https://www.cms.gov/regulations-and-guidance/guidance/transmittals/downloads/dwnlds/r6pdbpdfpdf
          12. Centers for Medicare & Medicaid Services. Learn How Medigap Works. Accessed October 25, 2023. https://www.medicare.gov/health-drug-plans/medigap/basics/how-medigap-works
          13. Office of Inspector General. Special Advisory Bulletin, Pharmaceutical Manufacturer Copayment Coupons. September 2014. Accessed September 5, 2023. https://oig.hhs.gov/documents/special-advisory-bulletins/878/SAB_Copayment_Coupons.pdf
          14. Dr Christina Polomoff discusses the complex world of medication discount cards. Am J Manag Care. April 13, 2021. Accessed September 5, 2023. www.ajmc.com/view/dr-christina-polomoff-discusses-the-complex-world-of-medication-discount-cards
          15. Centers for Medicare & Medicaid Services. What Medicare Pat D plans Cover. Accessed September 7, 2023. https://www.medicare.gov/drug-coverage-part-d/what-medicare-part-d-drug-plans-cover
          16. Centers for Medicare & Medicaid Services. Final Contract Year (CY) 2024 Part D Bidding Instructions. April 4, 2023. Accessed September 6, 2023. https://www.cms.gov/files/document/final-cy-2024-part-d-bidding-instructions.pdf
          17. Centers for Medicare & Medicaid Services. Parts C&D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance. August 3, 2022. Accessed September 10, 2023. https://www.cms.gov/medicare/appeals-and-grievances/mmcag/downloads/parts-c-and-d-enrollee-grievances-organization-coverage-determinations-and-appeals-guidance.pdf
          18. Centers for Medicare & Medicaid Services. Medicare Appeals. Accessed August 23, 2023. https://www.medicare.gov/Pubs/pdf/11525-Medicare-Appeals.pdf
          19. Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual Chapter 14 – Coordination of Benefits. September 17, 2018. Accessed September 11, 2023. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Chapter-14-Coordination-of-Benefits-v09-14-2018.pdf
          20. Centers for Medicare & Medicaid Services. Medicare Prescription Drug Coverage and Your Rights. Accessed September 12, 2023. https://www.cms.gov/outreach-and-education/outreach/partnerships/downloads/yourrightsfactsheet.pdf

          Accommodating Disabilities in Experiential Education: Easier Than it Seems, Full of Reward

          Learning Objectives

           

          After completing this application-based continuing education activity, pharmacist preceptors will be able to

          • DEFINE types of learning disabilities that preceptors are likely to encounter
          • LIST the information the school of pharmacy should provide to preceptors
          • IDENTIFY accommodation that are appropriate for specific students
          • DESCRIBE reasonable accommodation in experiential education

            Education for disabled children. Handicapped kid on wheelchair in kindergarten. Equal opportunities, preschool program, special needs. Vector isolated concept metaphor illustration

             

            Release Date: December 10, 2023

            Expiration Date: December 10, 2026

            Course Fee

            Pharmacists: $5

            UConn Faculty & Adjuncts:  FREE

            There is no grant funding for this CE activity

            ACPE UANs

            Pharmacist: 0009-0000-23-059-H04-P

            Session Code

            Pharmacist:  23PC59-ACA37

            Accreditation Hours

            1.0 hours of CE

            Accreditation Statements

            The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-23-059-H04-P  will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

             

            Disclosure of Discussions of Off-label and Investigational Drug Use

            The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

            Faculty

            Jennifer Luciano, PharmD
            Director, Office of Experiential Education; Associate Clinical Professor
            UConn School of Pharmacy
            Storrs, CT

            Neha Patel
            2025 PharmD Candidate
            UConn School of Pharmacy
            Storrs, CT

            Jeannette Y. Wick, RPh, MBA, FASCP
            Director, Office of Pharmacy Professional Development
            UConn School of Pharmacy
            Storrs, CT

             

             

             

             

             

             

            Faculty Disclosure

            In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

            Jeannette Wick, Neha Patel, and Jennifer Luciano do not have any relationships with ineligible companies

             

            ABSTRACT

            From time to time, preceptors need to address the needs of students who have disabilities, be they visible or invisible. Students’ disabilities may include chronic diseases, physical limitations, or difficulty with processing information. This continuing education activity introduces various types of disabilities that preceptors may encounter and suggests a stepwise process to develop accommodation plans. It discusses information that preceptors will need or want to have on hand, and potential sources to obtain the information. It also describes the various stakeholders and the accommodation process and the potential benefits for the entire workplace.

            CONTENT

            Content

            INTRODUCTION

            Some pharmacy students have visible or invisible disabilities that require accommodation (a change or adaptation to adjust a situation to meet the student’s unique needs). Anecdotally, faculty at the University of Connecticut School of Pharmacy report that between 5% and 12% of students in a typical class in the last 10 years need accommodation. In terms of physical disabilities, institutions of higher learning have almost always built or altered existing buildings to accommodate students with disabilities with ramps, elevators, wide doors, and similar structural changes. Preceptors who work in larger organizations may have support teams that address or have already addressed physical disabilities. Those who work in smaller organizations or older buildings may be intimidated by the need to accommodate but will find that the law requires “reasonable” accommodation.

             

            Pharmacy preceptors are more likely to encounter students who have chronic disease (e.g., asthma, autoimmune syndromes, diabetes, etc.) or learning disabilities, including those who are neurodivergent (the SIDEBAR explains the concept of neurodiversity). While taking classes, pharmacy schools often (and are legally required to) provide accommodation for students with learning disabilities (see Table 1). They may provide double time or access to a quiet room during exams, permission to take breaks during class, or notetakers to help them depending on the disability type. Students with learning disabilities acquire, organize, retain, comprehend, or use verbal or nonverbal information differently than others. They have impaired perception, thinking, remembering, or learning processes.1

            Table 1. Types of Learning Disabilities1-7

             

            Learning disability Description
            Anxiety disorder Anxiety that does not go away and can worsen over time. Symptoms can interfere with daily activities such as job performance, schoolwork, and relationships. Subtypes of anxiety disorders include generalized anxiety disorder, panic disorder, social anxiety disorder, and various phobia-related disorders.
            Attention deficit hyperactivity disorder Causes an ongoing pattern of inattention and/or hyperactivity that interferes with functioning and/or development.
            • Inattention may manifest as difficulty staying on task, sustaining focus, and staying organized; these problems are not due to insubordination or lack of comprehension.
            • Hyperactivity manifests as involuntary constant movement, even when it is inappropriate, or excessive fidgeting, tapping, or talking. Adults with ADHD are often extremely restless or talkative.
            • Impulsivity is acting without thinking or difficulty with self-control. It may include a desire for immediate reward or inability to delay gratification. It may manifest as interrupting others or making key decisions while ignoring long-term consequences.
            Autism spectrum disorder (ASD) A neurologic and developmental disorder that affects how people interact with others, communicate, learn, and behave. Autism is known as a “spectrum” disorder because its wide variation in presentation and symptom severity.

            People with ASD often have:

            ·       Difficulty with communication and interaction with other people

            ·       Restricted interests and repetitive behaviors

            ·       Symptoms that affect their ability to function in school, work, and other areas of life

            Dysgraphia A neurological disorder characterized by writing disabilities that appear as distorted or incorrect writing (inappropriately sized and spaced letters, or wrong or misspelled words despite focused instruction).
            Dyscalculia Causes consistent failure to achieve in mathematics marked by difficulties with counting, working memory, visualization; visuospatial, directional, and sequential perception and processing; retrieval of learned facts and procedures; quantitative reasoning speed; motor sequencing; perception of time; and the accurate interpretation and representation of numbers when reading, copying, writing, reasoning, speaking, and recalling.
            Dyslexia Impairs a person’s ability to read. Although varies by individual, common characteristics include difficulty with
            • Phonological processing (the manipulation of sounds)
            • Rapid visual-verbal responding
            • Spelling

             

            SIDEBAR: Emerging Terminology and Necessary Understanding: Neurodiversity8-11

             

            Neurodiversity refers to the diversity of all people, but is often used in the context of autism spectrum disorder (ASD), neurological or developmental conditions, and learning disabilities. It is neither a medical term nor a diagnosis; it’s a descriptor used to replace the tendency to think of behaviors as normal or abnormal or to marginalize certain people based on their behaviors. When thinking about neurodiversity, it’s critical to remember that there is no one right way of thinking, learning, and behaving, and all differences are not necessarily deficits. Neurodiversity is not preventable, treatable, or curable. It’s the result of normal variation in the human genome. The term is used to promote equity and social justice for people who are members of a neurologic minority.

             

            Students who are neurodivergent experience and interact with the world around them in many different ways. Common characteristics among students who are neurodivergent include eye contact, facial expressions, and body language that are different than many other people’s.

             

            Students may or may not disclose (or even know) they are neurodivergent. When students do, it is important for preceptors to acknowledge neurodiversity and ask directly about a person’s preferred communication style and accommodations, many of which are described in the text of this continuing education activity. Many of the accommodations for people who are neurodiverse also help other students and employees who do not fall into neurologic minority categories, including

            • Offering or allowing individuals to make small adjustments to the workspace
            • Avoiding sarcasm, idioms, euphemisms, and implications
            • Providing concise instructions
            • Posting information about due dates and meetings as far in advance as possible
            • Treating all people with respect

             

            Preceptors should foster environments that are conductive to neurodiversity, and to recognize and emphasize each person’s individual strengths and talents while also providing support for their differences and needs. It’s also helpful to know that many large companies are now adjusting their hiring processes to attract people who are neurodivergent. They’ve found that although some people have trouble navigating the hiring process, their unique abilities are valuable, increase the company’s productivity, and often lead to remarkable product and process improvements.

             

             

            This continuing education activity is designed to help preceptors who encounter pharmacy students with disabilities develop workable plans. Preceptors should start by acknowledging a critical fact: accommodation isn’t special treatment. Accommodation levels the playing field so student pharmacists (and employees) can learn and do their best work.

             

             

            PAUSE AND PONDER: You’re a preceptor for your state university. In April, the experiential education office notifies that you have one student per month from June through April. Shortly after, a staff member from the experiential education office calls and tells you that the student scheduled for August needs accommodation. What should you expect going forward, and what is the best time to plan?

             

            Providing Reasonable Accommodation

            Institutions of higher learning usually have entire departments that develop policies, document the student’s type and degree of disability, and develop student-specific accommodation plans. When students who have disabilities go on clinical rotations, rotation sites may have no processes or policies to provide the same accommodation. Preceptors may not know how to cater to their needs. Often, practice sites need only to make minor adjustments to their environments, policies, and procedures. Once the organization makes the changes, the policies will be ready for future students! A PRO TIP is that an astute student who has disabilities may be willing to help edit and adjust policies; this insight can be valuable. However, the student may not want to help as this can be an added burden that other students don’t have.

             

            Five basic principles help schools ensure that clinical rotation sites provide reasonable accommodation for students on clinical rotations1,11,12:

             

            • Before going on rotation, it is critical for the school to document the student’s disability with a reliable diagnosis. The school’s department for students with disabilities usually does this.
            • All parties will need to work together to identify elements of the student’s disability that would cloud the preceptor’s ability to assess the student’s competence. Any accommodation should mitigate those elements.
            • Preceptors should work with the school to develop accommodation tailored to the specific rotation site and tasks to be accomplished at that site.
            • Three hundred sixty-degree communication is essential. Preceptors, students, school and rotation site administration, and disability service staff must collaborate and communicate.
            • Throughout the whole process, all parties must protect the student’s privacy.

             

            Students with disabilities are subject to a great deal of stigma not only from the outside world but also from preceptors. Ideally, schools should match these students with rotation sites and preceptors with prior experience accommodating students with disabilities.13 However, this may not always be possible. In ideal situations, preceptors are sympathetic and the relationship between the student and preceptor is open, non-judgmental, friendly, and relaxed. These characteristics set the stage for students to disclose their learning needs without fear of discrimination.14

             

            The school, however, must identify sites and preceptors based on the student’s accommodation needs without disclosing student-specific accommodation descriptions. Open and honest communication between students, the experiential education team, and representative(s) of the school’s disabilities office before they develop the rotation schedule can prevent problems later.13 Once the school confirms the student’s sites, it can share very basic student-specific details with the preceptor but only the student can share specific health information.1 In other words, the school can communicate the accommodation the student needs, but not the underlying diagnosis; that is private and only the student may disclose it.

             

            A challenge for students with physical disabilities is needing accommodation through multiple sites, which requires significant coordination and planning. A solution is providing multiple rotations at a single site where accommodation is available. When this solution is available, students can acclimate once.13 This can provide the best possible experience for the student, providing a level of comfort in the environment; conversely, this solution may force disabled students to stay at one site while their peers rotate from site to site and experience different healthcare teams. In institutions without pre-existing policies, schools would benefit by working with preceptors and the sites to develop guidelines for accommodating students. For students with physical disabilities, guidelines should address different types of mobility devices, physical dimensions of hospital facilities, safety requirements of the pharmacies, and access to particular areas.13 The preceptor should do this before the student begins working at the site. It would be unfortunate if a student arrived at a site only to find it was inaccessible.

             

            Step-by-Step to Accommodation

            Using a stepwise approach on site helps preceptors ensure that they provide reasonable accommodation to students.

             

            1. Raising awareness among the clinical team regarding disabilities, accommodation, and inclusive learning environments is a prudent first step. The team is able to do this by reviewing the literature, laws, and regulations. The Americans with Disabilities Act (ADA) Titles I, II, and III and the Rehabilitation Act (see Table 2) are the constellation of laws that prohibit discrimination and govern accommodation in pharmacy experiential education.15 Individual states may also have additional laws that protect disabled students.

             

            Table 2. Federal Laws and Regulations that Protect Students with Disabilties15

            Law/regulation Description
            Americans with Disabilities Act (ADA)
            Title 1: Employment ·       Prohibits discrimination in recruitment, hiring, promotions, training, pay, social activities, and other privileges of employment.

            ·       Restricts questions that can be asked about an applicant’s disability before a job offer is made

            ·       Requires that employers make reasonable accommodation for known physical or mental limitations of otherwise qualified individuals with disabilities, unless it results in undue hardship.

             

            Title II: Public sector ·       Requires state and local governments to give people with disabilities an equal opportunity to benefit from their programs, services, and activities

            ·       Requires reasonable modifications to policies, practices, and procedures where necessary to avoid discrimination, unless doing so would fundamentally alter the nature of their service

            ·       Does not require actions that would result in undue financial and administrative burdens

            ·       Indicates governmental agencies must communicate effectively

            Title III: Private sector ·       Explains public accommodation in businesses and nonprofits must not discriminate, exclude, segregate, or provide unequal treatment

            ·       Requires businesses and nonprofits to make  reasonable modifications to polices, practices and procedures and communicate effectively with people with hearing, vision, or speech disabilities

            ·       Requires employers to remove barriers and meet other access requirements.

            Rehabilitation Act of 1973
            Section 504 Prohibits programs or activities that receive federal funding from discriminating against disabled people.

             

            One area that all employers and employees need to understand is that accommodation can include variations on the workspace or equipment needed to complete various tasks, how work is assigned and communicated, the specific tasks, and the time and place that the work is done.16

             

            1. Establishing essential learning activities and outcomes for students helps all students, not just those with learning or physical disabilities. This means specifying essential functions, minimum competencies, expectations, and procedures that all students must be able to perform by the end of the rotation.15 Preceptors should note that accommodating a student’s needs does not mean lowering expectations.1 A PRO TIP here is that sometimes a student can meet the expectation with only small changes in the preceptor’s style. For students who have information processing issues, asking questions and then pausing for five seconds to allow the student to answer is better than rapid fire questions.1 (This is actually an approach that all preceptors and teachers need to use more in all situations. Pausing benefits everyone, including people who are not native English speakers.)

             

            1. The rotation site should make reasonable accommodation based on a reliable diagnosis that the student has documented via the school’s office of student disabilities. The pharmacy school’s office will also provide documentation of the requested accommodation to preceptors; students who have disabilities should not make the requests to preceptors on their own; they may, however, provide the accommodation letter and any information they want to share with the preceptor and copy the school’s director of experiential education if that is the school’s policy. One area that can be difficult for preceptors is the student’s healthcare appointments.1 A PRO TIP is to ask the student at the beginning of the rotation if you need to be aware of any scheduled appointments. Preceptors should also be very clear that the student must notify them of unanticipated appointments as soon as possible (or even before they call to schedule the appointment). If students miss time at rotations, they are responsible for making up the time.

             

            Documenting and discussing reasonable accommodation with the individual student who has a disability may be an uncomfortable or unfamiliar task for preceptors but will avoid problems later. Preceptors should meet with students to discuss exactly what they need in relation to their experiential outcomes (using the aforementioned list of specifying essential functions, minimum competencies, expectations, and procedures), asking questions such as1,15

            • What limitations do you anticipate experiencing on the rotation?
            • What tasks will you find problematic?
            • What have you done in the past to reduce or eliminate these limitations?
            • Do you anticipate needing us to make any modifications while you are here?
            • What will you do if you encounter an unanticipated obstacle?

             

            Here’s another PRO TIP: Knowing a few ways to accommodate disabilities will help preceptors help the student. For example, a student who has severe anxiety will find many rotations difficult and threatening. A preceptor can suggest that the student observe or “preview” activities before requiring interaction, especially if the site is fast-paced or chaotic. Allowing the student to arrive early may also help. Students who are challenged organizationally may benefit from one (not multiple) outline of what to expect every day.1

             

            1. The student should self-assess and document how the disability affects each general competency and how accommodation could mitigate each concern.1 Figure 1 describes the process of preceptors choosing accommodation.

             

             

             

            The preceptor and student should develop an accommodation plan together and document it in writing. An ideal plan would list the intervention or accommodation and how it supports the student, those involved in creating the accommodation, and the parties responsible for any financial costs (discussed below). 11 For example, in a pharmacy setting where a great deal of business is conducted over the phone using headphones, a student who has difficulty hearing may need a phone amplifier. If the student wears hearing aids, headphones may interfere with her ability to hear. The plan should also include specific days/times for periodic check-ins so the student and preceptor can assess whether the intervention/accommodation meets the students’ needs and is still reasonable for the site.11

             

            A PRO TIP for preceptors is to stay abreast of technology changes.16 If students have difficulty reading or writing—these are students with dyslexia or dysgraphia—many programs now have read-aloud or voice-to-text programs that are remarkably accurate. Some calculators will talk. Encourage students to use them. Asking students to listen to their work using a read-aloud program will also help them catch errors.

             

            PAUSE AND PONDER: You meet with your new APPE student and learn that he has serious visual impairment. He indicates he needs to use assistive devices (supplemental lighting, a magnifier). How would you initiate a discussion about who will secure these devices?

             

            The last step, which overlaps with the previous steps to some extent, is providing reasonable accommodation. Readers may read the term “reasonable accommodation” and wonder what is considered reasonable. Accommodation should not pose an undue financial or administrative hardship to the practice site.15 The law would not consider an accommodation reasonable if it decreased quality or posed safety issues to patients or imposed undue financial or administrative burden on the institution. It would also be unreasonable to change curricular elements or alter course objectives substantially. Preceptors might reach out to the school’s experiential education office who can contact the university’s legal department to determine whether a specific accommodation is reasonable. Or, preceptors can contact their own legal representatives. Preceptors and students need to communicate openly and honestly to determine reasonable accommodation together. Table 3 describes some examples of reasonable accommodation.

             

            Table 3. Examples of Reasonable Accommodation in Clinical Experiential Learning8,15-17

             

            Student Limitation Accommodation
            Anxiety ·       Embrace the learning experience and don’t be too hard on students when they make an error. Provide feedback and guidance for them to improve.

            ·       Plan the days and weeks, setting achievable goals, and prioritizing tasks.

            ·       Offer counseling services and other resources to support the student.

            Concentration difficulties ·       Use organization techniques that help students manage time and stay on track.

            ·       Ask students if using a highlighter to emphasize assignments that are priorities will help.

            ·       Step away from busy workplaces to provide directions in a quieter location.

            ·       Develop or have the student develop checklists for common tasks.

            Distractibility ·       Provide or allow students to use their own noise-canceling headphones or give them a private room to work.

            ·       Provide a quiet space away from noise and busy office traffic and a “Do Not Disturb” sign so students can work without interruption.

            ·       Avoid allowing or encouraging multitasking. Have students complete one thing at a time.

            Dyslexia ·       Encourage use of appropriate read-aloud and voice-to-text software.

            ·       Explain and provide a list of common or site-specific acronyms and other jargon.

            Neurodiversity ·       Sound sensitivity: offer a quiet break space, communicate expected loud noises (like fire drills), offer noise-canceling headphones.

            ·       Tactile: allow modifications to the usual work uniform

            ·       Movement: allow the use of fidget toys, allow extra movement breaks, offer flexible seating

            ·       Use a clear communication style:

            o   Avoid sarcasm, euphemisms, and implied messages.

            o   Provide concise verbal and written instructions for tasks, and break tasks down into small steps.

            ·       Inform people about workplace etiquette, and don’t assume someone is deliberately breaking the rules or being rude.

            ·       Try to give advance notice if plans are changing and provide a reason for the change

            ·       Don’t make assumptions – ask a person’s individual preferences, needs, and goals.

            ·       Be kind, be patient

            Poor organization ·       Set aside 15 minutes at the end of the day to plan the next day’s work.

            ·       Have students and all employees return important shared items to the same place each time they use them.

            ·       Consider a color-coding system for assignments or shelving.

            ·       Keep things visible on shelves, bulletin boards, or other places; avoid storage in drawers or closets.

            ·       Attach important objects physically to the place they belong.

            Processing disorders ·       Provide both written and oral instructions.

            ·       Follow-up important conversations with a brief e-mail

            ·       Ask the student to make notes and provide them to you for review.

            ·       Use the teach-back method; ask the student to repeat the information back so you can be sure you covered everything (and they heard the key messages)

             

            Emphasis on Planning Ahead

             

            Before rotations start, students with disabilities and preceptors should complete a practice walk-through at the rotation site to identify, modify, and make necessary adjustments.13 The experiential team must also understand the student’s career aspirations. Frank discussion will help all involved with rotation planning. The experiential team and the preceptor can address the students’ and preceptors’ concerns, needs, and goals in advance. Also, the person coordinating this process should identify and discuss costs and financial resources for the accommodation plan with all parties involved and determine who is responsible for the costs. This creates clear expectations. 13

             

            If during the check-in or at any time a situation changes, the plan needs revision to find a more acceptable or effective reasonable accommodation or an urgent concern arises, the student or the preceptor should contact the school immediately.13

             

            CONCLUSION

            Preparing and executing accommodation can be challenging. Preceptors who develop skills in this area help student pharmacists develop communication, collaboration, and planning skills they will use and improve all during their careers. Preceptors also assess the actual barriers associated with the student’s disability in a controlled environment and help students learn how to mitigate the challenges associated with their disabilities in future employment. A PRO TIP is to keep in mind that many employees have disabilities or have slightly different learning styles. Learning how to accommodate them from students and schools of pharmacy will benefit your entire work force. It may even help you!

             

             

             

             

            Pharmacist Post Test (for viewing only)

            1. A student has been diagnosed with attention deficit hyperactivity disorder (ADHD), a type of learning disorder. Which of the following BEST describes ADHD?
            A. A disorder characterized by writing disabilities that appear as distorted or incorrect writing
            B. A disorder that affects how people interact with others, communicate, learn, and behave
            C. A disorder that causes ongoing patterns of inattention and/or hyperactivity that interferes with functioning and/or development

            2. You observe that a student has difficulties counting, putting documents in numerical order, and calculating doses when the order specifies a mg/kg dosing. What type of disability is this MOST LIKELY to be?
            A. Dyslexia
            B. Dyscalculia
            C. Dysgraphia

            3. Once the school confirms a student’s site, what information can the school share with the preceptor?
            A. The required accommodation
            B. The student’s diagnosis
            C. The student’s health information

            4. How can the school of pharmacy help students with disabilities to be comfortable and meet their needs at various clinical sites?
            A. Informing the site that the student will be doing all their clinical rotations at that site
            B. Providing policies and student-specific accommodation plans that can be adjusted
            C. Only using preceptors who have experience accommodating students with disabilities

            5. Mary, a preceptor, is preparing for Elwin to start a rotation at her site. Elwin told the preceptor that he struggles with organization. They are identifying accommodation and exploring if they need to make any changes to the site. Which of the following is the most appropriate accommodation to keep the site organized for the student?
            A. Color-code the shelving system in the pharmacy
            B. Provide both written and oral instructions
            C. Provide directions away from the workplace

            6. A pharmacy student, Sarah, has attention deficit hyperactivity disorder (ADHD) and will be going on her clinical rotation. She has been in communication with the school and the preceptor about accommodation, indicating her key limitation is distractibility. Which of the following is the is the BEST accommodation the preceptor can provide?
            A. Encourage use of appropriate read aloud and voice to text software
            B. Plan the days and weeks, setting achievable goals, and prioritizing tasks.
            C. Provide a quiet space away and a “Do Not Disturb” sign

            7. Which of the following factors would a preceptor consider when providing a reasonable accommodation?
            A. The accommodation’s feasibility and financial cost
            B. The student’s academic grade point average
            C. The student’s specific diagnosis

            8. Which answer correctly lists the steps when choosing an accommodation for a student?
            A. Lower your expectations, assess whether the accommodation is meeting the student’s needs, analyze the required tasks
            B. Maintain your expectations, analyze the required tasks, periodically assess whether the accommodation is meeting the student’s needs
            C. Meet with the student, ask about the specific diagnosis of neurodiversity, develop a plan you think is suitable for the student

            References

            Full List of References

            REFERENCES
            1. Vos S, Kooyman C, Feudo D, et al. When Experiential Education Intersects with Learning Disabilities. Am J Pharm Educ. 2019;83(8):7468.
            2. Anxiety Disorders. National Institutes of Mental Health. Accessed August 9, 2023. https://www.nimh.nih.gov/health/topics/anxiety-disorders
            3. Autism Spectrum Disorder. National Institutes of Mental Health. Accessed August 14, 2023. https://www.nimh.nih.gov/health/topics/autism-spectrum-disorders-asd
            4. Attention-Deficit/Hyperactivity Disorder. National Institute of Mental Health. Accessed August 5, 2023. https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd
            5. Dysgraphia. National Institutes of Neurological Disorders and Stroke. Accessed August 5, 2023. https://www.ninds.nih.gov/health-information/disorders/dysgraphia
            6. Dyscalculia. Dycalculia.org. Accessed August 5, 2023. https://www.dyscalculia.org/
            7. Dyslexia. National Institutes of Neurological Disorders and Stroke. Accessed August 5, 2023. https://www.ninds.nih.gov/health-information/disorders/dyslexia
            8. Baumer N. What is Neurodiversity? Accessed August 14, 2023. https://www.health.harvard.edu/blog/what-is-neurodiversity-202111232645
            9. Neurodivergent. The Cleveland Clinic. Accessed August 15, 2023. https://my.clevelandclinic.org/health/symptoms/23154-neurodivergent
            10. Austin RD, Pisano GP. Neurodiversity as a Competitive Advantage. Harvard Business Review. May-June 2017. Accessed August 15, 2023. https://hbr.org/2017/05/neurodiversity-as-a-competitive-advantage
            11. Elliott HW, Arnold EM, Brenes GA, et al. Attention deficit hyperactivity disorder accommodations for psychiatry residents. Acad Psychiatry. 2007;31(4):290-296.
            12. Shrewsbury D. Dyslexia in general practice education considerations for recognition and support. Educ Prim Care. 2016;27(4):267-270.
            13. Kieser M, Feudo D, Legg J, et al. Accommodating Pharmacy Students with Physical Disabilities During the Experiential Learning Curricula. Amer J Pharm Ed. Published online April 2, 2021:8426.
            14. L’Ecuyer KM. Clinical education of nursing students with learning difficulties: An integrative review (part 1). Nurse Educ Pract. 2019;34:173-184.
            15. Vos SS, Sandler LA, Chavez R. Help! Accommodating learners with disabilities during practice‐based activities. 2021;4(6):730-737.
            16. Job Accommodation Ideas for People with Learning Disabilities. Learning Disabilities Association of American. Accessed August 5, 2023. https://ldaamerica.org/info/job-accommodation-ideas-for-people-with-learning-disabilities/
            17. Horesh A. Conquer Anxiety in Clinical Rotations: A Guide for Medical Students. Accessed August 9, 2023. https://futuredoctor.ai/anxiety-in-clinical-rotations/

            Who are you? Who are We? Professional Identity in Experiential Learning

            Learning Objectives

             

            After completing this application-based continuing education activity, pharmacist preceptors will be able to

              1. Describe professional identify formation
              2. Apply the steps in development of a professional identity
              3. Identify activities that develop professional identity appropriately

              Healthcare professionals with arms crossed.

               

              Release Date: November 1, 2023

              Expiration Date: November 1, 2026

              Course Fee

              Pharmacists: $7

              UConn Faculty & Adjuncts:  FREE

              There is no grant funding for this CE activity

              ACPE UANs

              Pharmacist: 0009-0000-23-049-H04-P

              Session Code

              Pharmacist:  23PC49-ABC37

              Accreditation Hours

              2.0 hours of CE

              Accreditation Statements

              The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-23-049-H04-P  will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

               

              Disclosure of Discussions of Off-label and Investigational Drug Use

              The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

              Faculty

              Jennifer Luciano, PharmD
              Director, Office of Experiential Education; Associate Clinical Professor
              UConn School of Pharmacy
              Storrs, CT

              Jeannette Y. Wick, RPh, MBA, FASCP
              Director, Office of Pharmacy Professional Development
              UConn School of Pharmacy
              Storrs, CT

              Ethan Yazdanpanah
              PharmD Candidate 2025
              UConn School of Pharmacy
              Storrs, CT

               

               

              Faculty Disclosure

              In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

              Jeannette Wick, Ethan Yazdanpanah, and Jennifer Luciano do not have any relationships with ineligible companies

               

              ABSTRACT

              Discovering what it means to be a good healthcare provider goes beyond knowledge acquisition and education for pharmacy students; it demands a transformative journey of professional identity formation (PIF). The pharmacy profession, through its professional organizations, has identified a number of core values, but as the profession changes, new core values are emerging. PIF occurs over a trajectory, starting in pharmacy school (or even before) and continuing throughout life. Preceptors can use a number of techniques to help pharmacy students with PIF, assuring that our future pharmacists hold the same values ats the profession at large. Exposing students to a variety of situations, asking open-ended questions, using teach-back methods, and introducing students to professional organizations are a few.

              CONTENT

              Content

              INTRODUCTION

              Let’s begin this continuing education activity with some questions. What makes a nurse a nurse? What makes a nurse a good or exceptional nurse? What makes an electrician an electrician? What makes an electrician a good or exceptional electrician? What makes a pharmacist a pharmacist? What makes a pharmacist a good or exceptional pharmacist? Those questions are no doubt difficult to answer. Preceptors may be making a list mentally of the qualities that the ideal nurse, electrician, or pharmacist should possess. Certainly, for each of these professions, education will be the foundation. Here’s a harder question: Is it possible to be a good or exceptional nurse, electrician, or pharmacist but a terrible person? And is it possible to be a good and loyal pharmacy employee, but not such a good pharmacist? All these questions speak to the concept discussed here: professional identity.

               

              Discovering what it truly means to be a healthcare provider goes beyond knowledge acquisition and education for pharmacy students; it demands a transformative journey of professional identity formation (PIF) starting even before introductory pharmacy practice experiences (IPPE) (perhaps with acceptance into a pharmacy program or during professionalism ceremonies) and continuing past graduation and over an entire career. As the introduction hints, preceptors must distinguish between education, professionalism, and professional identity. A quick way to differentiate between the latter two is that a student’s professionalism is outwardly observable. Professional identity, however, is defined by a student’s internal thinking, feeling, and acting like a member of the pharmacy profession and its community.1

               

              Pharmacists can use their extensive, science-based education to assume many professional identities; they may work in community, hospital, health-system, research, information technology, marketing, or a vast number of other positions. Viewing the history of the profession in just the last century, various identities have accumulated (rather than shifted) over time.2 The typical pharmacist’s main responsibility was once compounding. As the industrial revolution made it possible to produce dosage forms en masse, compounding fell out of favor and dispensing manufactured products became the primary focus of a typical pharmacist. Within just the last 20 years, pharmacists have made major inroads into establishing their role as necessary health care professionals rather than just retailers.3 Pharmacists have been shown to be key in improving therapeutic outcomes with a new focus on patient focused intervention.4 Pharmacists’ employment opportunities are growing and adapting to a changing field but the profession’s fundamental or core values are somewhat fixed. Table 1 lists the pharmacy profession’s current core values as promulgate by the American Pharmacists Association.

               

              Table 1. The Pharmacist’s Core Values5,6

              Commitment to the patient’s well-being ·       Engage in shared decision making and respect patients’ right to self determination

              ·       Protect patient life and aim for best outcomes

              Pharmaceutical expertise ·       Maintain competence in knowledge and abilities to ensure the safe and effective use of medication
              Reliability and care ·       Find balance between risk and benefit in treatments

              ·       Maintain trust and confidentiality with patients

              ·       Collaborate reliably with other healthcare professionals to ensure best health outcomes

              Social responsibility ·       Act with honesty and integrity in professional relationships

              ·       Avoid discrimination and seek healthcare equity in society

               

              PAUSE AND PONDER: Look at Table 1. What other values would you add to the table?

               

              As the profession’s identity evolves, pharmacists’ identities and their core values must follow suit. While pharmacists must be lifelong learners and adapt over time to new conditions, change is most readily achieved in the initial learning process as pharmacy students. In other words, you can teach old dogs new tricks, but it’s easier to teach puppies. In class, faculty teach students information a pharmacist should know and address how to outwardly act like a professional, but the profession demands something more: the development of a professional identity. We rely on our community of pharmacist preceptors to augment the various didactic courses to cultivate new pharmacist graduates who identify strongly with our core values.

               

              PIF is a crucial aspect of pharmacy experiential education. Students require experiential learning and immersion into the profession to assimilate the qualities that make pharmacists unique and different from other healthcare providers. The Accreditation Council for Pharmacy Education (ACPE)-required IPPE rotations provide students with important opportunities to influence PIF, and the PIF process continues during a student’s advanced pharmacy practice experiences (APPE).7

               

              The Pharmacy Student’s IPPE Rotation

              IPPE rotations serve a much broader purpose than students fulfilling educational requirements and completing dreaded 50-page workbooks that some schools use that aim to help them reflect on or consolidate learning. IPPE rotations should introduce students to the way front line pharmacists navigate real-world pharmacy practice situations. Students primarily relegated to counting pills and organizing stock in the back of a pharmacy are unlikely to develop professional identities. If students perceive that preceptors think of them as free labor or burdensome obligations, they will not engage in the deeper discussions about the preceptor as a person fulfilling professional obligations. Students should observe and actively take part in various aspects of the profession, applying theoretical knowledge acquired in classrooms to real-world situations. Practical knowledge gained through these experiences helps students to develop essential professional skills and test their learning.

               

              Experiential learning rotations should also expose students to different types of pharmacist positions and responsibilities. By observing different practice settings and interacting with pharmacists, patients, and other healthcare professionals, students can explore their interests, while realizing their strengths and developing professional values.

               

              Step-by-Step to Professional Identity

              Throughout pharmacy education, faculty members encourage students to exhibit professionalism; they may

              • suggest more productive ways to present ideas
              • prompt students to elevate or refine language or speak in ways patients will understand, or
              • suggest that certain clothing choices can diminish peoples’ view of them and their credibility

               

              While classroom faculty can teach and model the concept of professionalism, preceptors have the responsibility of supporting students in their PIF journey. Teaching starts the learning process; ultimately, students will need to “create their own adventures.” In other words, they must learn to apply aspects of specific material and explore different experiences to develop a professional identity. Relating to the definition of PIF, a pharmacy student’s PIF process must involve thinking, feeling, and acting like a pharmacist.

               

              To discuss professional identity, preceptors and all pharmacists who influence the student’s learning process must acknowledge the steps inherent in PIF. Personal identity is based on an individual’s concept of who they are and how others perceive them.7 Individuals develop personal identity in stages starting at birth but personal identity begins at birth and continues throughout life. Professional identity develops in a similar but slightly different way.

               

              Robert Kegan, a Harvard psychologist, developed a framework for longitudinal development of the self into a moral meaning-making entity that has had lasting impact on PIF in education of professionals.3,8-10 His framework includes six stages with stage 0 beginning at birth. Stages 0 and 1 concern young children’s development of basic motor function and sensing the physical world around them (and are not discussed here).8

               

              In relation to PIF, the health professional must pass through at least stages 2 through 4 of the framework: imperial, interpersonal, and institutional.10 This framework, with steps 2 through 5 shown in Table 2, defines the personal characteristics and related professional context of an individual in continuous stages of development. Individuals who reach the final stage, stage 5, or the inter-individual self-transforming stage, open themselves to multiple identities and other value systems, achieving full personal autonomy.8 Research shows that not all individuals reach stage 5.10,11 However, with effective socialization partnered with experience in the pharmacist’s potential identities, students may reach this level during their careers.

               

              Table 2. Kegan’s Stages of Personal and Professional Identity Development­8,10

              Stage Personal characteristics Professional context
              2. Imperial Individuals put their own needs and interests first but consider other people’s views. Individuals fill their professional roles but do so with a primary motivation of following rules. Individuals exhibit low self-reflection and may struggle to balance emotions with reason.
              3. Interpersonal Individuals are concerned with others’ perceptions of them and able to reduce focus on self-interest. Individuals balance multiple perspectives simultaneously. Individuals are idealistic and self-reflective, seeking others to guide them. Individuals manage emotions acceptably and generally understand right and wrong.
              4. Institutional Individuals assess relationships with a focus on self-defined principles and standards. Individuals define themself independently of others. Individuals can understand relationships by appreciating different values and expectations. They internalize professional values and do not allow emotion relating to needs, desires, and passion to gain control over reason.
              5. Self-transforming Individuals reconcile contradictory or paradoxical ways of constructing meaning. They can recognize the interdependencies of different systems or ways of thinking. The self-transforming professional has a strong sense of self but also relies upon others knowledge and opinion in professional development. The professional integrates other identities into the total professional identity.

               

               

              The constantly evolving pharmacy profession and the lack of a specific list of steps for PIF makes it challenging for students to define an identity (and preceptors to help them). As the profession continues to develop to offer a wide range of opportunities for pharmacists, preceptors will observe students finding varying paths of PIF. Different pharmacists will define the profession differently depending on their experiences. Pharmacy students might generally navigate this list of steps, common among many young people developing professionally12-15:

               

              1. Exploration: In any career path, exploration is the first step in PIF. In pharmacy, the American Pharmacists Association offers the Career Pathway Evaluation (https://www.pharmacist.com/Career/Career-Pathways) to help aspiring pharmacists find a path forward. IPPE and APPE rotations should ideally provide students with opportunities to explore various pharmacy practice settings and work with pharmacists with a range of responsibilities. Students need to augment their existing identities—formed by their upbringing and personal beliefs—as they begin their pharmacy education and careers. Students come from diverse backgrounds with varying past experiences, cultural values, learning styles, and personal characteristics.
              2. Reflection and integration: Educators should encourage students to reflect on their experiences, strengths, values, and areas for improvement. Reflection helps students align personal and professional values, shaping their professional identities. Self-reflection and reflection from preceptors during IPPE rotations is necessary for growth. For example, a technician told Jayne, a pharmacist for a chain pharmacy, that a patient was in the counseling room and ready for an immunization. Jayne took her student with her to observe. Jayne asked the student to review the necessary paperwork and make sure the patient, a 17-year-old adolescent, met all the criteria for the human papilloma virus vaccine. The student said he did. When Jayne reviewed the paperwork, she found one problem. She asked the patient, “Which of your parents is here with you today?” In Jayne’s state, the legal age of consent was 18. When contacted by phone, the parent agreed to come in immediately and Jayne administered the vaccination. After all was done, she spent just a few minutes talking to the student about the duty to protect and comply with the law, describing a couple of other instances when she encountered similar situations.
              3. Commitment and advocacy: Commitment to the pharmacy profession and dedication to lifelong learning are essential elements in the development of a professional identity. Pharmacy students will become spokespeople for the profession and advocate for the inevitable change from retail-based to clinically- or service-based work. Pharmacists with solid professional identities will be lifelong learners and educators.

               

              Students who have never worked in a pharmacy or observed a pharmacist at work (and some who have) may have inaccurate ideas about the profession. Preceptor Eddie encountered a curious situation when Adam, a P2 student, reported for an IPPE rotation. Adam was more than self-assured; Adam had an exaggerated sense of self-worth. He was bumptious (self-important or smug), so Eddie needed to work around Adam’s personal identity. Adam told Eddie that his older brother was a pharmacist who had told him that pharmacy schooling is pretty worthless. Adam said, “All you need to do is pass and you’re on your way to a darned good salary.” Eddie was astounded. Adam needed help reaching Step 2 of the PIF model—he was putting his own needs and beliefs first and disregarding others’ views. Eddie created a plan to help Adam develop more insight.

               

              Each day when Adam came to work, Eddie presented two or three situations from his work experience that required more than just a body behind a computer. He would ask Adam to work through the problems and present the answers by the end of the day. In this way, he educated Adam about professional responsibility and clarified the difference between a person with a pharmacy degree and an exceptional pharmacist. PIF’s goal is for students to move from playing or imagining the pharmacist’s role to internalizing the pharmacist’s identity and acting as pharmacists at the unconscious level. The process shifts emphasis from ‘doing’ to ‘being.’ While professionalism can be put on and taken off like a white coat, professional identity stays with the healthcare professional at all times. Eddie was able to improve Adam’s professionalism, which was poor at the rotations start, and contribute to Adam’s professional identity.

               

              PAUSE AND PONDER: When you were a student, which preceptors influenced your core values and how did you internalize them?

               

              Activities that Develop Professional Identity

              Preceptors who work in different types of positions need to acknowledge their personal and professional strengths and limitations to determine what they can realistically offer to students. Before taking on the preceptor’s or mentor’s responsibilities, professionals must be familiar with their own skillsets.7,14

              • The first step preceptors should take is to embrace self-reflection. Just as preceptors should encourage students to engage in reflective practice, pharmacy is a profession in which preceptors must be lifelong learners. Established pharmacists will continue to accumulate PIF-related experiences over time to aid their effectiveness in guiding others.
              • Preceptors will then need to plan intentionally and commit to helping students develop professional identity. A reluctant or unprepared preceptor usually cannot teach students effectively. Sometimes pharmacists with extensive work experience on the frontlines might feel that students come with a more contemporary knowledge base and therefore, they have nothing to teach them. However, that pharmacist could be well-positioned to support the student’s PIF by embracing how their professional experiences led to a deeper understanding of their profession and the pharmacist’s role in supporting patient outcomes.

               

              PAUSE AND PONDER: What are the most efficient ways to help your students develop professional identity in your practice location? What are the most important ideas you can teach? Are they the same?

               

              PIF is a gradual process that revolves around socialization, not classroom lecture. IPPE rotations provide an ideal platform for students to engage in activities that promote professional development. Preceptors can work with students to facilitate PIF during an IPPE rotation in several ways. 7,16,17

               

              Patient interactions: Direct patient interaction during IPPE can help students apply theoretical learning and develop communication skills, empathy, and a patient-centered approach to care. These experiences help students internalize a sense of responsibility toward patient well-being and strengthen trust in the caregiver-patient relationship.

               

              Preceptors should expose students to patient counseling sessions as observers as often as possible. Consider Leonard, a preceptor who frequently tells students, “I am not going to bring you into this counseling session because it is too complicated. You won’t understand what’s going on.” This is a mistake. IPPE is an opportunity for students to be exposed to difficult real-life examples before they have to handle them alone. These experiences help develop professional identity and may even stimulate an “ah-HA!” moment about pharmacist responsibility for the student. Preceptors who ask students a few open-ended questions (e.g., What did you see that surprised you? What three points did I emphasize? What counseling techniques will you remember from this?) prompt students to engage. Inviting students to see a situation that requires pharmacists to work at the top of their license introduces step 4 (institutional)  and epitomizes PIF. Leonard has the opportunity to show his version of an independent and talented pharmacist who contributes to healthcare positively.

               

              PIF opportunities need not be complicated. Sometimes PIF occurs concurrent with simple everyday tasks. Preceptors who walk students through their thought process when processing an order (i.e., Why does this document go here in the electronic medical record? Why am I looking at that lab before processing the order?) introduce students to the necessity of questioning routinely as a professional function. They can also ask students to find or calculate doses, explore drug interactions, and then provide the information to another interdisciplinary team member.

               

              Not all patient interactions are pleasant or welcome, but they may be professionally necessary. Alex, the pharmacist, was dismayed when a technician came to him and said, “Mrs. Royce is here and wants to talk to you,” while rolling her eyes. Mrs. Royce was notorious for being loud, disrespectful, and a know-it-all. Alex didn’t answer immediately. The technician said, “Shall I tell her you are busy?” Alex said he would talk to her and briefed the IPPE student on Mrs. Royce’s personality. He said he was concerned because Mrs. Royce had recently had surgery, had a reaction to the opioid that was prescribed, and was switched to tramadol. He explained that regardless of his personal feelings, he needed to deal with the situation. When he asked Mrs. Royce how he could help her, she said, “The oxycodone made me sick as a dog. My friend up the street who is a nurse says the tramadol I am taking now is not worth anything. I am taking it and it is super mild but at least it’s something. I have an anti-inflammatory, too. I know this is a first-world problem since this was an elective surgery, so I should not complain. I am just a whiner with pain.” Alex reassured her that no one deserves pain, even if the surgery was elective. Alex counseled the patient with these points18-20:

              • Tramadol is a funny drug. People with certain genetic variations called CYP2D6 deficiencies get less relief from it. It gets a bad reputation because many clinicians don't know that. Take it if it helps. And it sounds like it helps a bit.
              • Schedule your anti-inflammatory around the clock. Don't wait until the pain is horrible. Take it every four to six hours for a few days. Eat a little something when you take it.
              • Use warm or cold compresses if they help but use them only for 10 minutes at a time once every hour. (You don't want to fry or freeze your skin.) If warm helps, use warm. If cold helps, use cold.
              • Move around as much as you can. It increases blood flow to the area.
              • Have you tried some acetaminophen? Some people find that taking a couple of acetaminophen once or twice a day for a couple of days helps--it won't address the inflammation but it may help with pain.
              • Consider finding an acupuncturist and/or a massage therapist who specializes in pain.

              After the session, Alex explained that dealing with patients like Mrs. Royce is an obligation, as is not showing whether he likes her. This attitude aligns with the “interpersonal” step of PIF (step 3)—balancing multiple perspectives and putting others’ needs first. He said that all pharmacists encounter difficult patients. He also said that he planned to check in on her by phone the next day. He asked the student if anything surprised her, and she said, “Yes. You didn’t say anything about the nurse’s bad advice!” Alex explained that professionals don’t speak badly of each other, especially when the information from Mrs. Royce was hearsay. He said he trusts that Mrs. Royce, the consummate know-it-all, will talk to the nurse and the nurse will call if she wants more information. The student was able to teach-back the key points of professional identity:

              • Treat all patients with respect, even when they don’t return the favor
              • Counsel carefully
              • Do not disparage other healthcare providers (talk to them directly if you have a concern about their advice)
              • Follow-up.

              When the student asked this preceptor for a letter of reference several months later, the preceptor said, “Remember Mrs. Royce? Her attitude is entirely different now. She’s kind and respectful when she comes in.”

               

              Collaborative Practice: Preceptors can highlight interdisciplinary healthcare experiences, demonstrating teamwork, collaboration, and the ability to contribute effectively within a healthcare setting. In a health system setting, for example, many different pharmacists work in the same organization with varying responsibilities. A health system may include an inpatient and outpatient, specialized clinical, emergency department, investigational drug service, and oncology pharmacy. Each position requires modified professional identities and collaboration with different healthcare professionals. A preceptor can join forces with other pharmacists—a model that is increasingly popular and often called team precepting—to ensure students receive a well-rounded education in the short period of time provided.

               

              Exposure to eustress (healthy, stimulating kind and level of stress): A preceptor should take the time to facilitate a learning environment that optimizes the likelihood that PIF will occur. Preceptors can discuss situations that present ethical dilemmas during IPPE rotations, prompting critical thinking, ethical decision-making, and the development of moral reasoning. As students are exposed to common ethical dilemmas, they will begin to develop problem solving skills; build confidence; and think, act, and feel like pharmacists. Students who have not yet assimilated the second step of PIF—the imperial—may be more concerned with packing up to leave at their assigned quitting time than finishing a task. Helping students learn that sometimes the clock should not dictate decisions also develops professional identity.

               

              Exposure to unanticipated, stressful misadventure. Marguerite was precepting a student when a technician came behind the bench with arms raised and a robber holding a gun behind her. The four other employees and the student froze, and Marguerite handled the situation, emptying the vault into the robber’s duffel bag. After the robbery, everyone was shaken but no one was hurt. Although the store manager’s opinion was to send the student home, Marguerite insisted on a post-incident stress debriefing. It gave everyone the opportunity to vent and identify what they did well and what they could do better, and reduced the likelihood of post-incident stress.21 As they met, the police returned and said they had apprehended the robber because Marguerite had placed a tracking device in the duffel bag. Marguerite has traversed all the steps of PIF. She considered others in her decisions, balanced multiple perspectives, and maintained her standards.

               

              Although this is an extreme example that underscores the meaning of “unanticipated,” the student reported feeling better and understanding more about the pharmacist’s responsibilities. Other unanticipated events that can convey PIF include dealing with irrationally irate customers, diffusing the situation with a vaccine refuser who wants to espouse her opinion loudly to other patients, or dealing with a patient or employee medical emergency in the workplace. Appropriate and deliberate use of emotion can also focus learners and enhance learning, especially when the material is moving or highlights the patient’s perspective. Preceptors should employ emotion as a teaching tool carefully, since negative emotion (e.g., anger, embarrassment) erodes trust and can disenfranchise students.

               

              Professional involvement: If time allows, preceptors can encourage students to engage with professional organizations. Attending conferences, workshops, state pharmacy board meetings, or seminars that promote professional growth, networking, and exposure to current trends in the pharmacy field builds professional identity. Preceptor Eddie, discussed previously, took Adam to a Board of Pharmacy meeting. Adam seemed uninterested until the Board discussed disciplinary action against a pharmacist who had failed to perform due diligence, leading to a patient’s death and a pharmacist with a drug abuse problem. Adam was less bumptious in the car on the way back to work, and Eddie took time to ask open-ended questions to mold Adam’s professional identity. He asked, “What questions do you have for me?” Adam said, “What is the chance they will get their licenses back?” It created a chance to talk about professional responsibilities and how state boards monitor and ensure public safety. Eddie asked a question of his own “What do you think the patients who experienced poor care or unprofessional behavior from those pharmacists think about the profession of pharmacy? In the world of social media, how far do you think those negative sentiments about pharmacists can spread?" This discussion moved Adam further through Step 2, and away from a preoccupation with self-interest.

               

              Formative feedback (feedback that helps students recognize knowledge gaps and molds the student’s beliefs and values; see the SIDEBAR) and encourage reflection. Preceptors should7

              • Provide students with regular feedback, but also schedule time for check-ins and reviews mid-rotation. As students’ professional identities develop, they will become their own sources of feedback.
              • Employ teaching methods such as using teach-back and open-ended questions.
              • Schedule time for students to work on workbooks or other tools for reflection and encourage discussion and questions.
              • Assign meaningful work to help students integrate ethical principles, evidence-based practice, effective communication, and patient-centered care.

               

               

              SIDEBAR: Formative Feedback22,23

              Formative feedback

              • refers to informal constructive feedback provided throughout a learning process
              • is ongoing and proactive
              • is specific and actionable
              • helps to develop self-awareness and independence
              • gives students the opportunity to reflect and adjust without being graded
              • and is not summative feedback (a method of assessment where students are evaluated and/or graded on their overall performance usually at the end of a learning period)

               

              Open ended questions are important in formative feedback. Just as healthcare professionals are encouraged to ask patients open-ended questions, preceptors should do the same with their students. Open-ended questions

              • give students the opportunity to participate in discussion actively and gain a deeper understanding of a topic or situation
              • can help the preceptor identify gaps in a student’s understanding
              • develop students’ critical thinking skills and autonomy to further their PIF
              • are especially useful after patient counseling or other interaction.

               

              Teach-back, or the "show-me" method, confirms whether a person—a patient or in this case, a student—understands the topic being explained. Pharmacists and other healthcare providers use the teach-back in patient counseling to facilitate better communication between patient and provider. This tool allows a healthcare provider to assess patient understanding by having a patient explain, or teach-back, what they took away from the counseling session. The healthcare provider can gently correct misunderstandings. Using teach-back with students is especially effective when

              • Students observe a complicated counseling session or process
              • Students are learning about a new medical device or a medication with an unusual administration route or schedule
              • Students need to research a topic that is new to them and may have missed some critical information
              • Students witness a situation that is emotionally charged or creates a safety concern

               

               

              Demonstrating vulnerability. Preceptors often want to hide their deficiencies, limitations, or weaknesses from students so students will have greater confidence in the preceptor’s expertise. Students need to see how mistakes happen and lead to improvement. They also need to see the ethical challenges that are inherent in pharmacy practice. Preceptor Terry received a phone call from a pharmacist who worked at another of her chain’s locations. She knew the pharmacist quite well, and the pharmacist said she had received a prescription for a patient well known to them for hydromorphone 8 milligrams. They were out of hydromorphone and the pharmacist asked if Terry had any 8 milligram tablets. Terry said she did, and the pharmacist said she would send the patient over and to expect him within 30 minutes. When the patient arrived, Terry filled the prescription and being alone with just the IPPE student, prepared to dispense it at the cash register. As required by law, she asked the patient for identification. Much to her surprise, the person presented his driver’s license and he was not the patient. In fact, the identification card was for the prescriber who had written the prescription, a medical resident at a local hospital. She asked the prescriber why he was picking up the prescription and he said that he was helping out the patient who was in terrible pain. It was late in the day, and Terry had received this referral from a colleague who she trusted. She dispensed the prescription despite her misgivings.

               

              The next day when the IPPE student arrived, Terry explained the immediacy of the situation and conflicting professional interests led to dispensing the prescription yesterday, but she still had some nagging doubts. With the prescription volume a bit slower now, she decided to do some follow up. She found that the “patient” had a number of prescriptions filled over months, most of which were filled at her colleague’s pharmacy. However, the initial prescriptions were filled in a town 40 miles away. She eventually called the hospital, found the name of the residents’ supervising physician, and contacted him. After brief discussion, he indicated that he would handle it going forward and that he appreciated the information. Although the supervising physician did not say outright that he suspected this resident of wrongdoing, the implication was that was the case. The supervising physician did follow through and eventually, the state requested documentation. Terry was able to talk through the situation with the student and explain the pharmacist's responsibility in cases like this. Terry exemplifies Step 4 of PIF. She was secure in her identity and despite the way others had handled this situation, she was concerned and confident enough to do the right thing.

               

              Teach-back is useful in many situations, but especially when processes are involved. In one busy pharmacy, a man approached the pharmacy student at counter. He said, “Can I get a shingles vaccine today?” The student, having no prior experience in a community pharmacy, politely asked the patient to wait while she asked the pharmacist. Her preceptor said quickly, “Get the patient’s insurance information and enter him into the system.” With the patient’s insurance card in hand, she began to enter his information. Unsure how to proceed, she asked the pharmacist for assistance again. A line began to form behind the man, so the pharmacist said, “Don’t worry, I’ll do it and you can watch.” The intern watched and thought the process looked easy enough. The pharmacist asked if she understands (a close-ended question), and she said yes. Later in the day, a new patient came in and the student began to enter the patient’s insurance information. She hit a point where she was unsure how to continue. But earlier she told her preceptor that she understood how to do it! She really thought she did know how! The student, becoming flustered, was embarrassed to ask for help again on something she had just learned. How could this situation have been avoided? If the preceptor had asked the student to describe the process, correcting any inaccuracies in recollection, and explained why pharmacies need to provide accurate information, the student would have been in a better position to help.

               

              Overall, preceptors need to provide students with the best experience possible with available time and resources. For example, a student may be in a health systems rotation in a department that has little patient interaction and plenty of down time. The preceptor may worry he cannot give the student the experience she deserves. This preceptor could assign the student to review a journal article on a relevant subject and present it to an interprofessional team of nurses, pharmacists, and doctors. Subsequently, the student may realize the pharmacist’s potential impact and help the student internalize what it means to be a pharmacist.

               

              PAUSE AND PONDER: Can you recall a time when you were taught how to do something, told your teacher you understood it, then could not perform the action on your own? As a preceptor, how would you avoid this situation with your own student?

               

              Finally, let's return to the questions asked at the beginning of this continuing education activity. In particular, the question of whether a pharmacist can be a good employee, but a bad pharmacist, is of tremendous interest right now. The situation it brings to mind is that of the good employee pharmacist whose supervisors urge him to dispense opioid prescriptions as written and avoid asking too many questions. Doing so makes customers happy, increases prescription volume, and reflects positively in the store’s metrics. Many pharmacists conducted themselves this way for many years, despite the fact that they probably had an inkling that they should be checking more closely or perhaps turning some prescriptions away. These pharmacists were not necessarily bad pharmacists, but their employers considered them good employees because they followed directions and turned a blind eye to a developing opioid epidemic.

               

              In November 2021, a federal jury in Ohio found three of the nation's largest pharmacy chains liable for contributing to the U.S. opioid crisis.24,25 The jury found that the prosecution provided ample evidence that some medications dispensed at chain pharmacies legally were sold on the black market. That finding has resonated nationally as state after state filed similar lawsuits. In December of 2022, two chain pharmacies agreed to share a $10.7 billion fine to settle allegations that they failed to oversee opioid analgesic prescriptions adequately. These funds are being distributed to states, local governments, and federally recognized tribes to improve opioid crisis abatement and remediation programs. Both chains agreed to improve their controlled substance compliance programs and provide mandatory training to pharmacists. Expediency in the short term and compliance with procedures that are unethical seldom avoid long term consequences.

               

              Other states have also secured settlements from pharmacies, and independent pharmacies have also been prosecuted. Discussing situations related to pharmacy that appear in the media is another way that preceptors can introduce discussion of our professional values. The nation is hopeful that pharmacists everywhere have learned that part of our professional identity is the necessity to speak up and to challenge our employers when they ask us to do things that walk the line of professionally ethical behaviors. Starting discussions with students about newsworthy events like this in which preceptors talk about self-interest, other people’s perception of pharmacy and pharmacists, and maintaining standards can advance our profession. Pharmacists are part of a complex system of drug distribution. We need to establish our core values and uphold them to keep society’s respect.

               

              CONCLUSION

              Pharmacy educators, preceptors, and mentors must realize the significance of IPPE and APPE rotations and their influence in shaping future pharmacists’ professional identities. Professional identity formation is essential for students’ transformation into successful and compassionate pharmacists. IPPE rotations with effective preceptors enable students to observe, participate, and reflect on various aspects of pharmacy practice. Often these exercises take very little time, and small actions can have tremendous impact. Through exploration, reflection, and commitment to the profession, students can develop professional identities that align with the core values and beliefs of the pharmacy profession and their own personal values.

               

              As students grow throughout their educational and professional careers, they will internalize what it means to be a pharmacist. Changes may not be apparent in the short amount of time a preceptor is with a student. If students are comfortable with the idea, preceptors can connect with them on LinkedIn, stay in contact through email, and be open to being a mentor to the student after the rotation ends. Pharmacy is a profession of many interconnected individuals with unique and valuable professional identities.

               

               

              Pharmacist Post Test (for viewing only)

              Who are you? Who are We? Professional Identity in Experiential Learning

              Post-test

              After competing this continuing education activity, preceptors will be able to
              ● Describe professional identify formation
              ● Apply the steps in development of a professional identity
              ● Identify activities that develop professional identity appropriately

              1. Lyle is a preceptor whose student arrives to work wearing a tee shirt with a silly slogan on it, a ball cap, and brightly colored foam clogs. The student puts on a wrinkled and somewhat dirty white coat and steps out behind the register to start helping patients in the line. What is Lyle’s main concern with regard to this student?
              A. Professionalism
              B. Cleanliness
              C. Professional identity

              2. As the end of the day approaches, a prescriber calls in a set of prescriptions for a child who has a serious infection. Lyle assigns his student to check the dosing. The student asks if he can do the task tomorrow morning, as it's late and he'd like to head home for dinner. He also says that the prescriber probably double checked her own work. What is the BEST way for Lyle to explain the importance of completing the task today?
              A. Explaining that one never knows when a patient will arrive to pick up prescriptions and how that reflects on the pharmacy staff. He is trying to help develop the student’s professionalism.
              B. Explaining that most prescribers rarely double check their own work so the pharmacy needs to do it before the prescriber leaves for the day. This encourages professional identity formation.
              C. Explaining that pharmacists have a duty to be diligent about medication doses, especially in pediatric patients. This should contribute to the student’s professional identity formation.

              3. Mr. Walker, a patient who has successfully overcome an addiction to heroin, presents a prescription for oxycodone after having dental work. He wants to talk to the pharmacist, and you invite your student to join you. Mr. Walker asks if the prescription is for an addictive substance and says that the dentist never asked if he had a current or previous addiction problem. He would like you to call the dentist and have the prescription changed. You agree, and when you return to the pharmacy, your student asks, “Why don't you have him call the dentist himself? We're really busy.” What part of the pharmacist core values should you discuss with this student?
              A. Pharmaceutical expertise
              B. Commitment to the patient’s well-being
              C. Social responsibility

              4. Which of the following describes Step 2 in Kegan’s Stages of Personal and Professional Identity Development?
              A. A student's primary concern is understanding others’ values and expectations.
              B. A student's primary concern is ensuring the team approves of her work.
              C. A student’s primary concern is in learning and following the rules of dispensing.

              5. Which of the following accurately represents the sequence in which students can be expected to develop professional identity?
              A. Learning the rules of pharmacy; learning to differentiate between right and wrong and working with other team members; removing emotion and using reason to make decisions
              B. Learning to differentiate between right and wrong and work with other team members; removing emotion and using reason to make decisions; learning the rules of pharmacy
              C. Removing emotion and using reason to make decisions; learning the rules of pharmacy; learning to differentiate between right and wrong and work with other team members

              6. Which of the following accurately describes PIF opportunities in the pharmacy?
              A. Preceptors who take IPPE students should use the simplest of examples to help students with PIF because students have little experience.
              B. Preceptors should concentrate on situations that are complex so that students see pharmacists practicing at the top of their licenses.
              C. Preceptors can use simple everyday tasks to help students understand the pharmacist's role and develop their professional identities.

              7. Which of the following activities would be MOST appropriate for an IPPE student who has never worked in a pharmacy with regard to professional identity formation?
              A. Having the student observe a controlled substance inventory and asking questions like, “Why do you think we conduct an inventory every day? What would we do if we found a discrepancy?”
              B. Having the student observe a technician who is running the cash register and coaching the technician to ask questions like, “Do you have any experience running a cash register or dealing with customers?”
              C. Having the student restock the OTC section of the pharmacy and make a list of OTCs that need to be ordered, and asking the student to justify her reasons for ordering the various drugs and the quantity she designates.

              8. Which of the following activities is MORE appropriate for an APPE student than an IPPE student to develop professional identity?
              A. Reviewing the case of a patient with drug resistant tuberculosis and several drug allergies and presenting the case on medical rounds with physicians and nurses
              B. Checking that the dose of amoxicillin for a 5-year-old child who weighs 36 pounds is correct and that the child has no allergy to penicillin antibiotics
              C. Asking the student to shadow you while you provide counseling to a patient who has a question about OTC cough and cold formulations

              9. A new IPPE student has a casual attitude about pharmacy and expresses opinions that indicate that she knows very little about professional responsibilities. Several times and despite gentle correction, she has counted controlled substances incorrectly and returned control substance bottles to the regular shelves, not the vault. Which of the following activities might increase her awareness of the pharmacist’s responsibilities and legal obligations?
              A. Having the student accompany you to your state’s Board of Pharmacy meeting
              B. Abandoning formative feedback and pointing out the student’s errors forcefully
              C. Restricting this student’s activity to handling the front end of the store only

              10. Your state announces that it will now impose significant restrictions on all prescriptions for a certain drug because of a growing number of patient deaths related to its abuse. During the morning huddle, your staff discusses the increased paperwork burden and the potential that patients will be upset. After the huddle, the student asks, “Why is this our problem? Shouldn't this be handled by the drug’s manufacturer?” What is the best answer?
              A. Technically pharmacists are nothing more than the medication police. Our job is to enforce the rules other create strictly and unemotionally.
              B. In an ideal world, pharmaceutical companies would take complete responsibility for the damage their drugs do. This is not an ideal world.
              C. Pharmacists are part of a complex system of drug distribution. We need to establish our core values and uphold them to keep society’s respect.

              References

              Full List of References

              REFERENCES
              1. Larose-Pierre M, Cleven AJ, Renaud A, et al. Reevaluating core elements of emotional intelligence in professional identity formation for inclusion in Pharmacy Education. American Journal of Pharmaceutical Education. 2023;87(6):100082. doi:10.1016/j.ajpe.2023.100082
              2. Kellar J, Paradis E, van der Vleuten CPM, oude Egbrink MGA, Austin Z. A historical discourse analysis of Pharmacist Identity in Pharmacy Education. American Journal of Pharmaceutical Education. 2020;84(9). doi:10.5688/ajpe7864
              3. Jarvis‐Selinger, S., Pratt, D.D., and Regehr, G. (2012). Competency is not enough: integrating identity formation into the medical education discourse. Academic Medicine 87: 1185
              4. Toklu HZ, Hussain A. The changing face of pharmacy practice and the need for a new model of pharmacy education. J Young Pharm. 2013;5(2):38-40. doi:10.1016/j.jyp.2012.09.001
              5. Kruijtbosch M, Göttgens-Jansen W, Floor-Schreudering A, van Leeuwen E, Bouvy ML. Moral dilemmas reflect professional core values of pharmacists in community pharmacy. Int J Pharm Pract. 2019;27(2):140-148. doi:10.1111/ijpp.12490
              6. https://www.ashp.org/-/media/assets/policy-guidelines/docs/endorsed-documents/code-of-ethics-for-pharmacists.ashx
              7. Johnson JL, Arif S, Bloom TJ, Isaacs AN, Moseley LE, Janke KK. Preparing pharmacy educators as expedition guides to support professional identity formation in Pharmacy Education. American Journal of Pharmaceutical Education. 2023;87(1). doi:10.5688/ajpe8944
              8. Kegan, R. (1982). The Evolving Self: Problem and Process in Human Development. Cambridge, MA: Harvard University Press
              9. Irby, D.M. and Hamstra, S.J. (2016). Parting the clouds: three professionalism frameworks in medical education. Academic Medicine 91: 1606–1611
              10. Swanwick T, Forrest K, O’Brien BC, Cruess RL, Cruess SR. The Development of Professional Identity. In: Understanding Medical Education: Evidence, Theory and Practice. Wiley-Blackwell; 2019:239-254.
              11. Hafferty, F.W. (2016). Professionalism and the socialization of medical students. In: Teaching Medical Professionalism (ed. R.L. Cruess, S.R. Cruess and Y. Steinert), 54–68. Cambridge: Cambridge University Press.
              12. Briceland LL, Martinez T. Exploring the impact of reflecting upon pharmacy experts’ written career guidance on Student Professional Identity Formation. INNOVATIONS in pharmacy. 2022;13(3):5. doi:10.24926/iip.v13i3.4778
              13. Arnoldi J, Kempland M, Newman K. Assessing student reflections of significant professional identity experiences. Currents in Pharmacy Teaching and Learning. 2022;14(12):1478-1486. doi:10.1016/j.cptl.2022.10.003
              14. Janke KK, Bloom TJ, Boyce EG, et al. A pathway to professional identity formation: Report of the 2020-2021 AACP student affairs standing committee. American Journal of Pharmaceutical Education. 2021;85(10). doi:10.5688/ajpe8714
              15. Luyckx K, Goossens L, Soenens B, Beyers W. Unpacking commitment and exploration: Preliminary validation of an integrative model of late adolescent identity formation. Journal of Adolescence. 2005;29(3):361-378. doi:10.1016/j.adolescence.2005.03.008

              16. AFPC Educational Outcomes for First Professional Degree Programs in Pharmacy in Canada 2017. Association of Faculties of Pharmacy of Canada. Accessed August 26, 2023. http://www.afpc.info/system/files/public/AFPC-educational%20Outcomes%202017_final%20Jun2017.pdf
              17. Elnicki DM. Learning with emotion: which emotions and learning what? Acad Med 2010;85:1111.
              18. Poulsen L, Brosen K, Arendt-Nielsen L, et al. Codeine and morphine in extensive and poor metabolizers of sparteine:pharmacokinetics, analgesic effect and side effects. Eur J Clin Pharmacol. 1996. 51(3-4): 289-295.
              19. Caraco Y, Sheller J, and Wood AJ. Pharmacogenetic determination of the effects of codeine and prediction of drug interactions. J Pharmacol Exp Ther. 1996. 278: 1165-1174.
              20. Lalovic B, Phillips B, Resler LL, et al. Quantitative contribution of CYP2D6 & CYP3A4 to oxycodone metabolism in human liver and intestinal microsomes. Drug Metab Dispos. 2004. 32: 447-454.
              21. Campfield KM, Hills AM. Effect of timing of critical incident stress debriefing (CISD) on posttraumatic symptoms. J Trauma Stress. 2001;14(2):327-340. doi:10.1023/A:1011117018705
              22. Formative Assessment and Feedback. Stanford | Teaching Commons. Accessed August 16, 2023. https://teachingcommons.stanford.edu/teaching-guides/foundations-course-design/feedback-and-assessment/formative-assessment-and-feedback#:~:text=Formative%20feedback%20helps%20students%20recognize,to%20meet%20the%20course%20outcomes.
              23. Formative and Summative Feedback. Teaching@Tufts. Accessed August 6, 2023. https://sites.tufts.edu/teaching/assessment/assessment-approaches/formative-and-summative-feedback/.
              24. Mann B. 3 of America's biggest pharmacy chains have been found liable for the opioid crisis. November 23, 2023. Accessed August 16, 2023. Ohio jury holds CVS, Walgreens and Walmart liable for opioid crisis : NPR
              25. Wile R. CVS and Walgreens to pay a combined $10.7 billion settlement for alleged opioid prescription lapses. December 12, 2022. Accessed August 16, 2023. CVS, Walgreens to pay $10.7 billion for alleged opioid prescription lapses (nbcnews.com)

              The Path to Time Management: Time to Hit the Road!

              Learning Objectives

              After completing this knowledge-based continuing education activity, pharmacy technicians will be able to

                • Describe how an individual technician’s time management impacts the whole pharmacy’s efficiency
                • List three time management techniques that could improve a technician's function
                • Recognize time management techniques to apply in specific settings and situations

                 

                Re-Release Date: September 24, 2023

                Expiration Date: September 24, 2026

                Course Fee

                Pharmacy Technicians: $4

                There is no funding for this CE.

                ACPE UAN

                Pharmacy Technician: 0009-0000-23-027-H04-T

                Session Codes

                Pharmacy Technician:  20YC65-TJX49

                Accreditation Hours

                1.0 hours of CE

                Accreditation Statements

                The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-23-027-H04-T  will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

                 

                Disclosure of Discussions of Off-label and Investigational Drug Use

                The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

                Faculty

                 

                Isabella Bean
                PharmD Candidate 2022
                UConn School of Pharmacy
                Storrs, CT

                Sara Miller, PharmD, RPh
                CVS
                Foxboro, MA

                May Zhang
                PharmD Candidate 2022
                UConn School of Pharmacy
                Storrs, CT

                Faculty Disclosure

                In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

                Isabella Bean, Sarah Miller and May Zang do not have any relationships with ineligible companies.

                 

                VIDEO

                html

                Pharmacy Technician Post Test (for viewing only)

                The Path to Time Management: Time to Hit the Road!

                LEARNING OBJECTIVES
                After completing this continuing education activity, the pharmacy technician should be able to
                1. Describe how an individual technicians' time management impacts the whole pharmacy’s efficiency
                2. List three time management techniques that could improve a technician's function
                3. Recognize time management techniques to apply in specific settings and situations

                1. Barbara and Linda are great multitaskers. They are able to work and talk while getting everything done effectively. While ringing out a customer, Barbara continues her conversation with Linda. What should Barbara have done instead?
                a. Paused the conversation, because it makes the customer feel unimportant
                b. Done nothing different—in situations like this, she never makes errors
                c. Asked someone else to ring the customer so she can go on her 15 minute break

                2. Lilly makes it to work within the 7 minute grace period every day. Technically she is on time, but she’s not ready and at her station at her 7:30 shift time. How does this disturb workflow when she takes advantage of the grace period every day?
                a. It doesn’t disturb workflow because she is not late. The grace period is in effect so that she doesn’t have to be in right when her shift starts.
                b. Exploiting the grace period means the other technicians who arrive before the official start time have to cover her station until she comes in.
                c. Employers know how often employees are late and why, and communicate problems like traffic congestion to local governments, so the effect on the workplace is positive.

                3. You’re heading to work and you know it takes exactly 11 minutes to travel there. Your shift starts at 9 am. What time do you leave?
                a. I leave by 8:40 am at the latest so that I have time to park and walk in.
                b. I leave at 8:49 am because I know it takes 11 minutes to get there.
                c. I leave at 9:00 am because I know they can handle me being a little late.

                4. You are entering in an insurance card that you haven’t seen before. You’ve been struggling with it for five minutes and can’t figure it out. You are unsure of how to proceed, but the pharmacist is busy. What do you do?
                a. Politely interrupt the pharmacist to ask your question
                b. Ask a more senior technician if they have seen it before
                c. Go to a different station to avoid this insurance card

                5. Laura is a new pharmacy technician. The customers will ask her where to find an OTC or grocery item frequently, but she doesn’t know yet. She asks you how she can become more familiar with where everything is. What do you say?
                a. Suggest that she ask the manager for front store training so that she can become more familiar with the store
                b. Tell Laura that it takes time to learn the store, and to keep asking the other techs and pharmacists
                c. Tell Laura she that she should identify this problem’s quadrant and decide whether to ask or act

                6. You are working in the pharmacy and a huge order arrives. You know you have to finish putting away the order before your shift ends, but prescriptions and patients keep popping up. What do you do?
                a. Prioritize the customers and prescriptions that are here now and do as much of the order as possible
                b. The other technicians are busy too, but leave it for them because you’ve had to put the order away on three recent days
                c. Multitask by putting the order away as you ring customers and retrieve and count controlled substances

                7. The phone is ringing! When you answer it, a provider is on the line. She’s very frustrated because she’s been on hold for 10 minutes, and she “doesn’t have the time for this kind of thing” and “needs an answer ASAP.” She has a clinical question about a medication you fill very frequently. What is the most appropriate response?
                a. ACT—you’ve been a tech for four years; you’ve seen this medication dozens of times. You know enough to answer the provider’s question.
                b. ASK—you’re in the middle of something else right now. Ask another tech to handle this provider.
                c. ASK—the pharmacist should take the call, since it involves a clinical question and you may not know all the details.

                8. The phone is ringing! When you answer it, a provider is on the line. She’s very frustrated because she’s been on hold for 10 minutes, and she “doesn’t have the time for this kind of thing” and “needs an answer ASAP.” She has a clinical question about a medication you fill very frequently. What quadrant of workplace activity best describes this situation?
                a. Quadrant 1: important and urgent
                b. Quadrant 2: important but not urgent
                c. Quadrant 4: not important and not urgent

                9. Flu season is coming. Martha, an experienced pharmacy technician, knows that the store serves a very elderly population. She decides to ask the pharmacist to order more high potency flu vaccines, in anticipation of a higher customer demand. This best describes which time management technique?
                a. Good organization
                b. Planning ahead
                c. Multitasking effectively

                10. You’ve just transferred pharmacies, and you’re trying to figure out the lay of the land. It’s really hard to find things in your new pharmacy. Some meds are ordered by brand name, some by generic. Topicals, inhalers, and DME are all combined on the same shelf. When you bring this up to other techs, they sympathize but say you’ll figure it out eventually, like they had to. Which time management technique would best solve this issue?
                a. Acting instead of asking
                b. Multitasking effectively
                c. Good organization

                References

                Full List of References

                References

                   

                  Prepping Pharmacist Preceptors on the Pharmacists’ Patient Care Process (PPCP)

                  Learning Objectives

                   

                  After completing this application-based continuing education activity, pharmacists will be able to

                    • Describe the PPCP model and its uses
                    • Apply the PPCP when students address clinical problems in the workplace
                    • Identify areas where pharmacy students need the most guidance when using the PPCP

                    Two healthcare professionals talking while looking at a vial filled with medication capsules

                     

                    Release Date: July 21, 2023

                    Expiration Date: July 21, 2026

                    Course Fee

                    Pharmacists: $7

                    UConn Faculty & Adjuncts:  FREE

                    There is no grant funding for this CE activity

                    ACPE UANs

                    Pharmacist: 0009-0000-23-028-H04-P

                    Session Code

                    Pharmacist:  23PC28-XPK68

                    Accreditation Hours

                    2.0 hours of CE

                    Accreditation Statements

                    The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-23-028-H04-P  will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

                     

                    Disclosure of Discussions of Off-label and Investigational Drug Use

                    The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

                    Faculty

                    Kimberly Ma
                    PharmD Candidate 2024
                    UConn School of Pharmacy
                    Storrs, CT

                    Jeannette Y. Wick, RPh, MBA, FASCP
                    Director, Office of Pharmacy Professional Development
                    UConn School of Pharmacy
                    Storrs, CT

                    Faculty Disclosure

                    In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

                    Kimberly Ma and Jeannette Wick do not have any relationships with ineligible companies

                     

                    ABSTRACT

                    Preceptors often work with students to review patient cases in an organized way. Experts developed the Pharmacists’ Patient Care Process (PPCP) in 2014 to provide a template that is consistent and concise, but also comprehensive. Using this process, students and licensed pharmacists develop SOAP notes to document the subjective and objective data they need to complete an assessment, and ultimately make a plan. PPCP stresses an important point: follow-up is critical and a well-written SOAP note can be extremely helpful in the follow-up process. This continuing education activity uses a case study to demonstrate how the PPCP process should work and emphasize areas where preceptors can provide tangential learning. It includes PRO TIPS for preceptors when they supervise students who are attempting to complete PPCP. It highlights the most common errors and suggest ways that preceptors can work with students to improve their experiential education.

                    CONTENT

                    Content

                    INTRODUCTION: A PATIENT CASE

                    JM, an 8-year-old white male presents to your clinic. It’s a pediatric care clinic located in an area where many financially challenged families live. After talking with his parents, you learn he was recently diagnosed with central precocious puberty (CPP). His endocrinologist recommends initiating therapy and would like to know what treatment you recommend. His parents also have questions.

                    Your spry pharmacy student jumps at the opportunity to write a SOAP note using the “PPCP.” To you, PPCP sounds like an illegal drug that was abused in the 1980s. She explains that the Pharmacists’ Patient Care Process (PPCP) is a standardized model for collaborative medication management. She clarifies what it entails and how to apply the process in a clinical setting.

                    PPCP’s Importance

                    Schools of pharmacy have taught the PPCP for the past few years. Preceptors who are unfamiliar with the process may find it helpful to review the PPCP as many students will take this approach when addressing clinical problems in the workplace.

                    PPCP: THE DETAILS

                    Teamwork in healthcare has achieved major goals for many patients (although we have room for improvement): accessible, affordable, and high-quality care. In addition to the many healthcare team members, pharmacists are critical contributors to care plans. Medication expertise equips pharmacists with the knowledge to reduce drug adverse events, prevent medication errors, and provide invaluable input for decision-making.1

                    In 2014, the Joint Commission of Pharmacy Practitioners (JCPP) developed a standardized process for medication management that could be used across interdisciplinary teams and dubbed it PPCP. JCPP’s members developed the approach using principles of evidence-based practice. The five steps—collect, assess, plan, implement, and follow-up—are tied together with careful communication and documentation.2 Pharmacists can remember the steps as the pneumonic “CAP-IF.”

                    SOAP Notes

                    The subjective, objective, assessment, and plan (SOAP) note provides a method of documentation for the collect, assess, and plan steps of the PPCP. SOAP notes are probably familiar to most preceptors, as clinicians have used them for roughly 50 years.3 Table 1 highlights the key components of SOAP notes.

                    Table 1. Components of a SOAP Note1

                     

                    Objective Information Subjective Information
                    ·       Current medication list (prescription and nonprescription)

                    ·       Medical history

                    ·       Physical assessments (i.e., blood pressure, heart rate, weight, height, respiratory rate, etc.)

                    ·       Laboratory results

                    ·       Chief complaint

                    ·       Symptoms

                    ·       Patient lifestyle habits, preferences, and beliefs

                    ·       Patient goals for care

                    ·       Socioeconomic factors

                    Assessment
                    ·       Problem: statement highlighting the chief complaint or main medication-related problem

                    ·       Rationale: the reasoning for the intervention cited from guidelines and supporting evidence from the collected information

                    ·       Goals of care: possible barriers to adherence, socioeconomic considerations, and desired outcome of intervention

                    Plan
                    ·       Specific recommendation or intervention based on practice guidelines (i.e., initiation of drug therapy, referral to another provider, or non-pharmacologic lifestyle modifications)

                    ·       Plan for upcoming sessions, specific monitoring parameters, and progress indicators

                     

                    Collect

                    Thorough collection of the right information supplies pharmacists with tools to make safe, effective decisions. A combination of objective and subjective information paints a more complete picture of a patient’s clinical status. If possible, pharmacists should obtain and verify their information across multiple sources. Past medical records, active medication lists, and laboratory results are great places to start.

                    When soliciting subjective information, pharmacists should use open-ended questions. Prompting patients with questions formatted to avoid “yes” or “no” answers allow providers to obtain more information in less time, prioritize chief complaints better, and minimize implicit assumptions.4

                    Back to the Case

                    Your head is spinning trying to sort all the “P’s” in PPCP, CPP, and JCPP, but your student assures you that she will start with collecting relevant clinical information. First, you and your student perform a physical assessment of JM including taking his height and weight. JM takes no medication except an occasional antihistamine, but if he took other chronic medications, this would be the time to direct your student to perform a medication reconciliation. Next, you prompt JM’s parents with open ended questions, and they recall JM’s past medical history. You should ask your student if JM needs to be involved in the discussion (see SIDEBAR). After meeting with JM and his parents, here is the relevant information your student jots down:

                    Subjective information

                    • At age 5, JM frequently soaked through his underarm clothing with pungent perspiration, so since then, he uses a strong deodorant
                    • He is starting to develop pubic and underarm hair
                    • He has some acne on his face and upper back
                    • JM occasionally tells his parents he feels “different” than his classmates because he is so much bigger and taller
                    • He has no past surgeries or hospitalizations
                    • Takes OTC multivitamins daily and loratadine for allergies in the spring

                    Objective Information

                    • Height = 4’8” inches
                    • Weight = 102 pounds
                    • DHEA Sulfate = Tanner stage III - 60 ug/dL (N = < 28 ug/dL)
                    • Clinical exam findings = testicle size indicates puberty
                    • X-ray bone age hand and wrist = greater than 2 standard deviations, 156 months (expected = 108.9 months)
                    • Luteinizing hormone (LH) = 0.4 units/L (N = < 0.3 units/L)

                    SIDEBAR: Pediatric Involvement in Healthcare Decisions5,6

                    In pediatric cases, clinicians may choose to consult only parents when making decisions regarding their child’s medical care. However, this practice, which is rooted in legal precedence, should shift to involve affected children to some extent. The American Academy of Pediatrics advocates that adolescents actively participate in decisions based on their ability and maturity. 5 While research is lacking on how exactly to assess a child’s aptitude to participate in decision making, some studies show that children can participate as young as age 5.6 Regardless, it doesn’t hurt to ask children if they have questions or concerns. In the case, JM is 8 and has voiced his concern previously about his height and size. Therefore, including him in the conversation is a possibility if his parents agree.

                    Preceptors can and should provide tangential learning when working with special populations. Reminding students that adolescents, older adults, people who have cognitive decline or dementia, and people for whom English is a second language will need careful counseling. Pharmacists and pharmacy staff will also need to select their words carefully and accommodate these patients’ needs. Assigning students to do some research on the various needs in these populations is an excellent way to help them develop skills and a professional identity.

                    Upon looking at your student’s notes so far, you assure her she has done well. However, you still have some questions. You remind her that sometimes information like height and weight requires additional evaluation and ask her to calculate JM’s BMI; she finds that it’s 22.9. You ask your student, “How does JM’s height and weight compare to the expected height and weight of boys his age?” To which she replies, “Pediatric growth charts will give us a better idea!” After consulting the growth charts, she determined and documented that JM falls within the 112th percentile for both measurements.

                    To make learning comprehensive, you could ask the student if the only kind of precocious puberty is central in nature. This will help your student learn to differentiate among different forms of similar diagnoses.

                    Assessment

                    An assessment of comprehensive patient information helps prioritize the problems that require attention. Pharmacists should consider all information when identifying the problem, the rationale, and the goals of therapy. Some example questions pharmacists can consider include1

                    Medication appropriateness

                    • What is the indication for each medication?
                    • What is the correct dosing?
                    • What are the common adverse effects?
                    • What are the possible drug interactions?

                    Factors that impact access to care

                    • What cultural factors create barriers to care?
                    • What socioeconomic factors impact the patient?
                    • What is the patient’s level of healthcare literacy?
                    • What goals does the patient or his parents have?
                    • What barriers impact patient adherence?

                    Additional services

                    • What preventive care measures does the patient qualify for?
                    • Which immunizations has the patient received?
                    • What other concerns does the patient have?

                    THE CASE RESUMED...

                    After compiling the objective and subjective information on JM, the student finds guidelines in the Journal of Clinical Endocrinology for the management of CPP.7 Due to JM’s symptoms and lab values showing consistencies with CPP, the guidelines recommend initiating a gonadotropin releasing hormone (GnRH) analog. Depending on JM’s and his parents' preferences, the endocrinologist can choose either an injectable (leuprolide) or long-acting implantable device (histrelin) provided the insurance covers it or the cost is manageable.

                    Once again, you should have some questions for your student. For example, asking the student to list the search terms and search engines she employed can shed light on her process. Another question might be, “Are these the only guidelines available?” You can show her that you used PubMed, as she did, but when you used Google Scholar, you found an excellent review article that lists five other publications. You suggest she look at them since expert recommendations can vary. She might also contact the endocrinologist and ask if he plans to follow the guidelines she identified, and if not, why not.

                    The endocrinologist messages back saying he agrees leuprolide and histrelin are both reasonable options to consider for first-line therapy. However, he also cites a 2019 update published on Hormone Research in Paediatrics. These guidelines recommend a third U.S. Food and Drug Administration (FDA)-approved option for the treatment of CPP, triptorelin.8 He says the student should consider this choice as a potential treatment for JM as well.

                    After reading the endocrinologist’s note, you emphasize to your student the importance of citing multiple guidelines when drafting an assessment. In this case, the FDA approved an additional treatment, triptorelin, in 2022. You walk through your student’s process of finding clinical information to identify more ways she can improve next time. Furthermore, you point out how the endocrinologist’s insight exemplifies the importance of interdisciplinary care.

                    Simultaneously, you and your student read through all three monographs and discuss the major differences you’d like to share with his parents. You ask the student to practice her delivery of the information, and she says, “Leuprolide is a long acting injectable administered intramuscularly (IM) or subcutaneously. Your doctor will administer the IM formulation every month, three months, or six months. “Triptorelin is similar to leuprolide, but is only available as a six month IM formulation. The other option is for your doctor to administer the subcutaneous formulation every six-months.9 On the other hand, histrelin comes as a long-acting 1¼ inch implant surgically placed into the upper arm every 12 to 24 months. For the first 24 hours after the surgery, JM should avoid swimming or bathing. As long as JM avoids heavy play or exercise for the first week, he will not have to worry about any further restrictions after that. The implant also requires surgical removal.”10

                    Now, you prompt the student to recall that JM’s parents expressed concern about what would happen if JM experienced an adverse reaction to the long-acting implantable device. They asked, “What is the procedure like?” and “If JM has a reaction to the implant, must he continue to wear it for 12 months or can the doctor remove it easily before then?”

                    The student does more research and says she will assure JM’s parents that this outpatient procedure lasts only 10 minutes, though the appointment may last 60 to 90 minutes. Most surgeons will just numb the area; however, children may undergo sedation if necessary. The surgeon will insert the narrow implant into a small approximately 5 mm opening made in the skin on the inner surface of the arm. With this option, JM can return to school the same day. The student plans to mention that complications don’t commonly occur, but minor discomfort and bruising may.11 The student plans to continue, “The implant may be removed immediately if JM presents at any time a severe allergic reaction or adverse effect. However, this is not common.”

                    Before you and the student document the assessment section of your SOAP note, the student indicates she will ask JM if he has questions. He shares that he “HATES needles” but is also scared of the surgery hurting.” The student plans to tell him not to worry because he won’t feel any pain during the operation. He can also choose to sleep during the surgery if he prefers.

                    Here, the preceptor should step in with gentle corrections about patient-appropriate language. First, most Americans have no idea what a 5 mm incision will look like. You ask her to calculate its length in inches and explain it by comparing it to something the child will recognize, like the size of small dice or a stack of 20 playing cards. Next, it’s critical to remind the student that we must never tell patients that something won’t hurt. This is a lesson students should learn during immunization training and creates an opportunity for cross training (applying this principle to other areas of pharmacy) that applies regardless of patient age. Healthcare professionals should never say, “This will not hurt a bit!” or anything similar. People have different pain thresholds making it impossible to predict whether it will hurt. Student pharmacists need to develop language they are comfortable with and use it. A good response if people ask if it will hurt is, “It may hurt or sting a little but just for a minute or two.” In this case, the preceptor suggests saying, “The doctor will numb the area.”

                    Finally, the preceptor may point out that “operation” can be a scary word for children. The student needs to use a word like “procedure” or find a way to avoid either of those words.

                    The preceptor should also point out that JM’s parents had also said they were worried about two things: (1) potential side effects and (2) the cost of care. They heard on the news that expenses associated with these medications can add up quickly. The cost of care and determining what the patient’s insurance will cover is probably foremost in the endocrinologist’s mind, too.

                    In terms of potential side effects, your student says that both GnRH analogs have similar side effect profiles. From the pediatric studies she read on GnRH adverse effects, she shares that signs of puberty may increase transiently with therapy before growth velocity eventually slows down. Some children experience weight gain, changes in appetite, body aches, headaches, gastrointestinal (GI) symptoms, or signs of a common cold. Parameters like physical growth and bone mass density may decrease during treatment but usually return to normal one year after treatment discontinuation.9, 10

                    Before selecting JM’s treatment option, it’s critical to evaluate insurance coverage since it’s on the forefront of everyone’s concerns. The student needs to determine if they have insurance and what the plan covers. She starts by finding information on ballpark cost. She reports a histrelin implant costs around $40,000. If the patient requires mild sedation when the doctor inserts the implant, the cost may increase. However, in some cases, the implant may be used for up to two years. Leuprolide’s median annual cost ranges from $20,000-$40,000 depending on the formulation.12 A single injection of triptorelin costs roughly $19,000, making the annual cost nearly $40,000 as well. Then says she will remind JM’s parents that while this may give them an idea, the cost may vary outside of that range.

                    Plan

                    Following the assessment, pharmacists work to develop a personalized patient care plan in collaboration with other healthcare professionals. The plan should reflect recommendations from the most recent evidence-based clinical practice guidelines. Pharmacists should focus on optimization of care in a safe, effective, and cost-effective manner.

                    1. Address medication-related problems and optimize medication therapy
                    2. Set specific, measurable, achievable, realistic, and timed (SMART) goals in the context of the patient’s healthcare goals and access to care
                    3. Involve patients to engage in education, empowerment, and self-management
                    4. Support non-pharmacologic interventions as appropriate

                    SMART Goals. When creating an action plan for patients, pharmacists should aim to set goals that are SMART.

                    • Specific instructions provide other clinicians with accurate information about the patient.
                    • Measurable outcomes provide clinicians the ability to evaluate the patient’s progress and whether the plan requires adjustments
                    • Achievable and realistic goals
                    • A timeline for the plan ensures healthcare providers routinely follow up with their patient

                    A PLAN FOR JM

                    After you document JM’s main problem, rationale, and goals for care in the assessment section, you move on to create his plan. Following careful consideration of the assessment, you and your student decide to recommend starting histrelin to treat his CPP since his insurance will cover it once the endocrinologist completes prior authorization forms. (Here, you suggest that the student find the prior authorization forms and volunteer to complete as many sections as she can for the endocrinologist. You explain that she can expedite the process and this is a skill she can apply to many different pharmacy practice locations.) Choosing histrelin is also a needle-free option, which may make JM happy. You remind your student that the plan should also include scheduling necessary appointments and follow-ups with JM’s other providers in addition to counseling on the specific adverse effects of the medication detailed in Table 2.

                    Table 2. Example SOAP note for JM 7

                    Name: JM

                    Age: 8    

                    DOB: 10/02/14

                    Allergies: Seasonal allergies, NKDA

                    Chief Complaint: Patient referred to clinic by endocrinologist for medication therapy; patient was recently diagnosed with central precocious puberty (CPP)
                    Subjective Information

                    JM is an 8-year old white male presenting to the clinic. He recently met with his endocrinologist on 6/28/23 and has been referred to the clinic for drug therapy to treat CPP. His parents confirm JM’s use of deodorant to combat excessive perspiration and body odor since the age of 5. He has also developed pubic and underarm hair in addition to acne on his face and upper back. His parents are concerned regarding JM’s reported insecurities at school due to his larger size.

                    PMH: no surgeries or hospitalizations Medications: daily multivitamin, OTC loratadine (prn for allergies)
                    Objective Information

                    Clinical exam findings = testicle size indicates puberty

                    112th percentile for weight and height

                    Relevant Labs: Bone age of 13, LH 0.4 units/L, DHEA sulfate 60 ug/dL

                    Height: 55 in Weight: 102 lbs BMI: 22.9 BP: 110/61 mmHg HR: 75 bpm Temp: 98.6 ℉ RR: 15
                    Assessment

                    Problem: Patient requires medication therapy for untreated indication.

                    Rationale: According to the Journal of Clinical Endocrinology Practice Guidelines for Central Precocious Puberty, JM requires hormone suppression therapy. Symptoms of rapid linear growth, advanced skeletal maturation, and basal LH levels > 0.3 units/L require treatment with GnRH analogs until the normal age of puberty.

                    Goals of Care: The goal of treatment is to reduce signs of premature pubertal progression while ensuring therapy is well tolerated and medication side effects are minimized. Patient’s parents would like to choose an option that is cost effective and safe.

                    Plan

                    Initiate histrelin 50mg SQ implant to be administered by JM’s surgeon every 12-24 months depending on safety and efficacy parameters evaluated at follow up appointments

                    Schedule surgery appointment with JM’s surgeon at earliest convenience

                    Schedule follow up in 3 months to evaluate pubertal progression, growth velocity, skeletal maturation, and tolerability

                    Counsel JM/JM’s parents on possible adverse effects including weight gain, changes in appetite, initial flare of puberty symptoms, GI symptoms, body aches/pains, and signs of common cold

                    Counsel JM’s parents on providing support to make JM feel good about himself. Children who are undergoing rapid development at this age may feel different when comparing themselves to other children their age.

                    Implement

                    During the implementation phase, pharmacists set the action plan into motion. This may include the administration of vaccines, initiating or discontinuing a medication, or scheduling the next follow-up appointment. Pharmacists, primary care physicians, or caregivers work together to provide care based on the goals made in the planning step.1

                    Follow-up and Monitor

                    The pharmacist in collaboration with other health care providers should follow-up with the patient as recommended in practice guidelines and referring back to the SOAP note. Continuous monitoring of medication appropriateness, adherence, safety, laboratory results, and patient concerns will indicate if the plan requires revision. Routine medication reconciliations, check-ups, or conversations with patients improve outcomes and help to achieve goals of therapy.

                    Putting it All Together

                    Upon completion of the SOAP note, you send the endocrinologist your recommendations. You contact JM’s parents to discuss scheduling a follow-up appointment in three months with the endocrinologist and counsel on histrelin.

                    IMPLICATIONS FOR PRECEPTORS

                    The Benefits. The PPCP model creates a reproducible framework that demonstrates clinical pharmacists’ contributions to medication-related outcomes.13 In addition to improving the quality and completeness of patient medical records, SOAP notes give pharmacists a place to start when working up a new patient. As students practice developing SOAP notes, preceptors should emphasize how the lessons they learn in one case can apply to future cases.

                    The Drawbacks. As more pharmacy programs integrate PPCP into their curriculum, new students will have access to courses that teach the model. But because the PPCP model is relatively new, many licensed pharmacists have not yet familiarized themselves with the process. Extracting the necessary information to write quality SOAP notes can also be time consuming. Depending on the setting, pharmacists may not have enough time to walk through every step with students. Finally, the PPCP method does not encompass all clinical situations. The framework relies on pharmacists to exercise clinical judgment and reasoning to modify the model as needed.

                    Uncomfortable Topics. Students often have little exposure to difficult topics. These may include end-of-life issues, psychiatric diagnoses, cultural or ethnic differences, drug abuse/misuse, and gender-related topics. In this case, students may feel strong discomfort in discussing matters related to sex and sexual development. Preceptors need to help students reduce their hesitancy when communicating with you and the patient because improper communication can lead to poor collection of relevant information. Keep in mind strong note-writing skills facilitate good care. Two things help: (1) practice, and (2) finding resources designed to help with difficult topics. The Conversation Project (https://theconversationproject.org/resources/healthcare/) is one such resource that can help students become more comfortable with difficult topics.

                    In addition, students may have implicit and explicit biases for uncomfortable topics such as the use of hormone blockers, which may bring to mind their use in transgender children. Creating a safe place for your student to share opinions provides a great opportunity for you to teach students how to avoid these biases. Preceptors need to remember that learning—especially if it changes a student's perspective or points out a student's mistake—can be threatening, and students can feel vulnerable while learning. It’s an emotional experience.6

                    To help guide students through these experiences, the SIDEBAR provides 10 additional tips preceptors can use when supervising the PPCP.

                    SIDEBAR: PRO TIPS for Preceptors Who Supervise the PPCP

                    (1) Don't let the acronym scare you! This is a new name for a process you've probably used knowingly or unknowingly for years.

                    (2) Encourage independence. Hand over the problem to the student once you've described the problem and fielded the student's questions. Establish a time for the student to be prepared to discuss it but check in periodically to see if the student is having trouble.

                    (3) Rescue when necessary. Some students will need more support than others. If a student is clearly flummoxed, spend more time and provide more direction.

                    (4) Promote interdisciplinary communication. Having students discuss a clinical problem with another clinician, either with you or on their own, fosters interdisciplinary care. Students will also learn from the other clinicians, which will lighten your load!

                    (5) When students present findings, always ask them to describe things like the search terms and search engines they used or the obstacles they encountered. Help them refine their processes to reduce barriers or find more appropriate resources.

                    (6) Consistently prompt students to determine if the case is typical or unusual. Asking questions based on a modification of the case can help students learn more globally.

                    (7) Don't "stay in your lane"! In this CE, the practice site is an ambulatory care location specific to pediatrics. The lessons a student learns in this rotation, if they go beyond pediatrics, will be invaluable. Helping students develop communication skills or analyze how disease states present or are treated in adults or other special populations will increase their clinical acumen in future rotations.

                    (8) Address implicit biases or misconceptions. Students may not know that an attitude or opinion is biased, incorrect, or simply rude.

                    (9) Debrief. After the PPCP is done, provide feedback, ask others who may have been involved to provide feedback, and ask the student to perform a self-assessment.

                    (10) Appreciate reverse mentoring. Remember that students often teach us new things!

                     

                    Common Sources of Error

                    Collecting too little information. Not all the information pharmacists need to collect will be obvious. In the patient case, the student collected important objective information like height and weight. However, without something like growth charts to evaluate JM’s height/weight compared to other kids his age, the information does not help in the assessment. Preceptors can aid students who are new to documenting SOAP notes when they are required to dive deeper into collected information. Students should not make assumptions as to what other clinicians know off the top of their heads. In this case, other areas where the preceptor helped the student included directing her to seek other expert opinions like the endocrinologist. That puts the “inter” in “interdisciplinary” care!

                    Collecting too much information. Pharmacists and students should collect information worthy of appraisal. In other words, only collect the necessary information that will contribute to the identification, prevention, and resolution of either the chief complaint or medication-related problems. If pharmacists/students do not actively use collected information to make the assessment or plan, they should omit it in the note. Documenting more information does not equate to better information. This leads to overly lengthy or confusing SOAP notes. Here, as in the previous error, preceptors should ask students to examine and explain their processes.

                    Not verifying information. All information should be verified across multiple sources like when performing traditional medication reconciliations. This prevents possible errors in note-taking that may arise from outdated documentation.

                    Sourcing one guideline. Depending on the disease state, the frequency in which guidelines are updated can vary. Preceptors should emphasize the importance of looking for multiple guidelines and paying attention to their publication dates. Occasionally, the FDA may approve new treatment options after the release of clinical guidelines or updates. In this case, the student completely missed an additional treatment option as a result of sourcing a single guideline from 2013. Similar to how preceptors should encourage students to verify collected information across multiple sources, preceptors should also encourage students to cross-check sources that aid in their assessment.

                    The assessment lacks evidence. As mentioned above, the assessment should communicate the assessor’s thought process. The information collected by the pharmacist/student should justify why the problem is a problem. If there is no subjective or objective information to back up the assessment, the assessment has no basis.

                    Forgetting recommendations on current medications. Pharmacists/students should not forget to include instructions for the patient’s current medications, not just the newly prescribed medications.

                    Forgetting non-pharmacologic recommendations. The plan section also encompasses non-pharmacologic interventions such as referral to another provider, ordering additional laboratory tests, education, or counseling on lifestyle interventions. Pharmacists/students should remember that not all patients require initiation of a new medication.

                    Being vague. When initiating new therapy appropriately, pharmacists/students should always provide specific recommendations with the drug name, dose, and frequency. Vague instructions such as “Initiate hormone blocker therapy” are unhelpful. Similarly, instead of “monitor for side effects,” pharmacists/students can list the specific symptoms that present most commonly.

                    Poor communication. Errors due to poor communication directly hinder the PPCP. Furthermore, clinicians with experience are not necessarily better communicators. Therefore, pharmacists should engage in education/training to constantly improve communication skills. SOAP notes should effectively communicate the pertinent information used to create a plan and document important details for the patient’s medical record.

                    Setting it and forgetting it. The PPCP is not a linear process. While this framework provides clinicians a place to start and a checklist of sections to complete in order, pharmacists should remember to review and revise all sections at any given time. For example, pharmacists may identify new information they should go back to collect as they work on their assessments. Preceptors should encourage their students to occasionally step back and evaluate the completeness and coherence of the SOAP note. Sometimes patient cases will require students to revise sections of the SOAP note they already completed.

                    And a New Case

                    Just before the end of the month, the endocrinologist sends yet another patient with precocious puberty to you. The patient LD is a 9-year old Hispanic female. Her endocrinologist recently diagnosed her with idiopathic precocious puberty and wants to know which treatment you recommend. Her parents also want to know why this is happening to their daughter. Before taking LD’s family from the clinic waiting room, you decide to let your student take charge of this case while you supervise. You ask your student “Now that you have practiced writing SOAP notes and know a little about this disease state, how will you approach the PPCP this time?”

                    The student says to you...

                    “I stored all my notes from the last case on precocious puberty from earlier this month. I have a document containing the guidelines from the Journal of Clinical Endocrinology along with several updated publications that cite all additional first-line medications approved after the original guideline’s release. I will start with the collection of subjective information such as LD’s symptoms and medical history followed by objective information, specifically pertaining to her growth statistics. I should calculate BMI and her height/weight percentiles since precocious puberty is usually associated with accelerated growth. Next, I will examine her relevant lab values. Since the patient is female, I will be looking out for progesterone levels this time. If possible, I shall cross-reference all of the information I collect across multiple sources.”

                    “Before I move onto making an assessment, I understand LD’s parents may feel very concerned about their daughter's condition. I don’t want to forget to address their question. I will explain that idiopathic precocious puberty does not have a definitive cause. To help them better understand, I’ll mention that idiopathic cases may result from anything ranging from a head injury in childhood to exposure to certain chemicals. Regardless of the cause, I will assure them there are several treatment options that may be appropriate for LD at this time. I can walk them through the pros and cons of all the available options.”

                    “Next, I would prompt LD’s parents with open-ended questions to learn more about their major concerns, potential barriers to medication therapy, and insurance eligibility. I know these are important considerations for my assessment. It would also be appropriate for me to engage with LD using appropriate language for a 9-year-old girl. I realize the topic may be uncomfortable to discuss, but without taking initiative of the discussion I may forget to include pertinent details in my SOAP note.”

                    “Finally, using the information I collected about the family’s preferences and LD’s medical history, I will draft the chief complaint, rationale for treatment, goals of therapy, and eventually a completed plan. The plan will include which treatment I recommend along with the dose, frequency, and which adverse effects are most common. I will write when I recommend a follow-up with her endocrinologist and make note of which lifestyle modifications may support her specific treatment. If the endocrinologist is on board, then we can collaboratively implement and follow-up with the patient as appropriate.”

                    You are overjoyed to hear that your student has taken what she learned from the previous case and applied it to this case as well. Although some of the parameters were different, such as the patient’s sex, she was able to anticipate how the changes may impact her SOAP note this time. While you identify a few areas in which she can improve, you are happy that she is continuing to expand her clinical pharmacy knowledge.

                    Conclusion

                    The PPCP model can be applied to any healthcare setting in which pharmacists practice. This comprehensive approach to patient-centered care has established a streamlined method of documenting patient information to be shared among healthcare teams. As the PPCP continues to grow in clinical settings, practicing pharmacists should become familiar with its methods and applications.

                    Pharmacist Post Test (for viewing only)

                    Prepping Pharmacist Preceptors on the Pharmacists’ Patient Care Process (PPCP)
                    Post-test
                    Learning Objectives
                    After completing this continuing education activity, preceptor-pharmacist will be able to
                    • Describe the PPCP model and its uses
                    • Apply the PPCP when students address clinical problems in the workplace
                    • Identify areas where pharmacy students need the most guidance when using the PPCP
                    POST TEST
                    1. Which of the following correctly lists the steps of the PPCP process in order?
                    A. Collect, plan, assess, follow-up, implement
                    B. Collect, assess, plan, implement, follow-up
                    C. Plan, collect, assess, follow-up, implement
                    2. Which of the following best describes the JCPP’s reason for developing the PPCP?
                    A. To establish a more efficient method of medical documentation
                    B. To provide an opportunity for pharmacists to expand their clinical role
                    C. To create a reproducible method of managing patient medications

                    3. Which of the following examples is a common error pharmacy students make when using the PPCP?
                    A. Avoiding discussion involving uncomfortable topics such as those sexual in nature
                    B. Spending too long counseling the patient as opposed to documenting the SOAP note
                    C. Omitting recommendations to follow up with the patient’s primary care provider
                    4. Which of the following is a common source of error with the PPCP?
                    A. Using a single clinical guideline for recommendations
                    B. Spending the most time documenting the assessment section
                    C. Cross-referencing medication lists against too many sources
                    5. A nurse practitioner calls your clinic and would like you and your student to work up a patient with stage II hypertension. The patient is a 64-year-old African American male who is currently taking amlodipine 2.5 mg and chlorthalidone 6.25 mg. His blood pressure was 150/90 mmHg at his last doctors appointment. Which of the following would be an appropriate first step?
                    A. Increase the dose of his medications. The SOAP note does not need to be performed as his blood pressure remains elevated due to subtherapeutic dosing.
                    B. Ask the patient about his/her medication adherence recently. This information will dictate how you decide to approach the patient.
                    C. Contact the patient’s local pharmacy for a complete list of active medications. This will be valuable information to collect prior to assessing the patient.
                    6. A student working on a SOAP note cites a 2012 guideline from Europe. The preceptor notices the student forgets to consider a first-line treatment option that was approved in 2022. What should the preceptor do at this point?
                    A. Call the physician to get his/her opinion on the newly approved medication
                    B. Discuss the importance of citing multiple sources with the student
                    C. When the student finishes the note, add in the missing information
                    7. Laboratory values belong under which of the following sections of the PPCP?
                    A. Assessment
                    B. Objective information
                    C. Subjective information
                    8. Your student is counseling a patient who has dementia. When you ask him to practice how he would counsel the patient, he looks puzzled and asks “What for? He has dementia and he won’t understand anyway.” How do you proceed?
                    A. Ask the student to find guidelines on how to determine when and how dementia patients should be counseled.
                    B. Tell him it was a trick question and that he is correct that dementia patients should never be counseled.
                    C. Explain pharmacists are legally required to offer counseling and he should be prepared if the patient requests it.
                    9. A preceptor and student are working in an ambulatory care clinic. A patient presents to the counter and says she has been experiencing terrible adverse effects from one of her medications. The patient places a bottle of sertraline on the counter. She believes this is the medication causing her persistent insomnia. After talking with the doctor, she has switched to taking it in the morning, but she claims it does not help. How should the preceptor advise the student to continue?
                    A. Advise the student to counsel the patient on ways to manage this adverse effect of sertraline. The student may consult the monograph or other recent guidelines.
                    B. Remind the student that persistent insomnia is a flag to contact the provider. The psychiatrist can handle this as it isn’t in the scope of the preceptor’s practice.
                    C. Advise the student to start by evaluating the patient’s past medical history and evaluating her medications before sending her back to see her doctor.
                    10. A general practitioner refers a patient with mild asthma to your clinic. He has recommended the patient to start SMART therapy and would like you to supply your recommendations through a SOAP note. Under your supervision, the student finishes collecting the necessary objective and subjective information and has begun a draft of the assessment as follows:
                    “The patient needs medication therapy for an untreated indication. According to the GINA guidelines, the patient should initiate a low dose inhaled corticosteroid plus a long-acting beta agonist combination in low doses as needed.”
                    Which of the following best describes the feedback the preceptor should give the student when applying the PPCP model?
                    A. The student has done a good job so far. However, the assessment should also consider patient concerns such as insurance coverage.
                    B. The student has done a good job so far. The student should provide specific doses and monitoring parameters for completeness.
                    C. The student has done a good job so far. The student should call the provider to check if they follow the GINA guidelines, and if not, why.

                    References

                    Full List of References

                    References

                       
                      REFERENCES
                      1. Joint Commission of Pharmacy Practitioners. Pharmacists’ Patient Care Process. Published May 29, 2014. Accessed June 21, 2023. https://jcpp.net/patient-care-process/
                      2. Cooley J, Lee J. Implementing the Pharmacists' Patient Care Process at a Public Pharmacy School. Am J Pharm Educ. 2018;82(2):6301. doi:10.5688/ajpe6301
                      3. Podder V, Lew V, Ghassemzadeh S. SOAP Notes. [Updated 2022 Aug 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 January. https://www.ncbi.nlm.nih.gov/books/NBK482263/
                      4. Takemura Y, Sakurai Y, Yokoya S, et al. Open-ended questions: are they really beneficial for gathering medical information from patients?. Tohoku J Exp Med. 2005;206(2):151-154. doi:10.1620/tjem.206.151
                      5. Taub S. Learning to Decide: Involving Children in their Health Care Decisions. Virtual Mentor. 2003;5(8): virtualmentor.2003.5.8. pfor3-0308. Published 2003 Aug 1. doi: 10.1001/virtualmentor.2003.5.8.pfor3-0308
                      6. Elnicki DM. Learning with emotion: which emotions and learning what?. Acad Med. 2010;85(7):1111. doi:10.1097/ACM.0b013e3181e20205
                      7. Fuqua JS. Treatment and outcomes of precocious puberty: an update. J Clin Endocrinol Metab. 2013;98(6):2198-2207. doi:10.1210/jc.2013-1024
                      8. Bangalore Krishna K, Fuqua JS, Rogol AD, et al. Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium. Horm Res Paediatr. 2019;91(6):357-372. doi:10.1159/000501336
                      9. Lexicomp. Wolters Kluwer Health, Inc. Updated June 20, 2023. Accessed June 21, 2023. https://online-lexi-com.ezproxy.lib.uconn.edu/lco/action/doc/retrieve/docid/pdh_f/129683?cesid=afdPrd0aazi&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dleuprolide%26t%3Dname%26acs%3Dfalse%26acq%3Dleuprolide#rfs
                      10. Lexicomp. Wolters Kluwer Health, Inc. Updated June 6, 2023. Accessed June 21, 2023. https://online-lexi-com.ezproxy.lib.uconn.edu/lco/action/doc/retrieve/docid/pdh_f/128793?cesid=4Ds6TlNfgKm&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dhistrelin%26t%3Dname%26acs%3Dfalse%26acq%3Dhistrelin
                      11. Supprelin LA (Histrelin) Subcutaneous Implant Procedure. Children’s Hospital of Philidelphia. Published May 4, 2021. Accessed June 21, 2023. https://www.chop.edu/treatments/supprelin-la-histrelin-subcutaneous-implant-procedure
                      12. Kaplowitz P, Hoffman, R. Precocious Puberty Medication. Medscape. Updated January 24, 2022. Accessed June 21, 2023. https://emedicine.medscape.com/article/924002-medication
                      13. Harris IM, Phillips B, Boyce E, et al. Clinical pharmacy should adopt a consistent process of direct patient care. Pharmacotherapy. 2014;34(8):e133-e148. doi:10.1002/phar.1459
                      14. Silverman LA, Han X, Huang H, Near AM, Hu Y. Clinical characteristics and treatment patterns with histrelin acetate subcutaneous implants vs. leuprolide injections in children with precocious puberty: a real-world study using a US claims database. J Pediatr Endocrinol Metab. 2021;34(8):961-969. Published 2021 Jun 21. doi:10.1515/jpem-2020-0721

                      What in the World: A Global Look at Healthcare and Drugs-RECORDED WEBINAR

                      About this Course

                      This course is a recorded (home study version) of the CE Finale Encore Webinars.

                       

                      Learning Objectives

                      Upon completion of this application based CE Activity, a pharmacist will be able to:

                      1.       Describe the key components of global healthcare systems
                      2.       Discuss the performance indicators of global health systems
                      3.       Compare pharmaceutical drug spending levels and trends globally
                      4.       Define medical tourism and analyze its associated risks and benefits

                      Release and Expiration Dates

                      Released:  December 16, 2022
                      Expires:  December 16, 2025

                      Course Fee

                      $17 Pharmacist

                      ACPE UAN

                      0009-0000-22-055-H04-P

                      Session Code

                      22RW55-CBA96

                      Accreditation Hours

                      1.0 hours of CE

                      Additional Information

                       

                      How to Complete Evaluation:  When you are ready to submit quiz answers, go to the BLUE take test/evaluation button.

                      Accreditation Statement

                      The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

                      Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs)  for completing the activity ACPE UAN 0009-0000-22-055-H04-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

                      Grant Funding

                      There is no grant funding for this activity.

                      Faculty

                      Bisni Narayanan, PharmD
                      Outpatient Pharmacy Services
                      Yale New Haven Health System
                      Pharmacy Supervisor- Operations
                      Hamden, CT

                      Faculty Disclosure

                      In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

                      • Dr. Narayanan has no relationships with ineligible companies

                      Disclaimer

                      The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

                      Content

                      Post Test

                      World Health Post Test – CE Finale

                      After completing this continuing education activity, pharmacists will be able to
                      1. Describe the key components of global healthcare systems
                      2. Discuss the performance indicators of global health systems
                      3. Compare pharmaceutical drug spending levels and trends globally
                      4. Define medical tourism and analyze its associated risks and benefits

                      Which of the following are key components in global health systems?

                      a. Wait times, patient satisfaction, propensity to result in personal bankruptcy, number of healthcare professionals employed, accreditation

                      b. Type of ownership (public vs. private), patient’s financial obligations, extent of coverage (e.g., preventive, inpatient, outpatient care, etc.)

                      c. Antibiotic resistance, risk of exposure to blood borne diseases, long distance travel, exposure to unusual infections

                      What is a common problem encountered in the universal payer model that is frequently used as a performance measure?

                      a. High out of pocket cost of care

                      b. Long wait times

                      c. Higher mortality rates

                      In comparison to other high-income countries, where does the U.S system’s administrative efficiency rank?

                      a. 9th

                      b. 10th

                      c. 11th

                      A student under your supervision is filling a prescription for a newly approved drug. She asks if it is a biologic and you say no, it is a drug (also called a small molecule) and explain the difference between a drug and a biologic, most of which are specialty medications. She says that she heard that long patent lives on innovative drugs fuel pharmaceutical drug spending. What do you tell her?

                      a. “You are incorrect. The largest contributor to increased spending for pharmaceuticals is specialty medications”

                      b. “You are incorrect. The largest contributor to increased spending for pharmaceuticals is COVID-19 therapeutics.”

                      c. “You are incorrect. The largest contributor to increased spending for pharmaceuticals is over the counter medications.”

                      Handouts

                      VIDEO

                      Teaching and Learning Certificate Program 2024-2027

                      In this comprehensive 28.5 CPE credit activity (with an additional 3.5 hours of optional CE credit), pharmacists, preceptors and residents will learn the concepts of teaching and learning as it relates to classroom, discussion group and experiential learning. Participants may participate at any level they choose, however, a Practice-based Certificate of Achievement will be awarded to those who have completed all phases of the education.

                      I learned so much and the materials learned have greatly help to improve the APPE and PGY-1 Rotations that I managed. Thank you for providing a well-informed, self-paced program that can accommodate working professionals!”  

                      -Lauren C.

                      University of Connecticut Faculty and Adjunct Faculty

                      • For registration without CE credit:  Contact Heather Kleven (heather.kleven@uconn.edu) and provide your NetID for access to the learning management system.  For those without a NetID, please contact Judy Vigneau at  860-486-9576 and  complete the Adjunct Faculty Appointment Form and email to  Judith.vigneau@uconn.edu 
                      • You must be actively (within the last 3 years and willing to take new students) taking UConn students to register for FREE.
                      • For registration with CE credit:  Visit our registration site.  After you register successfully, UCONN will send a confirmation e-mail with details concerning how to proceed.  You must be actively (within the last 3 years and willing to take new students) taking UConn students to register for half price CE.

                      Target Audience

                      Pharmacists, pharmacy preceptors and pharmacy residents who are interested in enhancing their skills in the area of teaching and learning.

                      This activity is not accredited for technicians

                      Learning Objectives

                      Module 1-Teaching Basics

                      Topic Faculty strong>Learning Objectives:
                      Blooms taxonomy-1.5 hour Wick 1. Differentiate between higher and lower order thinking
                      2. Compare and contrast old and new Bloom’s taxonomy
                      3. Describe the different levels of the taxonomy
                      4. Apply the taxonomy for planning lecture/activities
                      Learning objectives: Beginning with the end in mind-1 hour Wick 1. Compare and contrast learning objectives and learning goals
                      2. List the 3 parts of a learning objective
                      3. Write learning objectives that contain a measurable verb
                      4. Develop learning objectives that demonstrate higher order learning
                      Understanding learning styles-1 hour Wick 1. Discuss the concept of learning style
                      2. Evaluate the effectiveness of learning styles tool(s)
                      3. Formulate a view on the role of learning styles
                      Teaching philosophy and portfolios-1.5 hours-OPTIONAL Rickles-OPTIONAL 1. Explain the purpose of a teaching philosophy
                      2. Describe the components of a philosophy
                      3. Discuss the fundamental element of a teaching portfolio
                      4. Describe the material from oneself and from others that are contained in a teaching portfolio
                      5. Create a draft teaching portfolio
                      Syllabus Creation-1 hour Salvo 1. Describe the purpose of a comprehensive syllabus
                      2. List and explain the components of a syllabus
                      3.  Compare and contrast the elements included in various syllabi
                      4. Create or modify a course/rotation syllabus
                      Writing Exam Questions-1 hour Ehret 1. Compare and contrast the difference between true/false and one-best answer type questions
                      2. Construct effective stems and options for multiple choice exam questions
                      3. Detect problems with poorly written test questions
                      Assessments Beyond Examinations- 1.5 hour Wick 1. Explain the difference between criterion and norm-based grading
                      2. Weigh pros and cons of various assessment techniques
                      3. Discuss best practices for developing a rubric
                      4. Develop a rubric for evaluating an active learning activity
                      Designing inter-professional Education Activities-1 hour Dang 1.  List general principles, goals,and competencies of inter-professional education (IPE)
                      2.  Describe opportunities and challenges in developing and implementing IPE activities
                      3.  List strategies for incorporating IPE activities in the didactic or experiential environment
                      Explicit Instruction-1 hour Kleven 1.  Identify the main elements of explicit instruction
                      2.  Analyze a lesson plan outline using explicit instruction functions
                      3.  Explore strategies for processing content

                       

                      Module 2-Taking Teaching into the Pharmacy

                      Topic Faculty Learning Objectives
                      Empowering Preceptors to Teach: Defining Roles & Responsibilities-1 hour Seo 1. Explain the importance of precepting and mentoring in professional development
                      2. Define each of the 4 preceptor roles in teaching clinical problem solving (instructing, modeling, coaching, and facilitating)
                      3. Determine which preceptor role would be appropriate to use to help a resident progress, given specific case examples
                      Assessing your Student Pharmacists or Residents Performance Through Feedback- 1.5 hour Hritcko/Wick 1. Explain the role of the preceptor’s assessment in the overall evaluation of a student pharmacist by the school of pharmacy
                      2.  Develop strategies to collect student performance data throughout the rotational experience
                      3.  Identify methods to ensure that the evaluation of student pharmacists are fair, objective, and accurate
                      4.  List strategies to provide constructive feedback to students who are not achieving rotational goals and objectives
                      5.  Explain the for providing positive feedback to students
                      6.  Demonstrate effective feedback to students
                      Professional Identity-2 hour Wick/Luciano/Yazdanpanah 1.  Describe the professional identity formation process
                      2.  Apply the steps to help student and pharmacists at points in their careers develop a professional identity
                      3.  Identify activities that contribute to Professional Identity develop appropriately
                      Conflict Management & Communication in Pharmacy Practice Experiences- 1.5 hour White 1.  Differentiate between the various types of conflict that pharmacists and/or residents confront at their practice sites
                      2.  Identify common emotional and physical reactions to conflict and possible strategies to defuse the situation
                      3.  Explain how to use communication skills to resolve conflicts between preceptors and students while on their pharmacy practice experiences

                       

                      Module 3: Stepping Up Your Game

                      Topic Faculty Learning Objectives
                      Active learning, tools of the trade-1 hour Kleven
                      1. Define active learning.
                      2. List and describe various active learning strategies
                      3. Determine the best active learning strategy for a given situation.
                      4. Visualize concerns about active learning.
                      Effective Online Teaching & Learning- 1.25 hours Wick/Nolan 1. Recognize best practices in developing online courses
                      2. Describe 5 basic elements of course development
                      3. Differentiate between topics that are amenable to online teaching and those that are not
                      4. List some tricks and tips for making online learning more engaging
                      Integrating Pharmacy students into practice-0.75 hours Hritcko/Wick 1. Describe benefits and potential barriers to successful integration of students into pharmacy practice
                      2. Recognize opportunities to integrate students that will be valuable to students, preceptors, and practice institutions
                      3. Identify strategies and resources available to support pharmacy preceptors
                      Patient Cases:  Discussion, Construction and Assessment-1 hour  Wheeler 1.  Discuss theory behind case-based teaching
                      2.  Identify a strategy for discussing patient cases with students
                      3.  List some tools that could assist students with preparation for case discussion
                      4.  Explain the relationship between patient case design/discussions to Bloom’s taxonomy of learning
                      5.  Identify strategies for assessing student performance

                       

                      Module 4: Playing with the Big Dogs (Go Huskies!)

                      Topic Faculty Learning Objectives
                      A Review of Introductory Statistical Concepts(OPTIONAL)-2 hours Sobieraj 1. Define a framework for the application of evidence-based medicine to clinical practice
                      2. List the criteria that contribute to the quality of a trial
                      3. Distinguish between categorical and continuous variables and how this impacts outcome assessment in a trial
                      4. Interpret descriptive statistics in a given trial
                      5. Define, interpret, and calculate a relative risk, odds ratio, relative and absolute risk, and number need to treat
                      6. Use a 95% confidence interval to determine clinical and statistical significance
                      7. Define type I and type II error and their impact on trial results
                      Incorporating Scholarship into your Day- 1 hour Sobieraj 1. Identify research tips for various steps involved including formulation of a research question, biostatistics for researchers, working with the IRB, obtaining grant funding, and writing a manuscript
                      2. Provide examples of scholarship of teaching from the classroom setting
                      3. Provide examples of scholarship from the preceptor’s perspective
                      Ethical issues in Authorship and Scholarship-1 hour Wick 1. Identify the ICMJE criteria for authorship
                      2.  Discuss issues related to authorship criteria, student-faculty publications, and duplicate publications
                      3. Develop personal approaches for handling authorship criteria, author order, student-faculty publications, and duplicate publication cases
                      Clinical Teaching Venues:
                      Applying Pedagogy in a Big Wide World- 1.5 hours
                      White 1. Compare and contrast the roles and responsibilities of full time tenure track and non-tenure track faculty
                      2. Describe the advantages of being an adjunctive instructor of students and residents
                      3. Describe how to apply teaching skills to various settings
                      4. Describe how to gauge feedback aside from student evaluations of teaching
                      Continuing Professional Development-1 hour Nault 1. Explain the concept of Continuing Professional Development (CPD)
                      2. Outline the steps involved in the CPD process
                      3. Prepare an individualized CPD plan
                      ACPE Continuing Education Standards:  How to plan and deliver an exceptional activity- 1 hour Fitzgerald 1. Describe the ACPE standards for continuing pharmacy education
                      2. Explain the components of a needs assessment
                      3. Identify ways to measure outcomes from continuing education
                       Teaching Example-1 hour  CE Participant 1. Prepare a presentation using teaching and learning concepts
                      2. Deliver a presentation using teaching and learning concepts

                       

                      Activity Faculty

                      Devra Dang, PharmD, BCPS, CDE
                      Associate Clinical Professor, University of Connecticut, School of Pharmacy, Storrs, CT

                      Megan Ehret , PharmD, MS, BCPP
                      Associate Professor, University of Maryland, School of Pharmacy
                      Baltimore, MD

                      Jill Fitzgerald, PharmD
                      Director, Experiential Learning and Continuing Professional Development and Associate Clinical Professor
                      University of Connecticut, School of Pharmacy, Storrs, CT

                      Philip Hritcko, PharmD, CACP
                      Dean, School of Pharmacy
                      University of Connecticut School of Pharmacy, Storrs, CT

                      Nathaniel Rickles, PharmD, PhD, BCPP
                      Associate Professor of Pharmacy Practice
                      University of Connecticut School of Pharmacy, Storrs, CT

                      Marissa Salvo, PharmD, BCACP
                      Associate Clinical Professor Pharmacy Practice,
                      University of Connecticut School of Pharmacy, Storrs, CT

                      Teresa Seo, PharmD, BCPS, FASHP
                      Department of Pharmacy Services
                      UConn Health – John Dempsey Hospital
                      Farmington, CT

                      Diana Sobieraj, PharmD
                      Assistant Professor, Senior Research Scientist and Program Manager
                      University of Connecticut School of Pharmacy/Hartford Hospital Evidence-based Practice Center, Hartford, CT

                      Kathryn Wheeler, PharmD, BCPS
                      Associate Dean of Academic Affairs
                      Associate Clinical Professor of Pharmacy Practice
                      University of Connecticut School of Pharmacy, Storrs, CT   

                      C. Michael White, PharmD, FCCP, FCP
                      Department Head and Professor
                      University of Connecticut School of Pharmacy, Storrs, CT

                      Jeannette Y. Wick, RPh, MBA
                      Assistant Director, Office of Pharmacy Professional Development and Visiting Instructor,
                      University of Connecticut School of Pharmacy, Storrs, CT

                      Heather Kleven

                      Joanne Nault

                      Laura Nolan

                       

                      Faculty Disclosure

                      In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

                      None of the above listed faculty have actual or potential conflicts of interest associated with this presentation.

                      Activity Fees

                      General Registration–  $359.00

                      University of Connecticut Faculty and Adjunct Faculty – Free of charge without continuing education credit; or for $179.50 (50% group discount) continuing education credit.

                      • For registration without CE credit:  Contact Heather Kleven  (heather.kleven@uconn.edu) and provide your net ID for access to the learning management system.  For those without a NetID, please contact Judith Vigneau (judith.vigneau@uconn.edu) complete the Adjunct Faculty Appointment Form.pdf and email to Judith Vigneau (judith.vigneau@uconn.edu)
                      • For registration with CE credit:  Register using Registration Button above. Once registered a confirmation email with further details will be sent.

                      Grant Funding

                      There is no grant funding for this activity.

                      Requirements for Successful Completion

                      For those wishing to receive CE Credit and ACPE Teaching Certificate of Achievement:

                      •  Complete all of the required online modules and participate in the activities, including an evaluation of each activity within the huskyct system.
                      • Prepare and deliver a “teaching experience”
                      • Complete and send in the Verification of Participation form found on the HuskyCT site, and submit to Heather Kleven
                      • Once all of the activities have been completed, Visit our online CE Center at https://pharmacyce.uconn.edu/login.php and complete the course evaluation to have your CE credits uploaded to the CPE Monitor system

                      For those wishing to receive UConn School of Pharmacy Teaching Certificate of Completion (no CE Credit):

                      • Complete all of the required online modules and participate in the activities
                      • Complete the evaluation forms found under each activity on the HuskyCT site
                      • Prepare and deliver a “teaching experience”
                      • Complete and send in to Heather Kleven the Verification of Participation form found on the HuskyCT site

                      ACPE logo

                      The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Twenty-eight and one half contact hours (2.85 CEU’s) will be awarded to pharmacists who view the presentations, participate in the activities and complete the evaluations, and deliver their teaching example. Statements of credit for 0009-0000-24-030-H04-P, will be sent to CPE Monitor and can be printed from your CPE Monitor Profile. A Certificate of Achievement will be sent to those who complete all activities, evaluations and submit a complete Verification of Participation Form. Upon successful completion of the optional activities  ACPE UAN 0009-0000-21-035-H04-P,  and ACPE UAN 0009-0000-21-036-H04-P we will award 1.5 contact hours (0.15 CEU’s) and 2.0 contact hours (0.20 CEU’s), respectively.

                      Initial release date:  July 15, 2024
                      Planned expiration date:  July 15, 2027

                      Disclaimer:
                      The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

                      UConn Medical Writing Certificate

                      Emblem saying one of the best writing classes in Reedsy's 2023 class

                       

                      In this comprehensive 30.5 hour CPE credit activity, pharmacists, and pharmacy technicians (and any other interested healthcare providers) will learn the concepts and mechanics of medical writing from continuing education activities to policy writing to medical marketing.  A Practice-based Certificate of Achievement will be awarded to those who have completed the pre-requisites and all phases of this practice-based certificate program 0009-0000-20-076-B04-P and 0009-0000-20-076-B04-T.

                      Learning Objectives for Pharmacists and Technicians:
                      At the completion of this activity, the participant will be able to:

                      • Demonstrate the ability to apply the principles of good writing to common documents used in pharmacy, medicine, regulatory writing

                      • List specific approaches needed for various types of medical writing

                      • Write a variety of documents pertaining to medicine and pharmacy, including continuing education activities, slide kits, and scholarly works

                      • Assemble a portfolio of writing pieces that demonstrate the learner’s areas of expertise

                      See below to see all of the activities and their  learning objectives

                      To Register Click on Orange Registration Button above

                      Activity Learning Objectives Number of Credit Hours
                       Introduction to Medical Writing 0
                      1. Fundamentals of Writing -List the principles of good writing
                      -Recognize common errors in one’s own and others’ writing
                      -Apply Plain Language Guidelines
                      -Analyze writing samples for error, readability, and flow
                      3
                      2. References and Libraries -Compare and contrast reference types
                      -Select appropriate references
                      -Identify copyright infringement pitfalls and how to avoid them
                      -Compose AMA citations for common reference types
                      2
                      3.  Working with Clients -Describe clients’ typical expectations from medical writers
                      -List the necessary components in an LOA or contract
                      -Contrast clients expectations with one’s own strengths and limitations
                      -Complete an analysis of one’s readiness to pursue medical writing
                      0.75
                      4.  Developing Visuals

                      -Discuss when it may be appropriate to add visual aids into your writing
                      -List the basic components needed for constructing tables and figures
                      -Given information, construct a suitable table or figure
                      1
                      5. Scholarly Works -Outline the various types of scholarly publications
                      -Recall the key sections of scholarly manuscripts
                      -Identify and consult journal specific “Authors’ Guide” throughout the writing process
                      -Demonstrate ability to effectively peer review a manuscript
                       

                      2

                      6. Continuing Pharmacy & Medical Education -Discuss the purpose of quality continuing education
                      -Describe the elements of a good needs assessment proposal to obtain funding for continuing education
                      -Recognize the medical writer’s role in continuing education development
                      -Produce a 1200 word document with two learning objectives and three post-test questions that incorporates the principles taught here
                       

                      2

                      7.  Short Pieces & Educational Materials

                      -Recall available  educational media platforms
                      -Select a media platform tailored towards a specific audience
                      -Describe the essential components of patient education brochures and professional posters
                      -Evaluate the effectiveness of circulating patient education brochures and professional posters
                      2
                      8. Powerful Presentations -Identify the techniques necessary to create engaging presentations
                      -Demonstrate the ability to construct slide decks and graph inserts properly
                      -Differentiate high quality presentations from low quality presentations
                       

                      2

                      9. Communication -Describe informative, succinct, and professional correspondence with attention to protected health information
                      -Format professional documents of all types
                      -Recall the elements of a concise invoice
                      -Dissect customer complaints
                       

                      0.75

                      10. Research Documents -Identify  the purpose  of the various research documents
                      -List the different  types of writing styles
                      -Demonstrate the ability  to reference relevant resources
                       

                      2

                      11. Regulatory Writing -Describe  the purpose  of regulatory writing and its importance
                      -Identify regulatory documents  required for target products  at various development stages
                      -Use regulatory guidance to format and create proper documents
                      -Define the internal review process
                      1
                      12. Medical Marketing of Healthcare Products -List the ways in which writing for medical marketing projects differs from other types of writing
                      -Recall regulations that govern medical marketing
                      -Identify requirements that most pharmaceutical companies insist upon
                       

                      1

                      13. Finding Employment -List three ways to begin a search for medical writing jobs
                      -Identify companies (or types of companies) that hire medical writers
                      -Match your interests and abilities to suitable medical writing jobs
                       

                      0.5

                      14. Policy Writing

                      -Define Standard Operating Procedure
                      -Describe the components of the SCP document
                      -Discuss the format and writing style
                      0.5
                      Submission of Writing Example (Final Project) To complete the UConn Medical Writing Certificate Program, participants must produce a final project of approximately 5500 to 6000 word. Each participant will select a final project in collaboration with a UConn Medical Writing Certificate Program faculty member. The participant and the faculty members will select the type of assignment (e.g., needs assessment, continuing education activity homestudy, manuscript for submission to a journal), agree on a formal outline, and establish deadlines for draft and revision submissions. 10

                       

                      Activity Faculty

                      Kelsey Giara, PharmD
                      Medical Writer
                      Pelham, NH

                      Kelsey Fontneau Maytas, PharmD
                      CVS Pharmacy Manager
                      Shelton, CT

                      Sara Miller, PharmD
                      CVS Pharmacist
                      Franklin, MA

                      Bisni Narayanan, PharmD
                      Specialty Clinical Pharmacist
                      Yale New Haven Health
                      Hamden, CT

                      Stefanie Nigro, PharmD, BCACP, BC-ADM
                      Associate Clinical Professor
                      UConn School of Pharmacy
                      Storrs, CT

                      Paul Staffieri, PharmD
                      Clinical Manager
                      The Mount Sinai Hospital
                      New York, NY

                      Angela Su
                      PharmD Candidate 2024
                      University of Connecticut School of Pharmacy
                      Storrs, CT

                      Conner Walker, PharmD
                      Medical Writer
                      WriteAngle, Inc.
                      Torrington, CT

                      Jeannette Y. Wick, RPh, MBA
                      Director, Office of Pharmacy Professional Development and Visiting Instructor,
                      University of Connecticut School of Pharmacy, Storrs, CT

                       

                      Faculty Disclosure

                      In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

                      None of the above listed faculty have a relationship with ineligible companies.

                       

                      Acitivity Fees

                      General Registration– $1999.00

                      • Register above using the Orange Registration Button.  Once registered a confirmation email with further details will be sent

                      Grant Funding

                      There is no grant funding for this activity.

                      Requirements for Successful Completion

                      For those wishing to receive CE Credit and ACPE Certificate of Achievement:

                      • Complete all of the required online modules and participate in the activities, including an evaluation of each activity within the HuskyCT system.
                      • Prepare and submit a “writing example”
                      • Complete and send in the Verification of Participation form found on the HuskyCT site, and submit to Joanne Nault
                      • Once all of the activities are complete, visit our online CE Center at https://pharmacyce.uconn.edu/login.php and complete the course evaluation to have your CE credits uploaded to the CPE Monitor system

                        ACPE logoThe University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Thirty and one half contact hours (3.05 CEU’s) will be awarded to pharmacists and pharmacy technicians who view the presentations, participate in the activities and complete the assignments and evaluations, and deliver their final submission. Statements of credit for ACPE UAN 0009-0000-23-057-B04-P/T will be automatically sent to CPE Monitor and can be printed from your CPE Monitor Profile. A Certificate of Achievement will be sent to those who complete all activities, evaluations and submit a complete Verification of Participation Form.

                        Initial release date:  December 1, 2023
                        Planned expiration date:  November 30, 2026

                        Disclaimer:
                        The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

                        Teaching Philosophy and Portfolios (Optional)

                        Learning Objectives:

                        1. Explain the purpose of a teaching philosophy
                        2. Describe the components of a philosophy
                        3. Discuss the fundamental element of a teaching portfolio
                        4. Describe the material from oneself and from others that are contained in a teaching portfolio
                          Create a draft teaching portfolio

                        Activity Faculty

                        Nathaniel Rickles, PharmD, PhD, BCPP
                        Associate Professor of Pharmacy Practice
                        University of Connecticut School of Pharmacy, Storrs, CT

                        Faculty Disclosure

                        In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

                        Dr. Rickles does not have any relationship with an ineligible company.

                        Activity Fees

                        This activity costs $15

                        Grant Funding

                        There is no grant funding for this activity.

                        Requirements for Successful Completion

                        ACPE LogoThe University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. One and one half contact hours (0.15 CEU’s) will be awarded to pharmacists who view the presentation, and pass a post test with a 70% or better.  Statements of credit for 0009-0000-21-035-H04-P, will be sent to CPE Monitor and can be printed from your CPE Monitor Profile.

                        Initial release date:  July 15, 2021
                        Planned expiration date:  July 15, 2024

                        Disclaimer:
                        The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.